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ABSTRACT 
Molecular and Physiological Mechanisms of Toxin Resistance in Toad-Eating Snakes 
by 
Shabnam Mohammadi, Doctor of Philosophy 
Utah State University, 2017 
 
Major Professor: Dr. Alan H. Savitzky 
Department: Biology 
 
Many plants and animals are defended by toxic compounds, and circumvention of 
those defenses often has involved the evolution of elaborate mechanisms for tolerance or 
resistance of the toxins. Toads synthesize potent cardiotonic steroids known as 
bufadienolides (BDs) from cholesterol and store those toxins in high concentrations in 
their cutaneous glands. Those toxins protect toads from the majority of predators, 
including most snakes that readily consume other species of frogs. BDs exert their effect 
by inhibiting ion transport by the Na+/K+-ATPase (NKA). This ubiquitous 
transmembrane enzyme consists of a catalytic alpha-subunit, which carries out the 
enzyme's functions, and a glycoprotein beta-subunit, which provides structural stability. 
Inhibition of the NKA causes highly elevated intracellular Ca
2+
 levels and results in often 
lethal increased cardiac contraction strength. Molecular resistance to bufadienolides in 
snakes is conferred by mutations in the alpha-subunit of the Na
+
/K
+
-ATPase. I have 
found that these mutations are more prevalent in snakes than previously suggested, and 
that many genetically resistant species do not feed on toads. This suggests that possession 
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of the mutations alone does not carry substantial negative consequences, and that feeding 
on toads may have been an ancestral habit in some groups of snakes. I have further found 
evidence of tissue-specific variation in resistance to bufadienolides, and gene expression 
investigations revealed that the bufadienolide resistance-conferring mutations are not 
expressed equally among different organs. Variation in resistance among different tissues 
indicates that possession of the mutations does not protect all cells equally. Finally, by 
testing the physiological responses of resistant snakes to exposure to cardiotonic steroid, I 
have found that feeding on toads incurs negative consequences and that toad-specialized 
resistant snakes respond differently from nontoad-specialized resistant snakes. The 
presence of physiological consequences of toxin exposure may explain why feeding on 
toads has been lost in some lineages of snakes that retain resistance-conferring mutations. 
In summary, these findings indicate that genetic resistance of the Na+/K+-ATPase is 
necessary in order for snakes to survive acute toxicity of bufadienolides, but it is not 
sufficient to explain fully the physiological mechanisms involved in dealing with chronic 
exposure to the toxins. 
(186 pages) 
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PUBLIC ABSTRACT 
 
Molecular and Physiological Mechanisms of Toxin Resistance in Toad-Eating  
Snakes 
Shabnam Mohammadi 
 
Many plants and animals are defended by toxic compounds, and the evasion of 
those defenses by predators often has involved the evolution of elaborate mechanisms for 
resistance to those toxins. Toads are chemically defended by cardiotonic steroids known 
as bufadienolides, which exert their lethal effects by binding to, and inhibiting, Na
+
/K
+
-
ATPases on cell membranes. Select lineages of snakes from several geographic regions 
have evolved resistance to bufadienolides through mutations in the gene encoding their 
Na
+
/K
+
-ATPases and are able to feed on toads without suffering the normally lethal 
effects. I have found that mutations for resistance of Na
+
/K
+
-ATPases are more prevalent 
in snakes than previously suggested, and that many genetically resistant species do not 
feed on toads. This suggests that possession of the mutations alone does not carry 
substantial negative consequences, and a diet of toads may have been an ancestral trait in 
some groups of snakes. I have further found that certain organs of resistant snakes are 
better protected from the toxins than others. Variation in resistance among different 
organs indicates that the physiology involved in tolerance of the toxins is complex and 
that possession of resistance mutations does not protect all cells equally. Further 
investigations revealed that the mutations are not expressed equally among different 
organs. Finally, by testing the physiological responses of resistant snakes to cardiotonic 
  
vi 
steroid exposure, I have found that the exposure incurs negative physiological 
consequences and that the physiological responses differ between resistant snakes that are 
toad-specialized and those that are not. The presence of physiological consequences of 
toxin exposure may explain why feeding on toads has been lost in some lineages of 
snakes that retain resistance-conferring mutations. In summary, these findings indicate 
that genetic resistance of the Na+/K+-ATPase is necessary in order for snakes to survive 
acute toxicity of bufadienolides, but it is not sufficient to explain fully the physiological 
mechanisms involved in dealing with chronic exposure to the toxins.  
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CHAPTER I 
INTRODUCTION 
 
Cardiotonic Steroids and their Modes of Action 
 Many plants and animals are defended by toxic compounds, and circumvention of 
those defenses often has involved the evolution of elaborate mechanisms for tolerance or 
resistance of the toxins (Geffeney et al. 2002; Feldman et al. 2009; Agrawal et al. 2012; 
Ujvari et al. 2015; Mohammadi et al. 2016a). Toads synthesize potent cardiotonic 
steroids known as bufadienolides (BDs) from cholesterol and store those toxins in high 
concentrations in their cutaneous glands (Krenn and Kopp 1998). Those toxins protect 
toads from the majority of predators, including most snakes that readily consume other 
species of frogs (Phillips and Shine 2004; Phillips and Shine 2006; Mohammadi et al. 
2016b). Nonetheless, toad-eating (bufophagy) has evolved in at least 17 genera of snakes 
(Mohammadi et al. 2016a). 
Bufadienolides are one of two classes of cardiotonic steroids, cardenolides being 
the other (Krenn and Kopp 1998; Dvela et al. 2007). All cardiotonic steroids share the 
general structure of a steroidal body with a lactone ring on carbon 17 (Dvela et al. 2007). 
These compounds exert their effect by inhibiting ion transport by the Na+/K+-ATPase 
(NKA; Schoner 2002). This ubiquitous transmembrane enzyme consists of a catalytic 
alpha-subunit, which carries out the enzyme’s functions, and a glycoprotein beta-subunit, 
which provides structural stability (Köksoy 2002; Aperia 2007). Inhibition of the NKA 
causes highly elevated intracellular Ca
2+
 levels and results in often-lethal increased 
strenfth of cardiac contraction (Barry and Bridges 1993; Schoner 2002). Molecular 
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resistance to BDs in snakes is conferred by mutations in the alpha-subunit of the 
NKA (encoded by the gene ATP1a3; Ujvari et al. 2015; Mohammadi et al. 2016a). These 
mutations significantly lower the toxins’ affinity to the enzyme (Ujvari et al. 2015). Such 
a system of chemical defense and resistance between predator and prey exemplify the co-
evolutionary arms races that may drive genetic and phenotypic changes in the 
participating organisms. The ability to feed on toxic prey is an important innovation in 
snakes. However, our knowledge of the mechanisms underlying this innovation remains 
superficial.  
 
Molecular Resistance to Bufadienolides in Snakes 
 The molecular mechanisms of resistance to BDs in bufophagous snakes remained 
unknown until recently published work revealed amino acid substitutions in the BD 
binding pocket of one of three NKA gene paralogs (ATP1a3; Ujvari et al. 2015; Ujvari et 
al. 2016; Mohammadi et al. 2016a; the other two paralogs remain uninvestigated). Site-
directed mutagenesis has revealed that these mutations confer significantly increased 
resistance to BDs at the cellular level (Ujvari et al. 2015), and dose-response experiments 
have revealed a high level of resistance to acute exposure at the whole-body level in 
snakes that possess the mutations (Mohammadi et al. 2016b). Evidence from parallel 
systems of toxin adaptation suggests that the presence of amino acid substitutions in the 
NKA is not the only adaptation that confers resistance to steroidal toxins. Cardenolide-
resistant insects, for example, use a variety of mechanisms to deal with the toxins, in 
addition to target-site insensitivity of the NKA (Scudder and Meredith 1982; Despres 
2007; Petschenka et al. 2013; Bramer et al. 2015). To understand the origin and retention 
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of a trait, it is essential to determine the physiological mechanisms associated with 
possession of the trait. Therefore, it is necessary to combine genetic screens with 
physiological and functional assays.  
 
Physiological Mechanisms of Bufadienolide Resistance in Snakes 
 Adrenal hormones are likely candidates for promoting a resistant snake’s 
assimilation and digestion of BDs. Previous work has revealed a strong association 
between adrenal gland enlargement and bufophagy in snakes (Mohammadi et al. 2013). 
These endocrine glands produce the steroidal hormones aldosterone and corticosterone 
(Norris 2007). Aldosterone is a mineralocorticoid hormone known to signal increased 
expression of NKA, especially in the heart (Oguchi et al. 1993; Ikeda et al. 1991; Weber 
2001; Slayer et al. 2013). This suggests a possible compensatory role in counteracting the 
NKA-blocking effects of ingested cardiotonic steroids. It is therefore possible that the 
adrenal enlargement previously observed in bufophagous snakes is due in part to an 
increased number of aldosterone-producing cells. Corticosterone is a glucocorticoid 
hormone that is often used as a measure of physiological stress (Rich and Romero 2005; 
French et al. 2007; Hews and Baniki 2013). Previous studies have shown that an 
organism under sustained physiological stress will respond with enlargement of the 
adrenal glands (Fickess 1963; Ulrich-Lai et al. 2006). It is possible that physiological 
stress is a consequence of chronic exposure to bufadienolides through a diet rich in toads. 
Therefore the adrenal enlargement observed in bufophagous snakes might be due in part 
to stress resulting from consumption of the toxins. It is also possible that a combination 
of increased corticosterone and aldosterone contributes to that enlargement. 
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Physiological Consequences of Bufophagy in Snakes 
 Beyond the scope of the endocrine system, there are strong effects of cardiotonic 
steroids on cardiac contractility (Barry and Bridges 1993; Prassas and Diamandis 2008). 
These effects have been studied extensively in mammalian systems, as these steroids 
have a long history of use in the treatment of congestive heart failure (Barry and Bridges 
1993; Ruch et al. 2003; Nesher et al. 2007; Schoner and Scheiner-Bobis 2007; Prassas 
and Diamandis 2008; Wansapura et al. 2016). The increased intracellular Ca
2+ 
caused by 
inhibition of the NKA in myocardial cells results in an overload of Ca
2+
 in the 
sarcoplasmic reticulum (Ruch et al. 2003). To compensate for this overload the 
sarcoplasmic reticulum delivers Ca
2+ 
at higher concentrations and faster rates to muscle 
fibers, thereby causing stronger and faster cardiac contractions (Barry and Bridges 1993). 
One previous study investigated the effects of crude toad secretions on cardiac 
contractility in both resistant and non-resistant snakes, and found that the compounds 
generally caused tachycardia (Licht and Low 1968). However, other studies have shown 
that individual compounds can have differing effects on cardiac contractility (reviewed 
by Dvela et al. 2007). 
 
Dissertation Overview 
 The chapters that follow constitute an investigation of the molecular and 
physiological mechanisms of bufadienolide resistance in snakes. Chapter II provides 
evidence that molecular resistance to bufadienolides is widespread in snakes and not 
tightly coupled with bufophagy. Chapter III shows that tissue-level resistance to 
bufadienolides is not uniform among different organs in the body of resistant snakes. 
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Furthermore, Chapter IV shows that gene expression levels of ATP1a3 are also not equal 
among different organs. Finally, Chapters V and VI provide evidence for the presence of 
physiological consequences of bufophagy. 
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CHAPTER 2 
TOXIN-RESISTANT ISOFORMS OF NA
+
/K
+
-ATPASE IN SNAKES DO NOT 
CLOSELY TRACK DIETARY SPECIALIZATION ON TOADS 
 
 
 Toads are chemically defended by bufadienolides, a class of cardiotonic steroids 
that exert toxic effects by binding to and disabling the Na
+
/K
+
-ATPases of cell 
membranes. Some predators, including a number of snakes, have evolved resistance to 
the toxic effects of bufadienolides and prey regularly on toads. Resistance in snakes to 
the acute effects of these toxins is conferred by at least two amino acid substitutions in 
the cardiotonic steroid binding pocket of the Na
+
/K
+
-ATPase. We surveyed 100 species 
of snakes from a broad phylogenetic range for the presence or absence of resistance-
conferring mutations. We found that such mutations occur in a much wider range of taxa 
than previously believed. Although all sequenced species known to consume toads 
exhibited the resistance mutations, many of the species possessing the mutations do not 
feed on toads, much less specialize on that food source. This suggests that either there is 
little performance cost associated with these mutations or they provide an unknown 
benefit. Furthermore, the distribution of the mutation among major clades of advanced 
snakes suggests that the origin of the mutation reflects evolutionary retention more than 
dietary constraint. 
 
1. Introduction 
 Many plants and animals are defended by toxic compounds, and circumvention of 
those defenses often has involved the evolution of elaborate mechanisms for resistance to 
  
11 
the toxins [1–5]. Among animals, some defensive compounds are synthesized from 
nontoxic precursors, whereas others are acquired and stored (sequestered) from 
environmental sources, primarily diet, and redeployed defensively [3,6–8]. Toads 
(Bufonidae) synthesize potent cardiotonic steroids known as bufadienolides (BDs) from 
cholesterol and store those toxins in high concentrations in their cutaneous glands [6]. 
Those toxins protect toads from the majority of predators, including many snakes that 
readily consume other species of frogs. Nonetheless, specialized bufophagy (the 
consumption of toads as a major (> 80%) dietary component) or the sequestration of 
dietary BDs for defense occur in at least three genera of snakes on different continents 
(Table 2-1) [9–11]. Such systems of chemical defense and resistance between prey and 
predators exemplify the co-evolutionary arms races that can drive molecular and 
physiological changes in the participating organisms [12]. 
Studies involving independently evolved systems of chemical defense and their 
circumvention by predators have shown that resistance to toxic dietary items can be 
accomplished by similar molecular changes that confer target-site insensitivity [11–15]. 
Furthermore, there is evidence that tight coupling between resistance of predators and 
toxicity of prey in a co-evolutionary arms race can result when the predator incurs a 
performance cost from resistance [12]. When a toxin targets a critical cellular function, 
phenotypes resistant to that toxin sometimes evolve through parallel or convergent 
mutations of the same gene across multiple species or populations [11–13,16–18]. 
BDs and other cardiotonic steroids, including the plant-derived cardenolides 
(CDs) [19,20], target the ubiquitous cell-membrane enzyme Na
+
/K
+
-ATPase, inhibiting 
the transport of sodium ions out of the cell and potassium ions in. The Na
+
/K
+
-ATPase 
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molecule consists of a catalytic α subunit, with 10 transmembrane segments, which 
carries out the functional activities of the enzyme, and a glycosylated β subunit, with one 
transmembrane segment, which provides structural stability (Figure 2-1A) [22–25]. The 
H1-H2 extracellular loop of the α subunit comprises a significant portion of the binding 
pocket for cardiotonic steroids (Figure 2-1B). However, some sites on the H3-H4 and the 
H5-H6 extracellular loops also contribute to the binding pocket to a lesser extent [13], 
and recent evidence suggests that mutations near the C-terminal end also confer 
resistance [26].  
Several studies have found that two amino acid substitutions, one at position 111 
and the other at or near position 122 of the H1-H2 loop, confer lowered affinity for 
cardiotonic steroids in resistant insects, lizards, and snakes [11,13–15,27–30]. Dobler et 
al. [13] identified various amino acid replacements encoded by the gene for Na
+
/K
+
-
ATPase, including replacements at two positions in the H1-H2 extracellular loop, of 
several independent lineages of CD-resistant insects. Ujvari et al. [15] identified two 
similar amino acid substitutions in the H1-H2 extracellular loop of BD-resistant species 
of varanid lizards: a leucine (L) replaces a glutamine (Q) at position 111 (Q111L) and an 
arginine (R) replaces a glycine (G) at position 120 (G120R). Together, the Q111L and 
G120R substitutions were shown to confer significantly reduced affinity of Na
+
/K
+
-
ATPase for BDs when transfected into human kidney cells [15]. These two substitutions 
were subsequently found to occur in several species of snakes that are resistant to BDs 
[11]. Mohammadi et al. [29] investigated the extent of resistance conferred at the whole-
body level in a species of snake known to possess the Q111L and G120R mutations but 
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known to feed only rarely on toads. Those snakes were able to withstand concentrations 
of intraperitoneally injected BDs 200-fold higher than the mouse LD50. 
Site-directed mutagenesis of the gene that encodes for Na
+
/K
+
-ATPase in 
Drosophila melanogaster has revealed that the Q111L substitution alone, in CD-resistant 
insects, contributes slightly to resistance, whereas the mutation at position 122 (N122H, 
with histidine replacing asparagine) contributes significantly [13]. The N122H 
substitution results in a substantial biochemical change, replacement of a neutral amino 
acid by a positive one [13], so it is no surprise that this mutation significantly alters the 
sensitivity of insect Na
+
/K
+
-ATPases to CDs. Furthermore, since the G120R mutation in 
BD-resistant reptiles results in the same biochemical change two amino acid positions 
away from the N122H mutation of insects [11,15,29], it is safe to assume that the G120R 
mutation is likely the major contributor to lowered BD affinity in mutant reptile Na
+
/K
+
-
ATPases [15]. 
Adaptation to similar dietary toxins through the evolution of virtually identical 
amino acid substitutions across a range of taxa, spanning invertebrates and vertebrates, 
represents a striking example of convergent evolution. Previous studies have typically 
concluded that the resistance-conferring mutations co-occur with dietary specialization 
[11–14], suggesting that resistance to dietary toxins occurs only under strong selective 
pressure. 
A recent survey of genetic resistance to cardiotonic steroids across the Metazoa 
[11] noted a strong correspondence in snakes between Q111L and G120R mutations and 
predation on toads. Ujvari et al. [11] recovered three origins of resistance in their sample 
of 27 snakes and associated each origin with the assumption of toad-eating habits. Here 
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we expand the sample to 100 species of snakes, finding many more species that possess 
the resistance-conferring Q111L and G120R substitutions. We reconstruct the ancestral 
states for these taxa and find, in contrast to the more limited taxon sampling of Ujvari et 
al. [11], that the mutations for resistance occur more widely among snakes than does 
either specialized or opportunistic bufophagy. Indeed, the mutations occur in some 
species with diets restricted to prey that lack cardiotonic steroids. This lack of close 
correspondence between the mutation and toad consumption suggests that, in contrast to 
similar studies of predators on amphibians defended by tetrodotoxin (which blocks 
sodium channels) [12], resistance to BDs does not impose a significant performance cost 
or there is some other, unknown benefit. Furthermore, our results suggest that target-site 
insensitivity is necessary, but may not be sufficient, to permit dietary specialization on 
toads or the sequestration of dietary BDs. 
 
2. Materials and Methods 
(a) Selection and classification of study taxa  
Because our goal was to test whether a mutated Na
+
/K
+
-ATPase alone could 
explain the evolution of specialized bufophagous habits, we began by sequencing part of 
the ATP1a3 gene in previously unsequenced toad-eating species. Our criteria for toad-
eating habits is restrictive and does not include diet data from general and secondary 
sources, which classify some species based upon anecdotal dietary records or 
assumptions of diet based on the predator’s habitat. We based our dietary classification 
(Table 2-1) almost exclusively on dietary studies and other published reports in the 
primary literature. However, we also scored as (potentially) bufophagous those species 
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that possess the resistance mutations and have a broad diet of amphibians, even in the 
absence of specific reports of toads in their diet. This conservative assumption maximizes 
the perceived co-occurrence of the mutations and bufophagy. 
We also broadened our genetic sampling to include nontoad-eating sister taxa of 
the specialized and facultative toad-eaters, to determine whether the distribution of 
mutations for BD resistance closely correspond to toad-eating habits. Combined with 
other sequence data available in GenBank, we included data for 100 species of snakes 
(see supporting online materials). Although not shown in the figures, our phylogenetic 
analysis included 21 lizards (18 of them in the genus Varanus, plus one dactyloid, one 
agamid, and one scincid), as well as Sphenodon, Alligator, Gallus, and Xenopus, as 
outgroups. 
 
(b) Sequence data  
Ethanol-preserved tissue samples were obtained from the Louisiana State 
University Museum of Zoology. Other tissue samples were acquired from snakes 
collected in the field in Louisiana (permit no. LNHP-12-064), Utah (permit no. 
1COLL9134), and Nebraska (permit no. 477) or from previously frozen and ethanol-
preserved specimens in our laboratories at Utah State University and Kyoto University. 
DNA was isolated from tissues using either the DNeasy Blood and Tissue Kit (Qiagen
TM
) 
or the Phire Direct PCR Kit (Thermo Fisher
TM
). The H1-H2 extracellular loop of the 
ATP1a3 gene was amplified using the primers (Integrated DNA Technologies ®) 
ATP1a3Fwd (CGAGATGGCCCCAATGCTCTCA) and ATP1a3Rvs 
(TGGTAGTAGGAGAAGCAGCCGGT), which were modified from Moore et al. [31]. 
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Amplified DNA product was purified using the Wizard SV Gel and PCR Clean-Up 
System (Promega
TM
). DNA was sequenced on an ABI 3730xo Genetic Analyzer using 
BigDye Terminator Kit V.3.1. Sequences were aligned and analyzed using Geneious v. 
6.1.8 (Biomatters Ltd.). Sequences were translated to amino acids, and the 
hydrophobicity and isoelectric points of each residue were calculated using Geneious v. 
6.1.8 (Biomatters Ltd.). Some sequences were obtained from GenBank (accession 
numbers KP238131-KP23176, XM_007437572, and AZIM01015831). DNA sequence 
data generated in this study have been submitted to GenBank with the accession numbers 
KU738063-KU738139, KU933521, and KU950321. 
 
(c) Ancestral state reconstruction  
Stochastic character mapping [32] was used to obtain probabilistic reconstructions 
of ancestral states for nonsynonymous substitutions at amino acid positions 111 (2
nd
 
codon position, A vs. T) and 120 (1
st
 codon position A vs. G or C) (see Results). 
Character mapping was based on the time-calibrated squamate reptile phylogeny from 
Zheng and Weins [33], which we pruned to retain only the 121 species for which we had 
ATP1a3 sequences. Sequences were available for seven species that were not included in 
Zheng and Wiens’ phylogeny, although congeners were included in that tree. Therefore, 
we considered the sequenced species to be equivalent to their congeners for the purposes 
of the analysis, placing them at the same point on the phylogeny. The included species 
were Conophis vittatus (replacing C. lineatus), Rhabdophis leonardi (replacing R. 
nuchalis), Cyclophiops semicarinatus (replacing C. major), Dendrelaphis subocularis 
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(replacing D. tristis), D. punctulatus (replacing D. bifrenalis), Causus maculatus 
(replacing C. rhombeatus), and Vipera aspis (replacing V. ammodytes). 
We first obtained the joint posterior distribution of ancestral character states and 
the transition matrix for each nucleotide position. We allowed all transition rates to differ 
and assumed a flat prior on the root states. Posteriors were inferred using Markov chain 
Monte Carlo (MCMC) with a 10,000 iteration burn-in, 100,000 sampling iterations, and a 
thinning interval of 50 iterations. Two chains were run to evaluate convergence of the 
MCMC algorithm to the stationary distribution, and results were combined for inference. 
Stochastic character maps were simulated over the posterior distribution of the transition 
matrix and thus account for uncertainty in transition rates. This analysis was conducted 
using the make.simmap function in the R package phytools [34].  
 In contrast to CD-resistant insects, in which position 122 of Na
+
/K
+
-ATPase has a 
positive amino acid, we always observed a shift from a neutral to positive amino acid at 
position 120 in BD-resistant snakes. Therefore, we asked whether such a pattern could be 
explained by chance under the null model that both changes would have an equivalent 
effect and are equally likely. Our calculations were made over the posterior distribution 
of the character state reconstructions, thus accounting for uncertainty in the number of 
changes. 
 We next compared models of correlated versus independent evolution for the two 
amino acids. We fit continuous-time Markov models for trait evolution, either with 
separate transition matrixes for each amino acid (independent evolution model) or with a 
single transition matrix for the pair of amino acids (dependent, or correlated, evolution 
model) [34]. We obtained maximum likelihood parameter estimates using BayesTraitsV2 
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(25 starts were used for parameter estimation). Models were then compared using a 
likelihood ratio-test as described by Pagel [35]. 
 
3. Results 
(a) Amino acid substitutions  
Our analysis of Na
+
/K
+
-ATPase α3 subunit sequences for the H1-H2 extracellular 
loop revealed substitutions at several residues. In our survey of 100 species of snakes, we 
found two consistent amino acid substitutions in all taxa known to consume toads. At 
position 111 we found the Q111L substitution and at position 120 the G120R 
substitution, a result that is consistent with previously published findings (Figure 2-1C) 
[11]. These two substitutions always occurred together and almost always involved the 
same nucleotide changes. Notably, in addition to the occurrence of the Q111L and 
G120R substitutions in all bufophagous species included in our analysis, we found many 
instances of these same two substitutions (hereinafter, “resistance mutations”) across the 
phylogeny of snakes, including many species that rarely or never feed on toads. In 
addition to the Q111L and G120R substitutions, several other substitutions occurred at 
various positions among different groups. However, these changes are not known to alter 
the biochemical properties of the binding pocket to any significant extent, and thus are 
believed to be of no major functional consequence [11]. 
 
(b) Ancestral state reconstruction 
 Stochastic character mapping supported multiple gains and losses of the resistance 
mutations across the tree (Figure 2-2). We found evidence of 11 (95% credible intervals 
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[CIs] 2-18) transitions from A to T (with 8 reversals, 95% CIs 2-19) at position 2 of 
amino acid 111 and 11 (95% CIs 1-33) transitions from A to G (with 10 reversals, 95% 
CIs 1-32) at position 1 of amino acid 120. Given the total number of transitions and the 
paucity of taxa with only one of the resistance mutations, we can confidently reject the 
null model that changes at amino acid 111 and 120 are equivalent (binomial probability: 
median across MCMC replicates, p = 0.0005; mean across MCMC replicates = 0.0511). 
Moreover, a model of correlated or dependent evolution for amino acid positions 111 and 
120 was preferred relative to a null model of independent evolution (likelihood ratio = 
88.85, chi-sq with 4 d.f., p < 0.001).  
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4. Tables and Figures 
 
Figure 2-1. (A) Schematic diagram of an unfolded Na
+
/K
+
-ATPase molecule, showing 
the location of the Q111L and G120R substitutions on the H1-H2 extracellular loop. Box 
shows area enlarged in B. (B) Enlargement of the H1-H2 extracellular loop and the first 
two transmembrane domains. (C) The amino acid sequence of the first extracellular loop, 
indicating the substitutions at positions 111 and 120 that confer resistance to 
bufadienolides in snakes. Redrawn from Köksoy [21]. For a more detailed structural 
reconstruction of the interactions of the Na
+
/K
+
-ATPase and a BD, see Laursen et al. 
[25]. 
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Figure 2-2. Ancestral state reconstruction of the mutations to Na
+
/K
+
-ATPase that confer 
resistance to bufadienolides in snakes. Colored circles beside terminal taxa indicate the 
amino acid composition of Na
+
/K
+
-ATPase at the H1-H2 extracellular loop (red = 
resistant L111 and R120 and black = nonresistant Q111 and G120). The names of 
bufophagous species are shown in red, and nonbufophagous species are shown in black 
(Table 2-1) [10, 35–36]. Inferred ancestral states are denoted by pie charts that indicate 
the posterior probability of having (red) versus not having (black) the resistance 
mutations. Selected higher taxa are identified, and circles numbers identify nodes that are 
discussed in the text.  Note that the resistance mutations to Na
+
/K
+
-ATPase are not 
limited to taxa that prey on toads (as shown by the number of black species names beside 
red circles).  Two highly bufophagous species (Heterodon platirhinos and Xenodon 
merremii) and one that sequesters BDs (Rhabdophis tigrinus), indicated by green arrows, 
possess enlarged adrenal glands that may function in countering the effects of chronic 
exposure to bufadienolides. Inset: Heterodon platirhinos feeding on the toad Anaxyrus 
terrestris. Note the viscous skin secretion of the toad, which is rich in bufadienolides. 
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Table 2-1. Snake species included in this study, indicating the presence or absence of the 
resistance mutations of Na
+
/K
+
-ATPase and the presence or absence of toads in the diet. 
The dietary data are compiled almost exclusively from primary literature, a large portion 
of which includes comprehensive dietary studies rather than anecdotal observations. We 
considered most secondary literature to be unreliable for accurate dietary data. Due to the 
imperfect nature of dietary studies, we have taken a conservative approach and consider a 
species bufophagous if it is a generalist predator and there exists a record of at least one 
individual consuming a toad (i.e., marked “Yes” under “Toad in Diet”). Furthermore, we 
considered a bufadienolide-resistant snake bufophagous if it is a generalist predator with 
a high frequency of amphibians in the diet, even though there are no published records of 
toads. Bufadienolide-resistant species that are not considered bufophagous include 
primarily species with dietary specializations that do not include amphibians. Asterisks 
indicate species with diets including >80% toads or those that sequester dietary 
bufadienolides. 
Species 
Resistance 
mutations 
Toad in 
diet 
References 
Erythrolamprus mimus Yes No [1–2] 
Erythrolamprus aesculapii Yes No [1,3–8] 
Xenodon semicinctus Yes Yes [4] 
Xenodon neuwiedii Yes Yes [9–12] 
Xenodon merremi Yes Yes* [9–10,13–12] 
Philodryas olfersii Yes No [7,14–18] 
Clelia clelia Yes No [19] 
Oxyrhopus formosus Yes No [17–18] 
Hydrodynastes gigas Yes Yes [20] 
Helicops angulatus Yes No [7,14,21–24] 
Conophis vittatus Yes No [25] 
Dipsas catesbyi Yes No [23,26–27] 
Atractus flammigerus Yes No [15] 
Leptodeira septentrionalis Yes Yes [28–30] 
Hypsiglena torquata Yes Yes [31] 
Farancia abacura No No [32–33] 
Diadophis punctatus No No [34–35] 
Carphophis amoenus No No [34] 
Contia tenuis No No [36] 
Heterodon simus Yes Yes [37–38] 
Heterodon nasicus Yes Yes [37–39] 
Heterodon platirhinos Yes Yes* [37,40–41] 
Thamnophis radix Yes No [42–45] 
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(Table 2-1 continued.) 
 
Thamnophis butleri 
 
 
Yes 
 
 
No 
 
 
[46–47] 
Thamnophis brachystoma Yes No [48–49] 
Thamnophis elegans Yes Yes [12,50–51] 
Thamnophis atratus Yes Yes [52–54] 
Thamnophis couchii Yes Yes [55–56] 
Thamnophis ordinoides Yes No [49,56] 
Thamnophis marcianus Yes Yes [57] 
Thamnophis cyrtopsis Yes Yes [58] 
Thamnophis melanogaster Yes No [59–63]  
Thamnophis sauritus Yes Yes [64] 
Thamnophis proximus Yes Yes [57,65–67] 
Thamnophis sirtalis Yes Yes [12,51,68–70] 
Nerodia fasciata Yes Yes [71–73] 
Nerodia sipedon Yes Yes [34–35,74] 
Nerodia rhombifer Yes Yes [71,74–76] 
Nerodia cyclopion Yes No [74–75] 
Regina grahami Yes No [71,74] 
Regina septemvittata Yes No [74,77–78] 
Storeria occipitomaculata Yes No [79–80] 
Storeria dekayi Yes No [79,81] 
Regina alleni Yes No [74,82–84] 
Regina rigida Yes No [74–75] 
Natrix natrix Yes Yes [85–88] 
Natrix tessellata Yes Yes [86,89] 
Natrix maura Yes No [90–91] 
Sinonatrix percarinata No No [92] 
Sinonatrix annularis No No [92] 
Xenochrophis piscator Yes Yes [93] 
Amphiesma stolatum Yes No [94] 
Rhabdophis leonardi Yes No [95] 
Rhabdophis tigrinus Yes Yes* [96–98] 
Rhabdophis subminiatus Yes Yes [99] 
Macropisthodon rudis Yes Yes [100] 
Lampropeltis getula No No [66] 
Lampropeltis calligaster No No [35,66] 
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(Table 2-1 continued.) 
 
Pantherophis obsoletus 
 
 
No 
 
 
No 
 
 
[35,66,101] 
Pantherophis alleghaniensis No No [102] 
Pituophis catenifer No No [103] 
Elaphe quadrivirgata No No [96–97,104] 
Euprepiophis conspicillatus No No [105] 
Drymarchon corais Yes Yes [106–107] 
Coluber constrictor No No [35,66,108–109] 
Dasypeltis scabra No No [110–111] 
Boiga irregularis No No [112] 
Lycodon rufozonatus Yes Yes [113] 
Cyclophiops semicarinatus No No [105] 
Dendrelaphis subocularis No No [114–115] 
Dendrelaphis punctulatus No No [116–118] 
Hemiaspis signata No No [119–121] 
Pseudechis australis No No [121] 
Acanthophis praelongus No No [122] 
Naja nigricollis Yes Yes [123] 
Naja melanoleuca Yes Yes [123–126] 
Naja naja Yes No [127–128] 
Naja atra Yes No [127–129] 
Hemachatus haemachatus Yes Yes [126] 
Dendroaspis angusticeps No No [130–131] 
Dendroaspis polylepis No No [131] 
Ophiophagus hannah No No [132] 
Boaedon fuliginosus No No [133] 
Hypsiscopus plumbea No No [134] 
Crotalus atrox Yes No [135–137] 
Sistrurus catenatus No No [138–140] 
Agkistrodon contortrix Yes No [66,141–143] 
Viridovipera stejnegeri No No [127,144] 
Bitis nasicornis Yes Yes [124,145] 
Bitis arietans Yes Yes [146] 
Cerastes cerastes Yes No [147–148] 
Causus maculatus Yes Yes [149] 
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(Table 2-1 continued.) 
 
Vipera berus 
 
 
No 
 
 
No 
 
 
[150–151] 
Vipera aspis No No [152–154] 
Acrochordus arafurae No No [155–156] 
Morelia spilota No No [157–158] 
Liasis fuscus No No [159–161] 
Python regius No No [162] 
Python molurus No No [163–165] 
Epictia albipuncta Yes No [166–167] 
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5. Discussion 
 Our results demonstrate that the mutations at positions 111 and 120 in the H1-H2 
extracellular loop of the Na
+
/K
+
-ATPase α3 subunit, which confer resistance to toad 
toxins in snakes [11,15,29], occur in a much wider range of species than previously 
believed, including many species that do not regularly, if ever, prey on toads (Table 2-1). 
The first extracellular loop (amino acid positions 111-122) comprises a major part of the 
cardiotonic steroid binding pocket, and the nonresistant gene codes for the amino acids 
glutamine at position 111 and glycine at position 120. The observed substitution of 
leucine at position 111 results in a biochemical residue change from polar-neutral to 
nonpolar-neutral, which increases the hydrophobicity of the residue but does not change 
the isoelectric point. The substitution of arginine at position 120 results in a biochemical 
residue change from nonpolar-neutral to polar-positive, which increases the isoelectric 
point and decreases the hydrophobicity of the residue. Although the physiological effect 
of the G120R substitution has not been specifically tested, it is biochemically similar to 
the residue change caused by the N122H substitution in milkweed insects (change from a 
neutral to positively charged residue), which has been shown to confer significantly 
lowered binding affinity to CDs [13]. Furthermore, the combined substitutions of Q111L 
and G120R have been shown to confer a much lower affinity to BDs than the wild-type 
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gene in vertebrate cells [15]. Although the Q111L substitution does contribute to 
resistance in cardenolide-resistant invertebrates [13], evidence from insect phylogenies 
suggests that it is a necessary intermediate step that leads to the later appearance of other 
substitutions in the H1-H2 extracellular loop [4]. A similar relationship presumably 
explains the consistent co-occurrence of substitution Q111L with G120R in BD-resistant 
snakes. 
The distribution of the resistance mutations Q111L and G120R among colubroid 
snakes, including their widespread appearance in many species that do not prey on toads, 
raises a number of important issues that were obscured by the limited taxon sampling of 
previous studies. The occurrence of such mutations among nontoad-eating species 
suggests that possession of these mutations does not carry a high performance cost. 
Paradoxically, however, investigations of the ion transport activities of some resistant 
Na
+
/K
+
-ATPases have shown that the mutations do in fact lower the enzyme’s function 
[36-37]. It appears that in insects, the deleterious effects of the lowered enzyme function 
are circumvented by the presence of a secondary Na
+
/K
+
-ATPase isoform [37]. It is thus 
likely that in snakes Na
+
/K
+
-ATPase isoforms α1 and α2 might be contributing similarly. 
This contrasts sharply with the limited distribution of mutations for resistance in snakes 
that consume amphibians defended by tetrodotoxin (TTX) [12]. TTX targets voltage-
gated sodium channels, and the mutations that confer resistance to TTX also impart a 
substantial countervailing cost, as measured by locomotor performance [38–39]. Several 
point mutations have been documented among TTX-resistant snakes [12], and their 
occurrence is tightly linked to the consumption of TTX-defended amphibians. In the best-
documented case, involving the natricine snake Thamnophis sirtalis and the newt Taricha 
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granulosa, geographic differences in the level of TTX in the newt are mirrored by 
differences in the level of innate resistance of the sodium channels in the snake [40]. 
Populations of snakes that consume low levels of TTX exhibit low levels of resistance. 
In contrast to such close correspondence between prey toxicity and sodium 
channel resistance to TTX, our data document the occurrence of BD-resistance mutations 
in Na
+
/K
+
-ATPase among many species that are not known to consume toads at all, 
including specialized predators on mollusks (Dipsas catesbyi, Storeria occipitomaculata), 
crayfishes (Regina spp.), fishes (Nerodia rhombifer, Helicops angulatus), and mammals 
(Crotalus atrox, Agkistrodon contortrix) (Table 2-1). It is possible that the same mutation 
protects a few of these taxa against other toxins that exert yet unknown pharmacological 
effects (as in some mollusks [41] and other invertebrates [42-46]). However, most 
nontoad-eating species that possess the resistance mutations appear not to derive any 
benefit nor incur a substantial cost from the mutated form of Na
+
/K
+
-ATPase. Future 
studies should address that inference directly. 
Our study includes relatively broad taxon sampling of the three largest 
subfamilies of colubrid snakes. The sister lineages Natricinae and Dipsadinae (Figure 2-
2) both include large numbers of taxa that possess the resistance mutations. The species 
in both lineages consume a wide variety of prey, and both subfamilies include species 
that are highly bufophagous or sequester BDs. Our results indicate a 0.61 probability that 
resistance to BDs originated in the common ancestor of both of these groups (Figure 2-2, 
node 3) and was independently lost in two extant lineages. Interestingly, both of these 
subfamilies include early branches that are highly bufophagous or sequester BDs, 
suggesting the possibility that consumption of toads characterized early members of both 
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radiations, and possibly their common ancestor. Arguably the most highly bufophagous 
genus of snakes, Heterodon of North America, lies near the base of the Dipsadinae, 
although members of the sister lineage of Heterodon (which includes Farancia, 
Diadophis, Carphophis, and Contia) lack the resistance mutations, most likely through 
secondary loss of those residues (Figure 2-2, node 2). The other highly bufophagous 
lineage of dipsadines, the genus Xenodon (sensu lato, including the nominal genera 
Waglerophis and Lystrophis [47]), is nested more deeply within the Dipsadinae, as a 
member of a diverse South American radiation (Figure 2-2, node 1). 
Among the Natricinae, the overwhelming majority of species possesses the 
resistance mutations. A basal split (Figure 2-2, node 5) separates an exclusively Asian 
lineage from one that includes a few Asian species, as well as a number in Europe and the 
large North American tribe Thamnophiini. The exclusively Asian lineage includes the 
genus Rhabdophis, most members of which possess defensive structures known as nuchal 
or nucho-dorsal glands [48]. Some species accumulate high concentrations of BDs from 
toads consumed as prey and release the toxins to deter the snakes’ predators [3,49]. 
Furthermore, female Rhabdophis tigrinus can transfer prey toxins to their embryos before 
oviposition [50], and a recent field study demonstrated that females preferentially forage 
for toads during the reproductive season, presumably increasing the likelihood of 
provisioning their embryos with BDs [51]. Therefore, although toads comprise a 
numerically small element of the diet in this species [52], the snakes often retain high 
levels of BDs in their tissues. The sampled species of Natricinae exhibit only a single 
example of likely secondary loss of the resistance mutations, the East Asian genus 
Sinonatrix (Figure 2-2, node 4). That genus of highly aquatic fish-eaters (Table 2-1), is 
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sister to the West Asian, European, and North American natricines, all of which possess 
the resistance mutations and one of which, Natrix natrix of Europe, frequently consumes 
toads. 
The third broadly sampled colubrid subfamily, the Colubrinae, displays a different 
evolutionary picture. Of 15 species sampled, only two distantly related species possess 
the resistance mutation (and are known to feed on toads). Our analysis suggests a 91% 
probability that the ancestor of the Colubrinae (Figure 2-2, node 6) lacked the mutation. 
Thus, although all species in our sample that are known to prey on toads possess the 
resistance mutations, the recovered pattern is one in which only a few members of the 
ancestrally nonresistant Colubrinae evolved resistance, whereas many members of the 
ancestrally resistant Natricinae and Dipsadinae retained the mutations despite consuming 
prey other than toads. These results argue that historical contingency plays a strong role 
in the origin of genetic resistance to BDs and suggest that the performance cost of 
retaining the mutations is low, even when it confers no evident advantage. 
Two other large and widespread families, Viperidae and Elapidae, possess 
bufophagous genera, both of which occur in Africa. Viperids exhibit greater variation in 
the distribution of the resistance mutations than other major lineages. However, the 
bufophagous viper Causus is basal to a radiation of African Viperinae (Figure 2-2, node 
8), of which all sequenced taxa retain those mutations. The Eurasian genus Vipera 
diverged before the African radiation and lacks the mutations. The other major lineage of 
vipers, the Crotalinae, exhibits a diversity of Na
+
/K
+
-ATPase sequences. However, our 
sampling of Viperidae is limited, and further sequencing is needed to resolve the origins 
of resistance in this family with confidence. Among the Elapidae, the bufophagous 
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African genus Hemachatus is sister to the diverse radiation of African and Asian Naja 
(Figure 2-2, node 7), which includes a number of facultative toad-eaters. Unfortunately, 
our sampling includes only a single species of Lamprophiidae, a large and ecologically 
diverse African colubroid radiation that is sister to the Elapidae. The only sequenced 
lamprophiid, Boaedon fuliginosus, lacks the resistance mutations, but further sampling of 
this family is desirable, especially considering that one species of the lamprophiid genus 
Crotaphopeltis feeds largely on toads [9]. 
It is possible that some generally nontoad-eating taxa may rarely encounter and 
consume bufonids, either as adults or as juveniles. (Information on the diets of young 
snakes are especially limited.) However, it is doubtful that rare instances of toad 
consumption would have driven the evolution of the resistance mutations, especially in 
the varied dietary specialists discussed above. It is more likely that species belonging to 
ancestrally resistant lineages may occasionally consume bufonids when encountered, 
despite a diet consisting primarily of other prey. Such a scenario is not inconsistent with 
our conclusions. Conversely, however, we predict that nonresistant snakes would rarely, 
if ever, survive such a rare predatory event. 
Recent time-calibrated phylogenetic studies of toads and snakes support the 
hypothesis that toads arrived on all occupied continents prior to, or coincident with, the 
evolution of specialized bufophagous snakes.  The Bufonidae are believed to have arisen 
in South America, after the breakup of Gondwana approximately 88 Ma, and dispersed 
north and then west across the Bering Strait, establishing lineages in Eurasia and Africa 
before returning to the Americas across a North Atlantic land connection about 43 Ma 
[53]. The presence of BDs in the most basal genus of bufonids, Melanophryniscus, is 
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uncertain, although its species are chemically defended by the indolealylamine 
bufotenine and by alkaloids sequestered from arthropod prey [54]. Skin extracts from 
Melanophryniscus appear to inhibit Na
+
/K
+
-ATPase [55]. BDs are present in Atelopus 
[55], which is sister to all remaining bufonids in both the New and Old Worlds. 
Furthermore, a more derived clade of Neotropical bufonids (Rhinella) diverged from a 
North American ancestor about 41 Ma, so the presence of BD-defended toads in South 
America clearly predates the origin of the bufophagous South American genus Xenodon 
about 18 Ma. Similarly, the origin of the notably bufophagous genera Heterodon (North 
America, 30 Ma), Rhabdophis (East Asia, 29 Ma), Natrix natrix (Europe, 13 Ma), 
Hemachatus (Africa, 23 Ma), and Causus (Africa, 30 Ma) all postdate the completion of 
the bufonid diaspora [33].  
Importantly, dates vary for the divergence of the related colubrid subfamilies 
Natricinae and Dipsadinae, both of which include relatively basal bufophagous genera 
and large numbers of genera that possess the resistance mutations. Indeed, our analysis 
indicated a fairly high probability that the ancestor of Natricinae + Dipsadinae (Figure 2-
2, node 3) possessed those mutations. A detailed analysis of the Natricinae suggested that 
they originated in eastern Asia approximately 35 Ma (Figure 2-2, node 5), later 
establishing lineages in Africa, Europe, and North America [56]. Consistent with that 
scenario, the most basal dipsadines, Thermophis and Stichophanes, occur in Asia, 
whereas all other members of the subfamily are limited to the New World, including the 
highly bufophagous Heterodon and Xenodon. More recently, Zheng and Wiens [33] 
dated the divergence of Natricinae and Dipsadinae to about 48 Ma. These two divergence 
estimates bracket the date for the re-entry of toads into the New World from Eurasia 
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(about 43 Ma; 38) and are reasonably consistent with an origin of the mutations in the 
ancestor of Natricinae + Dipsadinae in Asia while in sympatry with bufonids. 
The earliest lineage of snakes in which we found the resistance mutations is 
Epictia albipuncta (Leptotyphlopidae; Figure 2-2, node 9), our only sample from the 
large but poorly understood radiation of Scolecophidia. That possibly paraphyletic group 
of five families and about 400 species [33,57] underwent an initial split into three major 
lineages about 123-125 Ma [57], long before the origin of toads. Given the presence of 
the resistance mutations in some varanid lizards [11,15], it is possible that the mutations 
may have been present in the common ancestor of all snakes. Alternatively, resistance 
may have evolved independently in scolecophidians, nearly all of which specialize on a 
diet of social insects, either ants or termites [8]. Ants are defended by a diverse array of 
alkaloids [42–43], and some termites possess terpene toxins [43–46], although the 
diversity of toxins in the early life history stages on which scolecophidians largely feed is 
not well known. The pharmacological effects of most of ant and termite compounds also 
are poorly understood, and thus it is uncertain whether the same mutations to Na
+
/K
+
-
ATPase that confer resistance to BDs would protect against those prey. However, 
evidence of resistance to both BDs and alkaloids has been demonstrated in Heterodon 
platirhinos, a highly bufophagous species that also is resistant to TTX in newts, although 
the mechanism for its resistance to TTX remains unknown [58]. Clearly, additional 
sequencing of diverse scolecophidian species is needed, together with a better 
understanding of the physiological effects of their prey’s defensive toxins.  
Although our sampling efforts were biased toward certain lineages, our data are 
sufficient to demonstrate that the presence of BD resistance mutations across the 
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phylogeny of snakes does not correspond closely to the consumption of toads. 
Nonetheless, it is true that all bufophagous snakes in our sample possess the resistance 
mutations. Comparison of the physiological effects of a controlled dose of the BD 
gamabufotalin on a species with the resistance mutations, Nerodia rhombifer, and one 
that lacks the mutations, Pituophis catenifer, revealed sharply different responses [29]. N. 
rhombifer, a specialized predator on fishes, exhibited no signs of distress when subjected 
to mass-specific doses 20 times greater than those that proved lethal to P. catenifer. This 
suggests that the resistance mutations are indeed protective against the acute effects of 
BD consumption. Furthermore, the widespread occurrence of the resistance mutations 
among nontoad-eating snakes suggests that possession of the resistance mutations does 
not impose a large performance cost. However, the inclusion of toads as an occasional 
prey item among the genetically resistant species, together with the relative rarity of 
species that either specialize on a diet of toads or sequester dietary BDs, suggests that the 
cost of chronic exposure to those toxins poses a greater physiological challenge and may 
require additional mechanisms of resistance. 
In parallel invertebrate systems, a variety of mechanisms confer resistance to 
CDs, including detoxification by enzymes, excretion, and exclusion from sensitive 
tissues, in addition to target-site insensitivity [1–2,4–5]. As such, target-site insensitivity 
may not always be required as a precursor for tolerance to toxic prey. Furthermore, 
several resistance mechanisms against environmental toxins can exist within a single 
species. For example, dichlorodiphenyltrichloroethane (DDT) resistance in insects can be 
achieved by amino acid substitutions in the voltage-gated sodium channel [17,59] and 
also through increased expression of detoxifying enzymes [17,60]. This further suggests 
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that, although the resistance mutations of Na
+
/K
+
-ATPase may be sufficient to protect a 
snake from the acute effects of BD ingestion, additional physiological adaptations may be 
required to protect highly bufophagous taxa and those that sequester BDs against the 
chronic effects of toxin exposure. Some CD-resistant insects show tissue-specific 
increases of mutant Na
+
/K
+
-ATPase expression that reflect the relative exposure of 
different tissues to CDs [14]. A similar mechanism in bufophagous snakes may involve a 
specific endocrine response to BDs. Mohammadi et al. [10] demonstrated that three 
independently evolved snakes that specialize on toads possess highly enlarged adrenal 
glands in comparison with their nontoad-eating sister taxa (Figure 2-2). Adrenal 
corticosteroid hormones exert diverse physiological effects, and aldosterone in particular 
has been linked to increased expression of Na
+
/K
+
-ATPase in cardiac cells [61]. 
Although target-site insensitivity clearly plays an essential role in the survival of 
toad-eating snakes, it is not tightly coupled to bufophagy. The occurrence of the 
resistance mutations among species with varied diets suggests that the mutations impose 
little performance cost. To understand the evolution of highly specialized bufophagous 
snakes, it will be necessary to move beyond target-site insensitivity and investigate the 
complex, interconnected physiological pathways that confer resistance to chronic BD 
exposure. 
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CHAPTER 3 
TOAD TOXIN-RESISTANT SNAKE (THAMNOPHIS ELEGANS) EXPRESSES HIGH 
LEVELS OF MUTANT NA
+
/K
+
-ATPASE mRNA IN CARDIAC MUSCLE 
 
 
 Toads are chemically defended by bufadienolides, which are lethal to most 
predators. These toxins exert their lethal effects by binding to and disabling the Na
+
/K
+
-
ATPases of cell membranes. Many species of snakes exhibit resistance to the effects of 
bufadienolides due to target-site insensitivity of the Na
+
/K
+
-ATPase. Mutations that 
confer resistance have previously been identified in ATP1a3, the gene that codes for the 
Na
+
/K
+
-ATPase α-3 paralog. We have found that this mutant gene is expressed at a 
significantly elevated level in heart tissue compared to gut, kidney, and liver of the 
bufadienolide-resistant snake, Thamnophis elegans. Furthermore, we found that exposure 
to bufadienolides elicits a significant increase in the expression levels of ATP1a3 in the 
heart, but not in the kidneys, liver, or gut one hour after exposure. We suggest that 
upregulation of ATP1a3 in the heart plays an important role in the physiological 
processes involved in tolerance of bufadienolides among genetically resistant snakes. 
 
1. Introduction 
 Toads are chemically defended by potent cardiotonic steroids known as 
bufadienolides (BDs; Chen and Kovaříková, 1967; Garraffo and Gros, 1986; Krenn and 
Kopp, 1998), which render them lethal to most predators (Phillips and Shine, 2006; 
Ujvari et al., 2013; Mohammadi et al., 2016a). BDs are one of two classes of cardiotonic 
steroids (together with cardenolides), which exert their lethal effects by binding to and 
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disabling Na
+
/K
+
-ATPases (NKAs) of cell membranes (Barry and Bridge, 1993; Rose 
and Valdes, 1994; Barrueto et al., 2006; Dvela et al., 2007). Inhibition of this 
transmembrane enzyme triggers a compensatory reaction by the Na
+
/Ca
2+
 exchanger, 
which causes highly elevated intracellular Ca
2+
 levels and results in increased and 
prolonged cardiac muscle contraction and decreased heart rate (Rose and Valdes, 1994; 
Krylov, 2000). BDs occur in toads (Bufonidae), as well as fireflies (Lampyridae; Krenn 
and Kopp, 1998; Dvela et al., 2007), and are distinguished from cardenolides by a six-
membered, as opposed to five-membered, lactone group at the C-17 position. Two plant 
genera, Helleborus and Kalanchoe, also produce BDs (Wissner and Kating, 1971; Muhr 
et al., 1995; Krenn and Kopp, 1998). Among the cardenolides are pharmacologically 
significant compounds such as digoxin and ouabain, which have been used by humans in 
the treatment of heart failure for over 200 years (Schoner, 2002). 
 Several lineages of snakes have evolved resistance to BDs, through mutations that 
lower the affinity of the toxins to NKAs, and can prey readily on toads (Ujvari et al., 
2015; Mohammadi et al., 2016b), whereas snakes without the mutations die from 
attempted predation on toads (Shine, 2010; Mohammadi et al., 2016a). Ujvari et al. 
(2015) demonstrated that taxa across the Metazoa have independently evolved mutations 
of NKA that confer resistance to cardiotonic steroids. A phylogenetic analysis concluded 
that absence of a mutation that confers resistance is ancestral to the family Colubridae, 
although the presence of the mutated form appears to be ancestral to the subfamily 
Natricinae, to which T. elegans belongs (Mohammadi et al., 2016b).  
 The α-subunit of NKA contains the BD binding pocket (Morth et al., 2007; 
Ogawa et al., 2009; Laursen et al., 2015), and snakes possess three paralogs of this 
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subunit (frequently referred to as isoforms in the literature) encoded by the genes 
ATP1a1, ATP1a2, and ATP1a3 (Babonis et al., 2011; Castoe et al., 2013; Vonk et al., 
2013). Differences in their function are poorly understood. Mutations that confer 
resistance to BDs in snakes are known to occur in ATP1a3 (Ujvari et al., 2015; 
Mohammadi et al., 2016b). It is possible that ATP1a1 and ATP1a2 also possess mutations 
that confer resistance, but the amino acid sequences of those paralogs have not yet been 
studied in BD resistant snakes.  
 To date, there have been no published studies investigating the abundance of the 
mRNAs for the genes encoding the three α-paralogs in snakes. Previous studies that have 
investigated the mechanisms of BD resistance in reptiles have focused almost exclusively 
on target-site insensitivity of the NKA (ATP1a3; Ujvari et al., 2013; Ujvari et al., 2015; 
Mohammadi et al., 2016a; Mohammadi et al., 2016b). However, in order to understand 
better the physiology of BD resistance, it is imperative to move beyond target-site 
insensitivity and investigate the physiological pathways that may also contribute to 
resistance. A logical step is to determine the tissue-specific expression levels of the 
mutant NKA α-3 gene, ATP1a3. We predict higher levels of ATP1a3 mRNA in tissues 
that receive significant exposure to BDs and those that rely heavily on high numbers of 
functioning NKAs, such as the kidneys (Katz, 1982; Ferrandi et al., 1996). Increased 
expression of ATP1a3 mRNA in such tissues would differentially protect them from 
NKA inhibition. 
 We tested this prediction by measuring the expression levels of ATP1a3 in tissues 
that would likely be affected or come in contact with ingested BDs of a species known to 
possess the resistant mutations of ATP1a3 (Mohammadi et al., 2016b), Thamnophis 
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elegans. We measured ATP1a3 expression levels in the absence of BDs and following 
exposure to an injected BD. We limited our study to the paralog ATP1a3 because it has 
been the focus of all previous studies of NKA resistance in reptiles. Furthermore, DNA 
sequences of paralogs ATP1a1 and ATP1a2 are not available for BD-resistant snakes.  
 
2. Materials and methods 
2.1 Experimental subjects 
 Eleven adult snakes (T. elegans; Table 3-1) were collected in Utah (Cache 
County; permit no. 1COLL9134), transported to Utah State University (Logan, Utah, 
USA), housed individually in 37.8 L glass terraria with newspaper substrate, provided 
with water ad libitum and a hide shelter, and fed with thawed, commercially purchased 
mice (RodentPro.com, LLC) once per week. Snakes were cared for and handled in 
compliance with Utah State University Institutional Animal Care and Use Committee 
(IACUC) regulations (protocol #2078).  
 
2.2 Experimental treatments 
 The snakes were randomly assigned to one of two treatments: control or BD. Five 
percent dimethyl sulfoxide (DMSO; Fisher Scientific, Inc.) served as the solvent for the 
BD doses, and was thus used as the control treatment. Six snakes were given a mass-
adjusted volume dose (equivalent to BD dose) of 5% DMSO as a control, and the other 
five were given a mass-adjusted dose (0.149 M/g) of the BD gamabufotalin (PiChemicals 
®, Lot # PI201406082068 and # PI1201206031583) dissolved in DMSO (Table 3-1). The 
BD dose was selected based on previously published experiments and represents 100 
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times the intravenous LD50 of mice and approximately 10 times the intraperitoneal lethal 
dose for a non-resistant snake (Yoshida et al., 1976; Mohammadi et al., 2016a). Doses 
were administered by intraperitoneal injection. At exactly one hour post-injection, snakes 
were sacrificed by decapitation and immediately dissected for tissue samples of heart, 
liver, kidney, gut (small intestine), and skeletal muscle. Tissue samples were preserved in 
RNAlater® (Ambion
TM
) and stored at -80°C until RNA extraction. 
 
2.3 Extraction of mRNA and cDNA synthesis 
 RNA was extracted from tissues using the RNeasy Mini Kit (Qiagen©), 
quantified and checked for purity using a micro-volume spectrophotometer (NanoDrop 
2000, Thermo Scientific
TM
). We were unable to extract sufficient RNA from the skeletal 
muscle samples, and thus that tissue was omitted from the analysis. For cDNA synthesis 
we used the Superscript III reverse-transcription kit (Invitrogen
TM
) including both Oligo-
dT20 and random hexamer primers. A final concentration of 50 ng/μl in 20 μl volume was 
reverse transcribed for each sample, and homogeneity across samples was confirmed 
visually using a 2% agarose gel. All cDNA was stored at -20°C until use in the qPCR 
analysis.  
 
2.4 Primer design and qPCR analysis 
Quantitative PCR primers were designed to amplify the target gene, ATP1a3 
(FWD 5’-GTTTTGTCGCCAGCTCTTCG-3’ RVS 5’-ACCCAGGTACAGGTTGTCTC-
3’; Primer3 software Untergasser et al., 2012), and the ribosomal protein reference genes, 
L8 (FWD 5’-AACTGTTCATTGCAGCGGAGG-3’ RVS 5’-
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TGAGCTGAGCTTTCTTGCCAV-3’; Babonis et al., 2011) and 18S (FWD 5’-
CCGATGCTCTTAACTGAGTGTCT-3’ RVS 5’-
GGTCCAAGAATTTCACCTCTAGC-3’; Primer3 software Untergasser et al., 2012) in 
T. elegans. L8 and 18S were chosen as reference genes due to their consistent expression 
across tissue types (Filby and Tyler, 2007; Babonis et al., 2011). We checked primer 
specificity for ATP1a3 against ATP1a1 and ATP1a2 with a nucleotide BLAST against 
the Python bivittatus genome on GenBank (NCBI). The BLAST search returned with a 
100% match on ATP1a3, a 77% match on ATP1a1, and an 85% match on ATP1a2. All 
qPCR primers amplified ~100-215 bp amplicons. Primers were designed to cross exon-
exon borders, to ensure there was no amplification of genomic DNA. Primer specificities 
were first tested using standard PCR amplification and visualized on a 2% agarose gel. 
Specificity was further ensured by visualization of the amplicons’ melting curves 
(StepOne
TM
 Real-Time PCR System; Applied Biosystems
TM
). 
 Primer efficiencies, which represent measurements of amplification efficiencies in 
qPCR reactions, were measured using a five-point 1:10 dilution series of cDNA 
combined from all tissues. A linear regression of the dilution curves was performed for 
each gene, and primer efficiencies were calculated using the following formula: PCR-
efficiency = 10 
(-1/slope)
 (Pfaffl, 2001). Primer efficiencies were as follows: ATP1a3 
87.21%, L8 82.94% and 18S 92.27%.  
 We measured mRNA abundance in the tissues from which we were able to extract 
sufficient mRNA (n = 26) using qPCR. We loaded 10 µl duplicates of reaction mixtures 
(Maxima SYBR Green/ROX qPCR Master Mix, Thermo Scientific
TM
) into 48-well 
optical plates (MicroAmp®, Applied Biosystems
TM
). In addition to the standard qPCR 
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master mix, each reaction contained 10 ng of reverse transcribed cDNA. Reactions were 
run in duplicate on a StepOne
TM
 Real-Time PCR System (Applied Biosystems
TM
), using 
the following cycling protocol: step 1: 98°C for 10 mins (initial denature); step 2: 98°C 
for 15s, 60°C for 20s, 72°C for 30s (repeated for a total of 45 cycles); and step 3: melting 
curve analysis (to ensure amplification of only a single product). Inter-plate variation was 
5.88% for 18S amplification, 0.87% of L8 amplification, and 3.6% for ATP1a3 
amplification.  
 
2.5 Statistical analysis 
 Fold-increase was calculated from cycle threshold (Ct) values for each sample 
using the method of Pfaffl (2001), according to the following formula: ratio = 
(Etarget)
∆CP
target 
(control – sample)  
/ (Eref)
∆CP
ref 
(control – sample)
. When comparing fold-increase 
between different tissue types, calculations for each sample were normalized to the mean 
Ct values of all tissues for the target gene and the reference genes. When comparing fold-
increase within tissue types, calculations for each sample were normalized to the controls 
of that tissue. The data did not meet the assumption of homogeneity of variance, and thus 
we used nonparametric analyses. Both untransformed and log-transformed data were 
analyzed, with identical statistical results, so log-transformed data are presented here to 
improve their graphic presentation. To test for differences in expression between tissues, 
we used the Kruskal-Wallis multiple comparison approach with Bonferroni corrections. 
To test for differences between control and BD-treated samples, we used independent 
Welch’s t-tests (unequal variance two-sample t-tests) for each tissue type. Statistical 
analyses were performed using JMP 12.2.0 (SAS Institute Inc., 2015). Graphs were 
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generated using GraphPad Prism 6.0h (GraphPad software, 2015). The significance level 
was set at α < 0.05 for all statistical comparisons unless when corrected for multiple 
comparisons with Bonferroni corrections, in which case alpha level was set at α < 0.0083. 
 
3. Results 
 To quantify differences in ATP1a3 expression between heart, liver, gut (small 
intestine), and kidney tissues, we analyzed the expression levels relative to the average Ct 
values for all tissues combined, for the target and reference genes (Figure 3-1; 3-1). The 
Kruskal-Wallis test with Bonferroni corrections revealed significant differences between 
heart and gut (adjusted p = 0.0486), kidney (adjusted p = 0.0258), and liver (adjusted p = 
0.0348), with heart expressing higher levels in all three comparisons.  
 To determine whether exposure to BDs causes upregulation of ATP1a3 we 
compared expression between control and BD-treated samples for each tissue type 
(Figure 3-1). The Welch’s t-tests revealed significant differences in the heart (t(2) = 
3.2085, p = 0.0495) (Figure 3-1). There were no statistically significant changes in the 
levels of expression following injection of BD among gut (t(2) = 0.9165, p = 0.4275), 
kidney (t(2) = 1.1635, p = 0.3382), or liver (t(3) = 0.2783, p = 0.7947) (Figure 3-1).  
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4. Tables and Figures 
 
Figure 3-1. Change in ATP1a3 expression in tissues of BD-treated snakes (DMSO + BD) 
compared to those of control snakes (DMSO only). Data for each tissue are normalized to 
the mean Ct value of all tissues combined. Heart exhibited significantly higher expression 
of ATP1a3 compared to kidney (adjusted p = 0.0258), gut (adjusted p = 0.0486), and liver 
(adjusted p = 0.0348). The heart also exhibited significant upregulation in response to BD 
exposure of the snake (t(2) = 3.2085, p = 0.0495). Changes in gene expression were 
measured one hour after injection. Data are represented as mean ± SEM.  
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Table 3-1. List of snakes used in this study, with accompanying locality and morphometric data. GB denotes gamabufotalin. 
ID Species Locality Sex 
Mass 
(g) 
SVL 
(cm) 
TL 
(cm) 
Treatment 
Administered 
 Dose 
Time  
 Mass (GB) 
Administered 
(mg) 
Dissection 
Time 
Volume  
Injected 
(mL) 
KM18 Thamnophis elegans Utah - Cache Valley M 37.8 54 69 5% DMSO 12:42 - 
 
13:42 0.630 
KM13 Thamnophis elegans Utah - Cache Valley M 20.7 47 62 5% DMSO 12:43 - 13:43 0.345 
KM27 Thamnophis elegans Utah - Cache Valley M 25.7 50 61 5% DMSO 12:45 - 14:45 0.428 
KM26 Thamnophis elegans Utah - Cache Valley M 23.8 48 59 5% DMSO 12:46 - 13:46 0.397 
KM38 Thamnophis elegans Utah - Cache Valley M 29.8 51 66 5% DMSO 12:47 - 13:47 0.497 
KM21 Thamnophis elegans Utah - Cache Valley M 22.4 45 59 5% DMSO 12:48 - 13:48 0.373 
KM33 Thamnophis elegans Utah - Cache Valley M 13.5 41 51 0.149 M/g GB 12:50 1.350 13:50 0.225 
KM31 Thamnophis elegans Utah - Cache Valley M 15.4 39 54 0.149 M/g GB 12:54 1.540 13:54 0.257 
KM34 Thamnophis elegans Utah - Cache Valley M 16.8 45 58 0.149 M/g GB 12:55 1.680 13:55 0.280 
KM35 Thamnophis elegans Utah - Cache Valley M 34.2 51 61 0.149 M/g GB 12:56 3.420 13:56 0.570 
KM36 Thamnophis elegans Utah - Cache Valley M 29.9 56 70 0.149 M/g GB 12:58 2.990 13:58 0.498 
 
  
6
3
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5. Discussion 
 The results of this study provide preliminary insights into the regulatory patterns 
of ATP1a3 in a BD-resistant snake. Specifically, we have found that the mutant ATP1a3 
gene is expressed at significantly higher levels in heart tissue than in kidney, gut, or liver 
tissues in the genetically BD-resistant snake, T. elegans. Furthermore, we have shown 
that BD exposure causes significant upregulation of ATP1a3 mRNA in the heart. These 
results suggest that the heart is more strongly protected against BDs than the other tissues 
tested from T. elegans. Given the known effect of cardiotonic steroids on cardiac muscle, 
this is not a surprising result. Unfortunately, it is not known whether the other two NKA 
α–paralogs, ATP1a1 and ATP1a2, also possess resistance-conferring mutations or how 
their levels of expression vary among tissues. We predict that other snakes that achieve 
BD resistance through target-site insensitivity of the NKA may share a similar tissue-
specific pattern of ATP1a3 gene expression as T. elegans. A recent upsurge in studies of 
the evolution of mutant NKAs in a wide range of organisms (Dobler et al., 2012; Zhen et 
al., 2012; Ujvari et al., 2013; Ujvari et al., 2015; Petschenka et al., 2013; Aardema and 
Andolfatto, 2016; Mohammadi et al., 2016b) has made this enzyme a model for the study 
of parallel and convergent evolution (Storz, 2016). However, in contrast to that strong 
focus on the molecular basis for cardiotonic steroid resistance (i.e., target-site 
insensitivity), there is a paucity of data on whether additional physiological mechanisms 
are involved in the resistance among vertebrates. 
 Although cardiotonic steroids target the NKAs of all cells, research on the effects 
of these compounds in mammalian systems has focused on their impacts on the heart 
(Licht and Low, 1968; Katz, 1969; Hirai et al., 1992; Fridman et al., 2002; Schoner and 
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Scheiner-Bobis, 2007). Furthermore, the discovery of endogenous cardiotonic steroids in 
mammals has shifted the view of these compounds from toxins to hormones that function 
in maintaining blood pressure and cardiac contractile homeostasis (Kelly and Smith, 
1994; Schoner, 2002; Schoner et al., 2003; Schoner and Scheiner-Bobis, 2005; Schoner 
and Scheiner-Bobis, 2007). Accordingly, their toxic effects are often viewed now as a 
hormonal effect at levels 10-fold or higher than the physiological level. Evidence 
suggests that endogenous cardiotonic steroids in mammals are produced in the adrenal 
glands (Dimitrieva et al., 2000; Schoner and Scheiner-Bobis, 2007), and thus it is 
possible that they are transported throughout the body in a manner similar to that of other 
adrenal hormones. Binding globulins transport non-polar steroid hormones through the 
bloodstream to their target cells, where in some cases interactions with docking proteins 
cause them to release the steroids, which then interact with other membrane receptors 
(Rosner, 1990; Antolovic et al., 1998; Rosner et al., 1999; Schoner, 2002; Willnow and 
Nykjaer, 2010). Previous studies have shown that mammals possess a cardiotonic steroid-
specific binding globulin, which binds to the steroids with high affinity and inhibits their 
function (Antolovic et al., 1998; Antolovic et al., 2000; Schoner et al., 2003). These 
binding globulins are produced at high concentrations in the kidneys, where they likely 
protect the NKAs of those tissues (Antolovic et al., 2003). We do not yet know whether 
snakes, like mammals, possess BD-specific binding globulins or endogenous cardiotonic 
steroids, much less the role they might play in the metabolism of BDs in snakes.  
 Beyond heart tissue, it is interesting that ATP1a3 mRNA was not relatively 
abundant in the kidneys (Figure 3-1), where overall expression of the NKA is known to 
be greatest (Katz, 1982). The NKA plays a vital role in maintaining sodium homeostasis, 
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and thereby water balance, in all vertebrates (Ferrandi et al., 1996). We anticipate that 
ATP1a1 and/or ATP1a2, which code for alternative paralogs of the NKA α-subunit, will 
be shown to exhibit relatively higher levels of expression in those tissues. Mammalian 
kidneys and liver primarily express ATP1a1 (Orlowski and Lingrel, 1988), and recent 
evidence from insect NKAs suggests that mutations of the NKA may compromise the 
enzyme's functionality as an ion pump (Dalla and Dobler, 2016). It is possible that the 
mutations of ATP1a3 in resistant snakes might also compromise the enzyme’s ion 
pumping function, and thus may explain the low level of mutant ATP1a3 mRNA in the 
kidneys of T. elegans, where functioning NKAs are vital. However, this hypothesis has 
yet to be tested in snakes.  
 Although our results did reveal a significant change in ATP1a3 expression in the 
heart in response to BD exposure in snakes, it is likely that one hour following exposure 
was insufficient to elicit a full response. Ikeda et al. (1991) showed that the adrenal 
hormone aldosterone causes an increase in NKA gene expression that peaks at six hours 
after exposure in an in vitro preparation of rat heart tissue. Oguchi et al. (1993) found that 
expression in rat heart peaks 24 hours after aldosterone exposure in vitro. Although we 
do not know whether aldosterone stimulates expression of NKA in snakes, Mohammadi 
et al. 2017 showed that the Japanese snake Rhabdophis tigrinus, which sequesters BDs 
from its prey, responds to BD exposure with increased levels of circulating aldosterone. 
Furthermore, Mohammadi et al. (2013) showed that several highly specialized toad-
eating snakes, including R. tigrinus, possess greatly enlarged adrenal glands. It is 
therefore possible that BD exposure in genetically resistant snakes elicits increased NKA 
expression in response to higher circulating levels of aldosterone. However, in order to 
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determine whether BDs play any role in mediating NKA regulation, it would be 
necessary to measure simultaneously the changes in NKA expression and circulating 
aldosterone for at least 48 hours after BD exposure. 
 The results of this experiment provide preliminary insights into the role of 
ATP1a3 gene expression in BD resistance of a resistant snake and suggest that further 
exploration of such expression would be worthwhile. We have documented the relative 
abundance of the resistance-conferring ATP1a3 mRNA in heart, liver, gut, and kidney 
tissues of a genetically BD-resistant snake and have compared the relative change in 
expression among tissues following exposure to a BD. Future studies should examine the 
expression of ATP1a1 and ATP1a2 under the same conditions, to determine the levels of 
expression of the other two α-paralogs, and should compare those values among a 
number of phylogenetically independent BD-resistant species.  
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CHAPTER 4 
TISSUE-SPECIFIC VARIATION IN CARDIOTONIC STEROID SENSITIVITY OF 
NA
+
/K
+
-ATPASE IN SNAKES 
 
 
 
 Cardiotonic steroids comprise a diverse group of compounds found in both 
animals and plants. Some species of plants, insects, and amphibians chemically defend 
themselves from predators with high concentrations of these compounds. Resistance to 
cardiotonic steroids in snakes that prey on chemically defended amphibians is conferred 
by amino acid substitutions in at least one of three Na
+
/K
+
-ATPase paralogs, the 
molecular target of the compounds. These substitutions lower the enzyme’s binding 
affinity to cardiotonic steroids. Despite recent advances in our understanding of this 
adaptation, little is known about the physiological mechanisms that contribute to 
resistance in snakes. We have used an in vitro assay to determine the tissue-specific 
levels of sensitivity to cardiotonic steroids in resistant snakes. We measured sensitivities 
in brain, heart, liver, gut, and kidney, and we compared these sensitivities between 
resistant and non-resistant species. We found that the heart and kidney are the least 
sensitive tissues in resistant snakes, whereas brain, gut, and liver are sensitive to 
cardiotonic steroids. All tissues are sensitive in non-resistant species. 
 
1. Introduction 
 Cardiotonic steroids comprise a diverse group of plant and animal-derived 
compounds that exert their effects by binding to and disabling the Na
+
/K
+
-ATPases 
(NKAs) of cell membranes (Krenn and Kopp, 1998; Steyn and van Heerden, 1998; 
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Barrueto et al., 2006; Laursen et al., 2015). The shared structural core of all cardiotonic 
steroids includes a steroidal skeleton with a lactone ring at C3 (Krenn and Kopp, 1998; 
Laursen et al., 2015; Tang et al., 2016). Bufadienolides and cardenolides comprise the 
two main classes, and they differ with respect to the number of carbons in the lactone 
ring (Krenn and Kopp, 1998; Tang et al., 2016). All bufadienolides possess a 6-
membered lactone ring, whereas cardenolides exhibit a 5-membered ring (Krenn and 
Kopp, 1998; Laursen et al., 2015). Animal-derived compounds are typically 
nonglycosylated, whereas plant-derived compounds often are glycosylated (Laursen et 
al., 2015; Tang et al., 2016). These properties can have specific influences on the binding 
properties of NKA (Laursen et al., 2015). However, all forms of cardiotonic steroids dock 
similarly to a specific extracellular binding pocket formed by the αM1-6 transmembrane 
domains and extracellular loops of the NKA α-subunit (Laursen et al., 2015; Tang et al., 
2016).  
 The NKA is a member of the P-type ATPase family, and it consists of a catalytic 
α subunit, which carries out the functional activities of the enzyme, and a regulatory β 
subunit, which provides structural stability (Bagrov et al., 2009). The roles of the NKA in 
physiological homeostasis are vast (reviewed by Bagrov et al., 2009). The enzyme 
continuously transports three Na
+
 ions out of the cell through phosphorylation of ATP 
and two K
+
 ions into the cell through dephosphorylation (Bagrov et al., 2009). This ion 
transport plays a vital role in the regulation of smooth and cardiac muscle contractions 
through the indirect maintenance of intracellular Ca
2+
 levels (Barry and Bridges, 1993; 
Dvela et al., 2007; Lichtstein et al., 2012). The presence of a cardiotonic steroid-specific 
binding pocket on the extracellular surface of the enzyme and the production of 
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endogenous cardiotonic steroids in mammalian adrenal glands indicate that these 
compounds have a physiological function in mammals (Dvela et al., 2007; Lichtstein et 
al., 2012).  
 The adaptations that allow select organisms, including many snakes, to tolerate 
normally lethal concentrations of cardiotonic steroids have been investigated widely in 
recent studies (Dobler et al., 2012; Zhen et al., 2012; Petschenka et al., 2012; Petschenka 
et al., 2013a; Mohammadi et al., 2013; Ujvari et al., 2013; Ujvari et al., 2015; Bramer et 
al., 2015; Mohammadi et al., 2016a; Mohammadi et al., 2017a; Mohammadi et al., 
2017b). Genetic resistance to cardiotonic steroids in snakes has been attributed to the 
presence of two amino acid substitutions in the αM1-2 extracellular loop of NKA, which 
lower the binding affinity of the enzyme to the steroids (Ujvari et al., 2015; Mohammadi 
et al., 2016a). Snakes possess three NKA α-paralogs (Babonis et al., 2011; Castoe et al., 
2011; Vonk et al., 2013). The resistance-conferring mutations have thus far only been 
identified in α-3 (ATP1a3) of the NKA (Ujvari et al., 2015; Mohammadi et al., 2016a). In 
a recent study, Mohammadi et al. (2017a) showed that the mutant ATP1a3 paralog was 
expressed at significantly higher levels in the heart of a resistant species, Thamnophis 
elegans, as compared to gut, liver, and kidney. The presence of amino acid substitutions 
beyond the αM1-2 extracellular loop or in α-1 and α-2 remain to be investigated.   
 Although much attention has been focused on the molecular source of resistance, 
the physiological adaptations of resistance can involve diverse mechanisms beyond 
target-site insensitivity (Scudder and Meredith, 1982; Despres et al., 2007; Petschenka et 
al., 2013b; Mohammadi et al., 2017a; Mohammadi et al. 2017b). High expression levels 
of ATP1a3 in the heart of resistant snakes suggest that cardiac tissue plays an important 
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role in mediating the toxic effects of cardiotonic steroids (Mohammadi et al., 2017b). 
Furthermore, the low levels of gene expression in the gut, liver, and kidneys suggest that 
alternate paralogs of the NKA might also possess resistance-conferring mutations or that 
other mechanisms may contribute to resistance. However, these possibilities have yet to 
be investigated. 
 Here we compare tissue-specific NKA sensitivities of brain, heart, liver, gut, and 
kidney to the cardenolide ouabain in three species of snakes, in order to gain a better 
understanding of the potential significance of each tissue in the physiological resistance 
of snakes. Rhabdophis tigrinus and Thamnophis elegans represent resistant species that 
possess target-site insensitivity (Ujvari et al., 2015; Mohammadi et al., 2016a). R. 
tigrinus has further evolved the ability to sequester and store dietary toxins in specialized 
structures known as nuchal glands (Hutchinson et al., 2007; Mori et al., 2012) and is thus 
compared separately. Elaphe quadrivirgata does not possess resistance-conferring 
mutations and is susceptible to the lethal effects of cardiotonic steroids (Mohammadi et 
al., 2017b). We hypothesized that tissue sensitivity to ouabain was dependent on the 
possession of resistance-conferring mutations in ATP1a3 and on the distribution and 
concentration of the mutant NKA throughout various tissues. We predicted that (1) the 
tissues of R. tigrinus and T. sirtalis would be less sensitive to ouabain, whereas those of 
E. quadrivirgata would be highly sensitive; and (2) that the heart would be the least 
sensitive tissue in the resistant species. 
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2. Materials and methods 
2.1. Study animals 
 Live snakes were collected from the field in Utah (Cache and Tooele Counties; 
permit no. 1COLL9134), Nebraska (Garden County; permit no. 477), and Japan (Kyoto, 
Okayama, Shizuoka, Shiga, Shimane, and Wakayama Prefectures; no permit required). 
All snakes were housed and used in accordance with Utah State University Institutional 
Animal Care and Use Committee (IACUC) regulations (protocol #2078), and with Kyoto 
University Graduate School of Science (protocol #H2605). 
 
2.2. Tissue preparation 
  Tissue samples (brain, heart, liver, gut, and kidney) were dissected from snakes 
and immediately stored at -80°C. NKAs were extracted from tissue samples following the 
protocol described by Petschenka et al. (2012). In brief, tissue samples were thawed and 
homogenized on ice in a 1 mL all-glass grinder (Wheaton) with 500 µl distilled H2O. 
Homogenates were subjected to sonication for 15 minutes in a chilled bath. Thereafter, 
samples were centrifuged at 10,000 x g for 10 minutes to precipitate debris. The 
supernatants were ultracentrifuged at 84,000 x g for 30 minutes at 4°C to sediment the 
membranes (centrifuge: Beckman Coulter; Optima TLX; rotor: TLA-100.3). The 
supernatants were discarded and the microsomal pellets were washed three times in 
distilled H2O, and then resuspended in 500 µl of distilled H2O. Samples were sonicated 
in a chilled bath for 30 minutes to fully re-suspend the microsomal pellets. The extracts 
were stored at -20°C until assayed.  
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2.3. Na
+
/K
+
-ATPase assay 
 Tissue extracts were assayed following the protocol described by Petschenka et al. 
(2013a). In brief, each sample was incubated with exponentially increasing 
concentrations of the cardenolide ouabain (Acrōs Organics, Lot # A0343825). Ouabain is 
used as a surrogate for a bufadienolide in this assay due to its high polarity, a 
characteristic that is required for this assay and not shared by any commercially available 
bufadienolide. The activity of Na
+
/K
+
-ATPases following ouabain incubation was 
determined by quantification of inorganic phosphate released from enzymatically 
hydrolyzed ATP (Sigma Aldrich, lot # SLBB8329V). Reactions were performed in 96-
well microplates (Fisherbrand), and absorbance at 700 nm was measured with a plate 
reader (BioRad Xmark spectrophotometer). 
 
2.4. Statistical analysis 
 Absorbance values were converted to percentage non-inhibited activity based on 
control measurements (Petschenka et al., 2013a). These data were plotted and IC50 values 
were obtained from nonlinear fitting, using a four-parameter logistic curve (Equation 1), 
with the bottom asymptote set to zero. 
𝑌 = 𝐵𝑜𝑡𝑡𝑜𝑚 + (𝑇𝑜𝑝 − 𝐵𝑜𝑡𝑡𝑜𝑚)
1 + 10(𝐿𝑜𝑔𝐼𝐶50−𝑋)∗𝐻𝑖𝑙𝑙𝑆𝑙𝑜𝑝𝑒 
 
Equation 1. Four-parameter logistic curve equation, where Top and Bottom represent the 
plateaus in the units of the Y axis, the IC50 is the concentration of agonist that gives a 
response halfway between Top and Bottom, and HillSlope describes the steepness of the 
family of curves. 
  
79 
 IC50 values were log transformed to better meet the assumptions of normality and 
homogeneity of variance and compared statistically using pairwise t tests. First, the IC50 
differences between species were compared by tissue types (Table 2), then the IC50 
differences between tissue types were compared by species (Table 3). P-values of 
multiple comparisons were adjusted using the Holm-Bonferroni method (Holm, 1979). 
All data were analyzed statistically with JMP software (Version 12.2.0, SAS Institute 
Inc.). Statistical significance was set at α = 0.05. Results are represented as means ± S.E. 
 
3. Results 
 Mean IC50 values for each independent group are listed in Table 4-1. Comparisons 
of tissue sensitivities to ouabain between species revealed that the resistant species, R. 
tigrinus and T. elegans, exhibited significantly higher IC50 values than the non-resistant 
E. quadrivirgata for heart and kidney tissues (Table 4-2; Fig. 4-1). There were no 
significant differences between the IC50 values of T. elegans and R. tigrinus in any tissues 
(Table 4-2). 
 Comparisons of tissue sensitivities to ouabain between tissues within species 
revealed that in R. tigrinus, the heart exhibited significantly higher IC50 values than the 
brain, gut, or liver, and the kidney displayed significantly higher IC50 values than the 
brain (Table 4-3; Fig. 4-2). T. elegans showed no significant differences between its 
tissues, and E. quadrivirgata exhibited significant differences between liver and kidney 
(Table 4-3; Fig. 4-2). 
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4. Tables and Figures 
 
 
Table 4-1. Mean IC50 values for each species by tissue, and the corresponding number of 
replicates used in this study. 
 
Tissue Species IC50 [M] ± SE n 
Kidney R. tigrinus  1.71 x 10
-2
 ± 8.24 x 10
-3
 6 
Kidney T. elegans  2.05 x 10
-2
 ± 3.0 x 10
-3
 5 
Kidney E. quadrivirgata  9.73 x 10
-6
 ± 8.31 x 10
-6
 4 
Heart R. tigrinus  1.66 x 10
-1
 ± 1.49 x 10
-1
 8 
Heart T. elegans  1.3 x 10
-2
 ± 4.36 x 10
-3
  5 
Heart E. quadrivirgata  5.6 x 10
-5
 ± 2.18 x 10
-5
 4 
Brain R. tigrinus  3.54 x 10
-4
 ± 1.6 x 10
-4
 7 
Brain T. elegans  3.38 x 10
-3
 ± 2.5 x 10
-3
 6 
Brain E. quadrivirgata  4.62 x 10
-4
 ± 4.2 x 10
-4
 6 
Gut R. tigrinus  4.69 x 10
-3
 ± 3.9 x 10
-3
 7 
Gut T. elegans  4.48 x 10
-3
 ± 2.15 x 10
-3
 6 
Gut E. quadrivirgata  1.95 x 10
-4
 ± 1.4 x 10
-4
 5 
Liver R. tigrinus  7.42 x 10
-3
 ± 4.84 x 10
-3
 7 
Liver T. elegans  1.03 x 10
-2
 ± 1.03 x 10
-2
 2 
Liver E. quadrivirgata  7.37 x 10
-4
 ± 4.6 x 10
-4
 5 
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Table 4-2. Results of log IC50 t-test comparisons between species by tissues. P-values are 
adjusted with the Holm-Bonferroni correction. Comparisons that yielded significant 
differences are bolded. R. tigrinus and T. elegans represent species with cardiotonic 
steroid resistance-conferring mutations in ATP1a3, whereas E. quadrivirgata does not 
possess these mutations and is susceptible to cardiotonic steroids. These comparisons are 
illustrated in Fig. 4-1. 
 
Tissue Comparison t value df 
Adjusted 
p-value 
Kidney R. tigrinus vs. E. quadrivirgata 6.2632 12 0.0003 
Kidney R. tigrinus vs. T. elegans 0.5384 12 0.6001 
Kidney T. elegans  vs. E. quadrivirgata 6.5128 12 0.0003 
Heart R. tigrinus vs. E. quadrivirgata 6.8333 14 0.0003 
Heart R. tigrinus vs. T. elegans -1.1129 14 0.2845 
Heart T. elegans  vs. E. quadrivirgata 5.292 14 0.0003 
Gut R. tigrinus vs. E. quadrivirgata 2.0439 15 0.1178 
Gut R. tigrinus vs. T. elegans 0.6208 15 0.5440 
Gut T. elegans  vs. E. quadrivirgata 2.5468 15 0.0669 
Brain R. tigrinus vs. E. quadrivirgata 1.2965 16 0.4246 
Brain R. tigrinus vs. T. elegans 0.9332 16 0.4246 
Brain T. elegans  vs. E. quadrivirgata 2.1487 16 0.1419 
Liver R. tigrinus vs. E. quadrivirgata 0.3073 11 0.7643 
Liver R. tigrinus vs. T. elegans -1.3462 11 0.6159 
Liver T. elegans  vs. E. quadrivirgata -1.0749 11 0.6159 
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Table 4-3. Results of log IC50 comparisons between tissues by species. P-values are 
adjusted with the Holm-Bonferroni correction. Comparisons that yielded significant 
differences are bolded. R. tigrinus and T. elegans represent species with cardiotonic 
steroid resistance-conferring mutations in ATP1a3, whereas E. quadrivirgata does not 
possess these mutations and is susceptible to cardiotonic steroids. These comparisons are 
illustrated in Fig. 4-2. 
 
Species Comparison t value df Adjusted p-value 
E. quadrivirgata liver vs. kidney 2.7588 19 0.1250 
E. quadrivirgata heart vs. kidney -1.8851 19 0.5984 
E. quadrivirgata liver vs. gut 1.9529 19 0.5913 
E. quadrivirgata brain vs. kidney -1.7729 19 0.6461 
E. quadrivirgata heart vs. gut 1.0694 19 1.0000 
E. quadrivirgata liver vs. brain 1.1662 19 1.0000 
E. quadrivirgata gut vs. kidney -0.9175 19 1.0000 
E. quadrivirgata brain vs. gut -0.8734 19 1.0000 
E. quadrivirgata liver vs. heart 0.7717 19 1.0000 
E. quadrivirgata heart vs. brain 0.292 19 1.0000 
R. tigrinus heart vs. brain 4.3002 30 0.0020 
R. tigrinus heart vs. gut 3.7845 30 0.0063 
R. tigrinus kidney vs. brain 3.2176 30 0.0248 
R. tigrinus heart vs. liver -3.0116 30 0.0364 
R. tigrinus kidney vs. gut 2.7379 30 0.0618 
R. tigrinus kidney vs. liver -2.0189 30 0.2625 
R. tigrinus liver vs. brain 1.2476 30 0.8872 
R. tigrinus heart vs. kidney -0.8062 30 1.0000 
R. tigrinus liver vs. gut 0.7483 30 1.0000 
R. tigrinus gut vs. brain 0.4993 30 1.0000 
T. elegans kidney vs. liver -2.9554 19 0.0810 
T. elegans heart vs. liver -2.6725 19 0.1359 
T. elegans gut vs. liver -1.8779 19 0.6064 
T. elegans brain vs. liver -1.6671 19 0.6714 
T. elegans kidney vs. brain 1.8355 19 0.6064 
T. elegans kidney vs. gut 1.5513 19 0.6865 
T. elegans heart vs. brain 1.4446 19 0.6865 
T. elegans heart vs. gut 1.1603 19 0.7809 
T. elegans kidney vs. heart 0.3474 19 1.0000 
T. elegans gut vs. brain 0.2981 19 1.0000 
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Fig. 4-1. Ouabain inhibition curves for the five tissues compared in this study. Each 
graph represents a comparison of tissue sensitivity for all species. Data points represent 
mean IC50 values ± S.E. See Table 4-2 for results of statistical comparisons of these data. 
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Fig. 4-2. Ouabain inhibition curves of the three species used in this study. Each graph 
represents a comparison of the different tissue sensitivities within a species. Data points 
represent mean IC50 values ± S.E. See Table 4-3 for results of statistical comparisons of 
these data. 
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5. Discussion 
The results of this study provide a tissue-level physiological measurement of resistance in 
snakes that are and are not adapted to withstand lethal concentrations of cardiotonic 
steroids. As predicted we have found that in the non-resistant species, E. quadrivirgata, 
all tissues are sensitive to ouabain (Fig. 4-1 and 4-2). We also found that in the 
genetically resistant species, R. tigrinus and T. sirtalis, both the heart and the kidney are 
highly insensitive to ouabain (Table 4-1; Fig. 4-1). Since T. elegans is known to express 
significantly higher levels of the resistant NKA paralog, ATP1a3, in the heart compared 
to liver, gut, or kidney (Mohammadi et al., 2017a), it is not surprising that we observed 
low sensitivity in cardiac tissue. However, despite the comparatively low expression 
levels of ATP1a3 in the kidney, we observed equally low sensitivity of kidneys to 
ouabain, compared to heart tissue, in the resistant species. However, the kidneys’ 
importance in maintaining sodium balance in the body relies upon the activity of NKA 
(Ferrandi et al., 1996), which may require the tissue to maintain resistance against 
ingested cardiotonic steroids in snakes that feed on toads. Several hypotheses could 
explain the observed insensitivity of the kidney in spite of its low level of ATP1a3 
expression. The first is that an alternate paralog of NKA also possesses resistance-
conferring mutations, and that this alternate paralog is expressed at high levels in 
kidneys. Another possibility is that the kidneys simply express very high levels of non-
resistant NKA to compensate for those that are disabled by cardiotonic steroids. A recent 
investigation of the effects of resistance-conferring mutations on the ion transport activity 
of NKA in cardenolide-resistant insects showed that the same mutations that protect them 
from cardiotonic steroids ingested through their diet also compromise the enzyme’s 
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efficiency (Dalla and Dobler, 2016). These insects compensate for the loss of function in 
their resistant NKA by co-expressing a non-mutated paralog. 
Because the kidneys play an important role in the maintenance of sodium and 
potassium balance in the body, compromising the efficiency of NKA in that tissue can 
have negative physiological consequences (Ferrandi et al., 1996; Tipsmark and Madsen, 
2003). The kidneys are also theoretically more susceptible to toxicity than most organs, 
due to the high rate of blood flow through the kidneys, even in a resting state, resulting in 
a higher rate of toxin delivery than to many other tissues (Hura and Stein, 2011). 
Furthermore, kidney secretion and diffusion processes can allow toxins to concentrate 
locally within the organs, further exacerbating the effects of toxins (Dantzler, 1992). 
Thus, they are likely one of the first organs to evolve insensitivity or resistance via 
natural selection.  
 High sensitivity of brain tissue in both non-resistant and resistant species is not 
surprising, due to the presence of a blood-brain barrier in reptiles (Shivers, 1979). That 
barrier protects brain tissue from exposure to circulating toxins, including ingested 
cardiotonic steroids (Shivers, 1979; Abbott et al., 2010). Thus, there would be no 
selective pressure to protect the NKA in those tissues from such toxins.  
 Perhaps the most interesting result of this study was the relatively high 
sensitivities of the gut and liver compared to the heart and kidney in resistant species 
(Tables 4-1 and 4-3; Fig. 4-2). The variation in sensitivity between different tissues 
within a resistant snake indicates the presence of complex physiological mechanisms 
involved in the uptake, transport, and metabolism of dietary cardiotonic steroids. One 
explanation could be related to how cardiotonic steroids are transported in the body. We 
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know that cardiotonic steroids are produced from cholesterol in the adrenal glands of 
mammals (Dmitrieva et al., 2000). As such, it is likely that these compounds are 
transported throughout the circulatory system in a manner similar to the transport of other 
adrenal steroid hormones.  
Corticosteroid binding globulins transport steroid hormones through the 
bloodstream (Dunn et al., 1981; Rosner, 1990; Antolovic et al., 1998; Rosner et al., 1999; 
Schoner, 2002). Mammals possess a cardiotonic steroid-specific binding globulin that 
binds to the steroids with high affinity, inhibiting their function (Antolovic et al., 1998; 
Antolovic et al., 2000; Schoner et al., 2003). Interestingly, these binding globulins are 
produced at high concentrations in the kidneys of mammals, where they likely protect the 
NKAs of those tissues from endogenous cardiotonic steroids (Antolovic et al., 2000). We 
have no knowledge of any analogous mechanisms in reptiles, and further work is needed 
to determine whether protection of tissues via sequestration of bufadienolides occurs in 
snakes. 
 One final relevant outcome of these results involves the biphasic character of 
sensitivity curves. All species exhibited evidence of a biphasic response to ouabain in the 
heart, gut, and liver as indicated by the discontinuous decline in NKA activity of the data 
points (Fig. 4-1 and 4-2). The discontinuous decline indicates the co-existence of at least 
two forms of NKA with different ouabain sensitivities in these tissues (Blanco and 
Mercer, 1998). However, further work is necessary to confirm whether multiple forms of 
NKA do indeed occur in these tissues. 
 Although the results of this study provide important information on the 
physiological mechanisms of cardiotonic steroid resistance in snakes, they present only a 
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superficial view of what increasingly appears to be a complex adaptive system. Future 
work should aim to determine the routes of uptake, metabolism, and excretion of ingested 
bufadienolides in order to better understand the physiology of this dietary adaptation in 
snakes. 
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CHAPTER 5 
CORTICOSTEROID RESPONSES OF SNAKES TO TOXINS FROM TOADS 
(BOFADIENOLIDES) AND PLANTS (CARDENOLIDES) REFLECT DIFFERENCES 
IN DIETARY SPECIALIZATIONS 
 
 
 
 Toads are chemically defended by cardiotonic steroids known as bufadienolides. 
Resistance to the acute effects of bufadienolides in snakes that prey on toads is conferred 
by target-site insensitivity of the toxin’s target enzyme, the Na+/K+-ATPase. Previous 
studies have focused largely on the molecular mechanisms of resistance but have not 
investigated the physiological mechanisms or consequences of exposure to the toxins. 
Adrenal enlargement in snakes often is associated with specialization on a diet of toads. 
These endocrine glands are partly composed of interrenal tissue, which produces the 
corticosteroids corticosterone and aldosterone. Corticosterone is the main hormone 
released in response to stress in reptiles, and aldosterone plays an important role in 
maintaining ion balance through upregulation of Na
+
/K
+
-ATPase. We tested the 
endocrine response of select species of snakes to acute cardiotonic steroid exposure by 
measuring circulating aldosterone and corticosterone concentrations. We found that 
Rhabdophis tigrinus, which specializes on a diet of toads, responds with lower 
corticosterone and higher aldosterone compared to other species that exhibit target-site 
resistance to the toxins but do not specialize on toads. We also found differences between 
sexes in R. tigrinus, with males generally responding with higher corticosterone and 
aldosterone than females. This study provides evidence of physiological adaptations, 
beyond target-site resistance, associated with tolerance of bufadienolides in a specialized 
toad-eating snake. 
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1. Introduction 
Toads (Bufonidae) are defended by potent cardiotonic steroid toxins known as 
bufadienolides (BDs), which are synthesized from cholesterol in their cutaneous glands 
and stored there in high concentrations (Krenn and Kopp, 1998). Those toxins protect 
toads from most predators, including many snakes that feed readily on other groups of 
frogs. Nonetheless, bufophagy (toad-eating) has evolved in several phylogenetically 
distant lineages of snakes (Mohammadi et al., 2016a; Ujvari et al., 2015; Mohammadi et 
al., 2013), which have evolved the ability to tolerate the normally lethal BDs of toads 
(Mohammadi et al., 2016b). At least one of those lineages has also evolved the ability to 
sequester, or store, those toxins for use in its own defense (Mori, 2012; Hutchinson et al., 
2012). 
Cardenolides (CDs) are another class of cardiotonic steroid and are primarily 
produced from sterols in plants (Agrawal et al., 2012). As with BDs, certain animals have 
evolved resistance to CDs, and a number of insect species can sequester the compounds 
for use in their own defense (reviewed in Opitz and Müller, 2009). Although the 
molecular structures of BDs and CDs are similar (Fig. 5-1; Córdova et al., 2016; Agrawal 
et al., 2012), there is evidence that the two classes of compounds have differing degrees 
of toxicity, at least in mammals (Barrueto et al., 2006). Both BDs and CDs exert their 
toxic effects by binding to an extracellular pocket of the membrane-bound enzyme 
Na
+
/K
+
-ATPase, rendering the molecule nonfunctional (Laurson et al., 2015; Schoner and 
Scheiner-Bobis, 2007; Krenn and Kopp, 1998). Furthermore, the discovery of 
endogenous CDs and BDs in mammals has shed new light on the significance of these 
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compounds, and the endogenous compounds are regarded as serving a hormonal function 
in the regulation of blood pressure (Dmitrieva et al. 2000; Dvela et al., 2007). 
 Comparisons of genetic sequences coding for the binding pocket have revealed 
that lowered affinity to binding of BDs in reptiles is conferred by at least two co-
occurring amino acid substitutions on the first extracellular loop of the Na
+
/K
+
-ATPase 
(Ujvari et al., 2015). However, the presence of those amino acid substitutions is 
widespread among snakes (Mohammadi et al., 2016a), suggesting that target-site 
insensitivity may not be the only adaptation that confers resistance in snakes that prey 
heavily on toads. Insects that consume CDs exhibit several mechanisms of resistance, 
including detoxification by enzymes, excretion, and exclusion, in addition to target-site 
insensitivity conferred by mutations (Petschenka et al., 2013a; Petschenka et al., 2013b; 
Després et al., 2007; Scudder and Meredith, 1982). It is likely that a high level of 
bufophagy also requires more than one mechanism of resistance. Consumption of highly 
toxic prey is advantageous to a predator because it provides access to an underutilized 
dietary resource and in some cases permits sequestered chemical defense (Hutchinson et 
al., 2007; Darst et al., 2005; Nishida 2002). However, those advantages may be 
accompanied by the physiological stress of metabolizing the toxins, or they might require 
upregulation of the target proteins, perhaps mediated by hormones. To understand the 
origin and retention of an adaptation such as bufophagy, it is essential to determine 
whether there are physiological trade-offs associated with expression of the adapted 
phenotype. Therefore, it is necessary to combine genetic screens with physiological 
assays. This can be achieved by comparing physiological responses to toxin exposure in 
species that do and do not exhibit the dietary adaptation. 
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 Vertebrates possess a suite of physiological responses to external challenges 
(Neuman-Lee et al., 2016a; Love and Williams, 2008; McEwen, 2007; Råberg et al., 
1998), and the hypothalamic-pituitary-adrenal (HPA) axis constitutes one of the most 
conserved mechanisms underlying these responses (Wingfield, 2005; Wingfield and 
Romero, 2001). The HPA axis interacts with other physiological systems by activating 
and/or suppressing a physiological cascade that stimulates hormonal secretion from the 
adrenal glands (Dhabhar, 2009; Norris, 2006; Sapolsky et al., 2000). Because 
enlargement of the adrenals is associated with bufophagy in several independent lineages 
of snakes (Mohammadi et al., 2013), investigation of the adrenal response to BD 
consumption is warranted. Adrenal enlargement in some vertebrates has been linked to 
chronic stress, which results in hypertrophy and increased activity of the tissues that 
produce stress-related corticosteroids (Ulrich-Lai et al., 2006; Fickess, 1963). Adrenal 
tissues of amniotes consist of chromaffin cells, which produce catecholamines, and 
interrenal cells, which produce glucocorticoids and mineralocorticoids (Norris, 2006). 
These hormones may play a role in offsetting the toxic effects of cardiotonic steroid 
ingestion. As such, enlargement of the adrenal glands would be beneficial by allowing 
higher-level production of these hormones. It is not yet known which of the adrenal 
tissues is responsible for the overall enlargement of the glands in bufophagous snakes, 
although the effect of BDs on Na
+
/K
+
-ATPase suggests that the interrenal tissue is a 
likely candidate. 
Corticosterone is the primary glucocorticoid metabolite in reptiles (Norris, 2006; 
Moore & Jessop 2003), and it plays important roles in mediating trade-offs during the 
stress response (Sapolsky et al., 2000). Accordingly, plasma corticosterone levels are 
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used as a standard hormonal measure of organismal stress in a wide range of experiments 
(Hopkins et al., 2016; French, 2008, 2007; Moore et al., 2000). Aldosterone is the 
primary mineralocorticoid hormone and is essential for maintaining sodium 
concentration, water balance, and blood pressure (Weber, 2001). The role of aldosterone 
as a signal for the expression of Na
+
/K
+
-ATPase has been widely investigated (Summa et 
al., 2001; Ahmad and Medford, 1995; Ewart and Klip, 1995; Oguchi et al., 1993; Ikeda et 
al., 1991; Verrey et al., 1987). This role suggests that adrenal enlargement in 
bufophagous snakes might be a result of increased aldosterone production, which could 
play a compensatory role in counteracting BDs by upregulating resistant Na
+
/K
+
-
ATPases. Indeed, significant upregulation of resistant Na
+
/K
+
-ATPases has been 
observed in the cardiac tissues of snakes that were exposed to BDs (Mohammadi et al., 
2017).  
Diverse bufophagous snakes have also been found to possess adrenals that are not 
only enlarged but also sexually dimorphic in size, with males possessing significantly 
larger adrenal glands than females (Mohammadi et al., 2013). This pattern of sexual 
dimorphism has not been observed in snakes with non-toad-specialized diets 
(Mohammadi et al., 2013). To date, there is no explanation for this dimorphism, although 
Mohammadi et al. (2013) suggested that female bufophagous snakes might be 
provisioning BDs to their offspring, thereby reducing the degree to which the tissues of 
females are exposed to BDs. At least one species, Rhabdophis tigrinus, is known to 
provision its embryos with BDs (Hutchinson et al., 2008).  
 Here we compare acute hormonal responses to cardiotonic steroid exposure in 
select species of snakes representing three groups, classified by the amount of 
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physiological BD exposure the group typically encounters in the wild: highly 
bufophagous and BD-resistant (BR), generalist predator and BD-resistant (GR), and non-
bufophagous and genetically non-resistant (NN). We measured circulating corticosterone 
and aldosterone levels following exposure to either a low dose of a BD (gamabufotalin), 
a low dose of a CD (ouabain), or a high dose of the BD. We designed this study to be 
both exploratory and, in part, hypothesis-driven. Our predictions are based on three main 
hypotheses: (1) corticosterone and aldosterone responses differ based on the degree of 
dietary specialization on toads; (2) responses differ between sex in highly bufophagous 
snakes; and (3) BDs and CDs elicit different responses in all three dietary groups. We 
predicted that corticosterone would be elevated in those snakes that are non-resistant 
relative to those resistant taxa, and that aldosterone would be elevated in the species that 
most frequently ingests toads. We also predicted that the aldosterone levels would be 
elevated in males compared to females in the toad-specialized species. Finally, we 
predicted that BDs and CDs would elicit different hormonal responses in all taxa. 
 
 
2. Materials and Methods 
2.1 Study species and functional groups 
The six species used in this study were assigned to three groups according to their 
diets and their genetic tolerance of toad toxins. Logistic constraints on the availability of 
specimens precluded sufficient sample size for testing each species separately, so species 
were pooled into functional groups for analysis. Limits on the availability of species that 
could be collected from the wild also precluded replication of one of these functional 
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groups. Nonetheless, species was treated as a random-effects factor in the statistical 
analysis. Rhabdophis tigrinus was categorized as bufophagous and genetically resistant 
(BR). Although bufonids comprise a relatively small proportion of the species’ diet 
(Kojima and Mori, 2015), R. tigrinus sequesters BDs from toads for use in its own 
defense, thereby exposing at least some of its tissues to BDs for an extended period 
(Hutchinson et al., 2007). Furthermore, females of this species are known to forage 
preferentially for toads during the season when vitellogenesis occurs (Kojima and Mori, 
2015). The generalist and resistant group (GR) included the congeners Thamnophis 
sirtalis, T. elegans, and T. radix.  T. sirtalis and T. elegans occasionally include toads in 
their varied diets, whereas T. radix primarily consumes earthworms (Tuttle and Gregory, 
2009; Dalrymple and Reichenbach, 1981; Kephart and Arnold, 1982; Hart, 1979; Arnold, 
1978; Gregory and Stewart, 1975). All species, however, possess mutations of the 
Na
+
/K
+
-ATPase gene that confers target-site resistance (Mohammadi et al., 2016a). The 
BD-susceptible species Pituophis catenifer and Elaphe quadrivirgata, which prey 
primarily on mammals and non-bufonid anurans, respectively (Mori and Moriguchi, 
1988; Rodríguez‐ Robles, 2002; Hamanaka et al., 2014), lack the mutations that confer 
target-site insensitivity and thus were classified as non-bufophagous and non-resistant 
(NN). A total of 89 snakes were used in this study, although missing data reduced sample 
sizes for specific analyses (Tables 5-7 and 5-8).  
 
2.2. Snake collection and animal care 
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 Live snakes were collected from the field in Utah (Cache and Tooele Counties; 
permit no. 1COLL9134), Nebraska (Garden County; permit no. 477), and Japan (Kyoto, 
Okayama, Shizuoka, Shiga, Shimane, and Wakayama Prefectures; no permit required) 
(Table 5-7). Snakes were cared for and handled in accordance with Utah State University 
Institutional Animal Care and Use Committee (IACUC) regulations (protocol #2078), 
and with Kyoto University Graduate School of Science procedures (protocol #H2605). 
Snakes from Utah and Nebraska were brought to Utah State University (Logan, Utah, 
USA), housed individually in 37.8 L glass terraria with newspaper substrate, and 
provided with water ad libitum and a hide shelter. Snakes from Japan were brought to 
Kyoto University (Kyoto, Kyoto Prefecture, Japan) and housed separately in plastic 
terraria (18.9 L) with newspaper substrate, water ad libitum, and a hide shelter. 
Rhabdophis tigrinus and Elaphe quadrivirgata were fed frogs (Pelophylax 
nigromaculatus) collected from the field. R. tigrinus were fed twice per week due to this 
species’ unusually rapid starvation rate (unpublished), whereas E. quadrivirgata were fed 
once per week. All other snakes were fed commercially purchased thawed mice 
(RodentPro.com, LLC) once per week.  
 
2.3. Toxin challenges: hormonal responses to bufadienolide and cardenolide exposure 
 Body mass of each snake was measured one week prior to the start of the 
experiment and was used for calculations of mass-adjusted dosage. Individual BR and 
GR snakes were randomly assigned to one of three doses, regardless of sex: 1.49x10
-2 
M/g BD, 1.49x10
-2 
M/g CD, or 1.49x10
-1 
M/g BD, and NN snakes were randomly 
assigned to one of two doses: 1.49x10
-2 
M/g BD or 1.49x10
-2 
M/g CD. The 1.49x10
-2 
M/g 
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dose was selected because it represents the minimum lethal concentration for non-
resistant snakes (Mohammadi et al., 2016b), and we were interested in comparing 
physiological effects between resistant and non-resistant species groups. A 10-fold higher 
dose, 1.49x10
-1 
M/g BD, was administered only to the two resistant species groups, to 
approximate more closely the amount of BD a snake might encounter from consumption 
of a whole toad (Mohammadi et al., 2016b; Córdova et al., 2016; Hutchinson et al., 2012; 
Zelnik, 1965).  
 A total of 89 adult snakes (Table 5-7; 34 females and 55 males) were tested two 
times in a repeated measures design, first for a control challenge and later for a treatment 
challenge (these constituted two levels of response measurements in the experimental 
design). Snakes were left in their respective terraria in a quiet room to acclimate 
undisturbed, except when fed, for one week. Following the acclimation week, control 
dose challenges were administered. Each snake was removed from its cage, and blood 
was collected from the caudal vein within three minutes (Romero and Butler, 2007) for 
measurement of baseline hormone levels. Immediately following the blood draw, the 
snake was administered a mass-adjusted intraperitoneal injection (delivered to the 
posterior region of the peritoneal cavity) of 5% dimethyl sulfoxide (DMSO; Fisher 
Scientific, Inc.) and then returned to its cage. DMSO served as the solvent for subsequent 
BD and CD doses and therefore represented the control challenge (Moon et al., 2004; 
Santos et al., 2003). Following the injection, the snakes were observed visually for 90 
minutes, for signs of a behavioral response. At 30 minutes post-injection (Neuman-Lee et 
al., 2016a; Romero and Butler, 2007) the snake was removed from its cage a second time, 
and blood was collected from the caudal vein for a measurement of response levels of 
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hormones. We note that the temporal scale of the blood sampling limited our ability to 
identify differences in temporal responses to the stressors between different species. Due 
to the exploratory nature of this study, we opted to use a single standardized time for 
comparisons across species groups. All blood samples were stored on ice for less than 
two hours. Plasma was then separated from blood cells by centrifugation and stored at -
20°C until assayed. Following the control dose challenge, snakes were left to re-acclimate 
in their terraria for an additional week. Following the re-acclimation week, the 
procedures were repeated with an injection of one of the three treatments, dissolved in 
5% DMSO. Snakes were administered either 1.49x10
-2 
M/g of a commercially available 
BD, gamabufotalin (PiChemicals ®, Lot # PI201406082068 and # PI1201206031583); a 
1.49x10
-2 
M/g dose of a commercially available CD, ouabain (Acrōs Organics, Lot # 
A0343825); or a 1.49x10
-1 
M/g dose of gamabufotalin. The 1.49x10
-2
 and 1.49x10
-1
 M/g 
doses will henceforth be referred to as the LOW and the HIGH doses, respectively.  
 
2.4. Hormone assay 
 Circulating corticosterone concentrations were determined by radioimmunoassay 
(RIA), using a previously described and validated method (Neuman-Lee et al., 2015; 
French et al., 2010). Circulating aldosterone concentrations were determined using a 
commercially purchased ELISA kit (Enzo Life Science Aldosterone ELISA, Lot # 
05151502B, 06231403, 06231403B, and 06231403C). Limited plasma volume resulted in 
the omission of three snakes (Table 5-7) from the corticosterone assay and 47 snakes 
from the aldosterone assay (see Table 5-7). Thus, of the 89 total snakes studied, 86 
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samples (33 females and 53 males) were assayed for corticosterone and 52 (24 females 
and 28 males) were assayed for aldosterone. 
Steroid hormones were extracted from samples using 30% ethyl acetate:isooctane, 
dried, and re-suspended in a buffer solution. Samples were assayed in duplicate for both 
corticosterone (MP Biomedicals, Lot # 3R3PB-19E) and aldosterone. The averages of the 
duplicates were used as the final value for statistical analyses. For the corticosterone RIA, 
the antibody cross-reactivity for corticosterone was 100%, with the next highest cross-
reactivity (deoxycorticosterone) occurring at 2.3% and all others <0.05%. The 
aldosterone ELISA cross-reactivity for aldosterone was 100%, with the next highest 
cross-reactivity (11-deoxycorticosterone) at 0.3% and all others <0.2%. We validated the 
ELISA with plasma samples and found a linearity of R
2 
= 0.966, and we tested for 
interference caused by samples with known quantities of aldosterone (5 pg/ml, 50 pg/ml, 
150 pg/ml). For each assay, we used aliquots of known hormone concentration to 
measure extraction recoveries. These recoveries were used to adjust final sample 
concentration values for any losses during the extraction procedures. Standards of known 
value and negative controls were included in every assay as references, to ensure 
accuracy. The mean intra-assay variation for corticosterone was 12.1% and accuracy was 
108.9%. The mean intra-assay variation for aldosterone was 8.05%, and accuracy was 
103.4%. 
 
2.5. Statistical analyses 
 One outlier (SM134; Table 5-7) was removed from the analyses because its 
baseline corticosterone values were abnormally high, and it was likely experiencing 
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physiological distress from an unknown source. Hormone measurements of 85 snakes (33 
females and 52 males) were thus used in the statistical analyses of corticosterone. Fifteen 
of these snakes (11 females and 4 males) were treated with HIGH BD and analyzed 
separately. Hormone measurements from 52 snakes (24 females and 28 males) were used 
in the statistical analyses of aldosterone. Sixteen of these snakes (10 females and 6 males) 
were treated with HIGH BD dose and analyzed separately. We calculated the Pearson’s 
correlation between baseline corticosterone and aldosterone levels and between response 
corticosterone and aldosterone levels, from plasma samples that were assayed for both 
hormones, to determine whether changes in circulating levels of one hormone influenced 
the other. There was a positive relationship between baseline corticosterone and 
aldosterone levels (r
2
 = 0.45, P = 0.0009, n = 49, CIs = 0.20-0.65). However, there was 
no relationship between response corticosterone and aldosterone levels (r
2
 = 0.23, P = 
0.1012, n = 49, CIs = -0.04-0.48). We therefore concluded that changes in circulating 
hormone levels in response to treatments were independent of one another.  
Baseline (i.e., pre-toxin injection) and response (i.e., post-toxin injection) 
hormone concentrations were log-transformed prior to analysis, to better meet 
assumptions of normality, homogeneity of variance, and linearity. The effects on 
circulating hormone concentrations in three groups of snakes of two toxins relative to 
solvent (5% DMSO) controls were assessed using an analysis of covariance in a split-plot 
design. Species group (BR, GR, or NN), treatment (LOW ouabain or gamabufotalin), sex 
(male or female) and challenge level (control or treatment) were incorporated as 
categorical fixed-effects factors. Due to low sample size and unbalanced sex distribution, 
sex was not included in the model for the analysis of aldosterone response to 
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gamabufotalin and ouabain. Individual snakes, nested within species, comprised the 
random-effects factor (i.e., experimental unit) for species group, treatment, and sex. 
Repeated measures on each snake comprised the random-effects factor associated with 
challenge level. Baseline hormone concentration prior to injection in each level was 
included as a fixed effects covariate to adjust for variable baseline levels among snakes. 
Using the ordinary least square method, we regressed mass against snout-vent-length for 
each species group and used the output residuals as body condition indices (Schulte-
Hostedde et al., 2005). Body condition indices were included as a fixed effects covariate 
to adjust for body condition variation among snakes. There was no evidence for 
interactions of mass with other fixed factors when included in the model, so we report 
here on a more parsimonious model that does not include those interactions. We used 
pre-planned contrasts with -Bonferroni corrections (Holm, 1979) when necessary to 
estimate the effects of treatment, relative to control, within each species group and 
between species groups.  
The models used to analyze corticosterone and aldosterone responses to HIGH 
gamabufotalin included only species group and challenge level as categorical fixed 
effects factors. Low sample size and unbalanced sex distribution precluded the inclusion 
of sex in these models. Other model details were as described above. 
Significance level was set at α = 0.05. All statistical analyses were performed 
using JMP 12.2.0 (SAS Institute Inc., 2015). 
 
3. Results 
3.1. Behavioral responses to treatment challenges 
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 All NN snakes challenged with LOW gamabufotalin displayed mouth-gaping and 
muscular tetany, followed by death within 40 minutes of dose administration. Similar 
responses were observed in NN snakes challenged with LOW ouabain, although the onset 
of these symptoms was delayed by approximately 30 minutes. Conversely, no BR snakes 
challenged with gamabufotalin or ouabain showed any behavioral signs of distress at any 
time following dose administration during the 90 minutes that they were monitored. 
Similarly, no GR snakes showed behavioral signs of distress in response to the 
gamabufotalin challenge. However, although all GR snakes survived the ouabain 
challenge, they reacted with occasional mouth gaping, body inversion, and cloacal 
eversion for the full 90 minutes of monitoring following exposure.  
 
3.2 Corticosterone response to LOW gamabufotalin and ouabain challenges 
 There were significant effects of species group, treatment, challenge level, sex, 
and the interaction of species group and treatment on corticosterone responses, and 
contrasts of factors revealed significant differences between several comparisons (see 
Tables 51 and 52 for a summary of these results). GR snakes had a higher corticosterone 
response than the other two species groups, which were not statistically distinguishable. 
Gamabufotalin elicited a stronger corticosterone response overall than did ouabain. The 
treatment challenge level elicited a stronger corticosterone response than the control 
challenge level. BR males had a higher corticosterone response than did females. See 
Figures 5-2A and 5-2B and 3 for graphs of raw data represented by this analysis. 
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3.3. Corticosterone response to HIGH gamabufotalin challenge (resistant species groups 
only) 
  There was a significant effect of species group on corticosterone response to the 
higher gamabufotalin dose (Table 5-3), with GR snakes having a higher response than 
BR snakes. There was no significant effect of challenge level or the interaction of 
challenge level and species group. See Figure 5-2C for raw data represented by this 
analysis. 
 
3.4. Aldosterone response to LOW gamabufotalin and ouabain challenges 
 There was a significant effect of species group on aldosterone response (Tables 5-
4 and 5-5), with BR snakes having a higher response than GR or NN snakes. However, 
there were no significant effects of treatment, challenge level, sex, or the interactions of 
these factors on aldosterone response (Table 5-4). See Figures 5-4A and 5-4B and 5-5 for 
graphs of raw data represented by this analysis. 
 
3.5. Aldosterone response to HIGH gamabufotalin challenge (resistant species groups 
only) 
 There was a significant effect of species group on aldosterone response to the 
higher dose of gamabufotalin (Table 5-6), with BR snakes having a higher response. 
There were no significant effects of challenge level or interactions of species group with 
challenge level. See Figure 5-5 for raw data represented by this analysis. 
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4. Tables and Figures 
 
Table 5-1. Summary of ANCOVA results for the analysis of LOW doses of 
gamabufotalin and ouabain on corticosterone response. Factors and interactions of factors 
that had significant effects on corticosterone response are bolded.  
 
Effect Tests df F ratio p-value 
baseline 
body condition 
1, 112 
1, 60 
15.5405 
0.0018 
0.0001 
0.9662 
species group 2, 56 18.8195 <0.0001 
treatment 1, 57 7.7644 0.0072 
challenge level 1, 64 10.7958 0.0017 
sex 1, 61 9.7322 0.0027 
species group*treatment 2, 56 3.6123 0.0335 
species group*challenge level 2, 65 2.413 0.0975 
species group*sex 2, 58 2.2569 0.1137 
treatment*challenge level 1, 63 2.2937 0.1349 
treatment*sex 1, 55 3.7673 0.0573 
species group*treatment*challenge level 2, 65 2.2255 0.1162 
species group*treatment*sex 2, 56 0.539 0.5863 
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Table 5-2. Summary of contrasts for the analysis of LOW doses of gamabufotalin and 
ouabain on corticosterone response. Patterns of interest observed in raw data prompted 
contrasts of species group* treatment*challenge level despite non-significant p-value for 
the interaction effect (see Table 1). P-values for contrast comparisons were adjusted 
using Holm-Bonferroni corrections. Contrast comparisons that were significantly 
different are bolded. 
 
Contrasts adjusted p-value 
BR vs. GR <.0001 
BR vs. NN 0.1948 
NN vs. GR <.0001 
BR – gamabufotalin vs. ouabain 0.2958 
GR – gamabufotalin vs. ouabain 0.6336 
NN – gamabufotalin vs. ouabain 0.0003 
gamabufotalin – BR vs. NN 0.0012 
gamabufotalin – BR vs. GR <0.0001 
gamabufotalin – GR vs. NN 0.0484 
ouabain – BR vs. NN 0.5640 
ouabain – BR vs. GR 0.0120 
ouabain – GR vs. NN 0.0002 
BR – males vs. females 0.0132 
BR – gamabufotalin control vs. treatment 1.0000 
BR – ouabain control vs. treatment 1.0000 
GR – gamabufotalin control vs. treatment 1.0000 
GR – ouabain control vs. treatment 0.0001 
NN – gamabufotalin control vs. treatment 0.9256 
NN – ouabain control vs. treatment 0.1940 
 
 
Table 5-3. Summary of ANCOVA results for the analysis of HIGH doses of 
gamabufotalin on corticosterone response. Factors that had significant effects on 
corticosterone response are bolded.  
 
 
Effect Tests df F ratio p-value 
baseline 
body condition 
1, 16 
1, 11 
59.6986 
2.225 
<.0001 
0.1648 
species group 1, 11 11.276 0.0067 
challenge level 1, 13 3.5542 0.0819 
species group*challenge level 1, 13 0.107 0.7489 
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Table 5-4. Summary of ANCOVA results for the analysis of LOW doses of 
gamabufotalin and ouabain on aldosterone response. Factors and interactions of factors 
that had significant effects on corticosterone response are bolded.  
 
Effect Tests df F ratio p-value 
baseline 1, 45 9.8024 0.0031 
body condition 1, 26 8.0125 0.0088 
species group 2, 26 8.0471 0.0019 
treatment 1, 25 0.8467 0.3662 
challenge level 1, 35 0.3289 0.5700 
sex 1, 25 0.3133 0.5806 
species group*treatment 2, 26 0.9804 0.3888 
species group*challenge level 2, 35 0.6090 0.5496 
species group*sex 2, 26 0.3874 0.6826 
treatment*challenge level 1, 35 0.0142 0.9058 
species group*treatment*challenge level 2, 34 0.4159 0.6631 
 
 
Table 5-5. Summary of contrasts for the analysis of LOW doses of gamabufotalin and 
ouabain on aldosterone response. P-values for contrast comparisons were adjusted using 
Holm-Bonferroni corrections. Contrast comparisons that were significantly different are 
also bolded. 
 
Contrasts adjusted p-value 
BR vs. GR 0.2196 
BR vs. NN 0.0015 
NN vs. GR 0.3255 
 
 
Table 5-6. Summary of ANCOVA results for the analysis of HIGH dose of 
gamabufotalin on aldosterone response. Factors and interactions of factors that had 
significant effects on corticosterone response are bolded.  
 
Effect Tests df F ratio p-value 
baseline 1, 22 6.5177 0.0181 
body condition 1, 12 1.6835 0.2183 
species group 1, 13 32.7168 <.0001 
challenge level 1, 14 0.6974 0.4173 
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species group*challenge level 1, 14 0.5822 0.4585 
 
 
 
Figure 5-1. Molecular structures of a bufadienolide (gamabufotalin) and a cardenolide 
(ouabain), redrawn from PubChem (2016a, b), depicting similarities and differences 
between the two cardiotonic steroid classes. Both compounds consist of a steroidal 
skeleton with a lactone ring attached to C17. Bufadienolides of toads differ from 
cardenolides by the presence of an additional carbon on the lactone ring and absence of a 
sugar moiety commonly attached to C3 in cardenolides. However, some bufadienolides 
of toads, known as bufotoxins, do have a suberylarginine side chain attached to C3. 
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Figure 5-2. Mean baseline (grey-hatched and solid grey bars) and response (black-
hatched and solid black bars) levels of corticosterone in (A) bufophagous and resistant 
(BR) (n = 8), generalist and resistant (GR) (n = 17), and non-resistant and non-
bufophagous (NN) (n = 15) snakes challenged with LOW dose of gamabufotalin; (B) BR 
(n = 7), GR (n = 14), and NN (n = 9) snakes challenged with a LOW dose of ouabain; (C) 
BR (n = 7) and GR (n = 8) snakes challenged with a HIGH dose of gamabufotalin. 
Control challenge was 5% DMSO. See Tables 5-1 and 5-3 for results of statistical 
analyses of these data. Error bars represent standard error.  
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Figure 5-3. Mean baseline (grey-hatched and solid grey bars) and response (black-
hatched and solid black bars) levels of corticosterone in (A) male and female 
bufophagous and resistant (BR) (male n = 3; female n = 5), generalist and resistant (GR) 
(male n = 12; female n = 5), and non-resistant and non-bufophagous (NN) (male n = 9; 
female n = 6) snakes challenged with a LOW dose of gamabufotalin and (B) male and 
female BR (male n = 6 female n = 1), GR (male n = 12; female n = 2), and NN (male n = 
6; female n = 3) challenged with a LOW
 
dose of ouabain. Control challenge was 5% 
DMSO. See Tables 5-1 and 5-2 for results of statistical analyses of these data. Error bars 
represent standard error.  
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Figure 5-4. Mean baseline (grey-hatched and solid grey bars) and response (black-
hatched and solid black bars) levels of aldosterone in (A) bufophagous and resistant (BR) 
(n = 6), generalist and resistant (GR) (n = 9), and non-resistant and non-bufophagous 
(NN) (n = 10) snakes challenged with a LOW dose of gamabufotalin; (B) BR (n = 5), GR 
(n = 2), and NN (n = 4) snakes challenged with a LOW dose of ouabain; (C) BR (n = 6) 
and GR (n = 10) snakes challenged with a HIGH dose of gamabufotalin. Control 
challenge was 5% DMSO. See Tables 5-4 to 5-6 for results of statistical analyses of these 
data. Error bars represent standard error. 
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Figure 5-5. Mean baseline (grey-hatched and solid grey bars) and response (black-
hatched and solid black bars) levels of aldosterone in (A) male and female bufophagous 
and resistant (BR) (male n = 2; female n = 4), generalist and resistant (GR) (male n = 7; 
female n = 2), and non-resistant and non-bufophagous (NN) (male n = 4; female n = 6) 
snakes challenged with a LOW dose of gamabufotalin and (B) male and female BR (male 
n = 3; female n = 2), GR (male n = 2; female n = 0), and NN (male n = 3; female n = 1) 
snakes challenged with a LOW
 
dose of ouabain. Control challenge was 5% DMSO. See 
Tables 5-4 and 5-5 for results of statistical analyses of these data. Error bars represent 
standard error.   
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Table 5-7. List of individuals with associated corticosterone and aldosterone measurements used in this study. Hormones that       
were not assayed for a given individual are indicated by a dot.  
 
  
ID Species Locality 
Species 
Group 
Sex Treatment 
Treatment 
Level 
Baseline 
Cort 
(ng/mL) 
Response 
Cort 
(ng/mL) 
Baseline 
Ald 
(pg/mL) 
Response 
Ald 
(pg/mL) 
1 2015-020 Rhabdophis tigrinus Okayama, JP BR M 1.49x10-2 M/g GB control 27.976 53.196 29.91 77.38 
  2015-020 Rhabdophis tigrinus Okayama, JP BR M 1.49x10-2 M/g GB toxin 43.132 86.045 36.40 251.32 
2 2015-046 Rhabdophis tigrinus Wakayama, JP BR F 1.49x10-2 M/g GB control 5.097 18.932 • • 
  2015-046 Rhabdophis tigrinus Wakayama, JP BR F 1.49x10-2 M/g GB toxin 13.463 33.742 • • 
3 2015-047 Rhabdophis tigrinus Wakayama, JP BR F 1.49x10-2 M/g GB control 12.883 30.278 31.62 100.24 
  2015-047 Rhabdophis tigrinus Wakayama, JP BR F 1.49x10-2 M/g GB toxin 5.177 20.968 17.89 85.38 
4 2015-048 Rhabdophis tigrinus Wakayama, JP BR M 1.49x10-2 M/g GB control 57.904 70.668 • • 
  2015-048 Rhabdophis tigrinus Wakayama, JP BR M 1.49x10-2 M/g GB toxin 48.128 75.727 • • 
5 2015-051 Rhabdophis tigrinus Wakayama, JP BR M 1.49x10-2 M/g GB control 24.764 54.384 17.15 114.93 
  2015-051 Rhabdophis tigrinus Wakayama, JP BR M 1.49x10-2 M/g GB toxin 43.109 47.846 21.64 80.30 
6 2015-052 Rhabdophis tigrinus Wakayama, JP BR F 1.49x10-2 M/g GB control 10.908 32.733 12.73 90.26 
  2015-052 Rhabdophis tigrinus Wakayama, JP BR F 1.49x10-2 M/g GB toxin 11.033 21.84 12.35 24.60 
7 2015-053 Rhabdophis tigrinus Wakayama, JP BR F 1.49x10-2 M/g GB control 11.884 12.631 12.10 39.92 
  2015-053 Rhabdophis tigrinus Wakayama, JP BR F 1.49x10-2 M/g GB toxin 6.173 13.598 19.19 23.55 
8 2016-068 Rhabdophis tigrinus Shimane, JP BR F 1.49x10-2 M/g GB control 6.957 13.631 15.54 48.82 
  2016-068 Rhabdophis tigrinus Shimane, JP BR F 1.49x10-2 M/g GB toxin 11.252 23.214 30.12 99.30 
9 2015-065 Rhabdophis tigrinus Sizuoka, JP BR F 1.49x10-2 M/g OB control 2.899 16.605 12.83 392.63 
  2015-065 Rhabdophis tigrinus Sizuoka, JP BR F 1.49x10-2 M/g OB toxin 7.855 14.254 12.56 30.29 
10 2015-028 Rhabdophis tigrinus Okayama, JP BR M 1.49x10-2 M/g OB control 22.689 60.047 17.05 102.45 
  2015-028 Rhabdophis tigrinus Okayama, JP BR M 1.49x10-2 M/g OB toxin 70.197 75.739 42.44 105.44 
11 2015-036 Rhabdophis tigrinus Kyoto, JP BR M 1.49x10-2 M/g OB control 25.302 52.538 • • 
  2015-036 Rhabdophis tigrinus Kyoto, JP BR M 1.49x10-2 M/g OB toxin 23.214 46.354 • • 
12 2015-008 Rhabdophis tigrinus Kyoto, JP BR M 1.49x10-2 M/g OB control 7.029 38.452 • • 
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  2015-008 Rhabdophis tigrinus Kyoto, JP BR M 1.49x10-2 M/g OB toxin 21.477 56.926 • • 
13 2015-009 Rhabdophis tigrinus Kyoto, JP BR M 1.49x10-2 M/g OB control 8.743 29.942 14.50 39.96 
  2015-009 Rhabdophis tigrinus Kyoto, JP BR M 1.49x10-2 M/g OB toxin 66.043 74.704 60.17 348.28 
14 2015-013 Rhabdophis tigrinus Okayama, JP BR M 1.49x10-2 M/g OB control 13.391 67.096 • • 
  2015-013 Rhabdophis tigrinus Okayama, JP BR M 1.49x10-2 M/g OB toxin 19.797 46.401 • • 
15 2015-016 Rhabdophis tigrinus Okayama, JP BR M 1.49x10-2 M/g OB control 35.148 60.333 23.30 27.24 
  2015-016 Rhabdophis tigrinus Okayama, JP BR M 1.49x10-2 M/g OB toxin 67.096 91.584 32.07 161.92 
16 2015-015 Rhabdophis tigrinus Okayama, JP BR F 1.49x10-1 M/g GB control 10.853 40.041 13.35 31.79 
  2015-015 Rhabdophis tigrinus Okayama, JP BR F 1.49x10-1 M/g GB toxin 13.754 32.098 29.81 134.14 
17 2015-084 Rhabdophis tigrinus Kyoto, JP BR F 1.49x10-1 M/g GB control 8.964 24.548 23.01 106.87 
  2015-084 Rhabdophis tigrinus Kyoto, JP BR F 1.49x10-1 M/g GB toxin 16.524 68.45 8.25 175.25 
18 2015-085 Rhabdophis tigrinus Kyoto, JP BR M 1.49x10-1 M/g GB control 5.473 19.69 15.89 105.20 
  2015-085 Rhabdophis tigrinus Kyoto, JP BR M 1.49x10-1 M/g GB toxin 24.36 103.961 19.12 145.46 
19 2015-086 Rhabdophis tigrinus Kyoto, JP BR F 1.49x10-1 M/g GB control 11.104 25.743 22.92 58.96 
  2015-086 Rhabdophis tigrinus Kyoto, JP BR F 1.49x10-1 M/g GB toxin 21.932 61.92 30.65 105.17 
20 2015-039 Rhabdophis tigrinus Kyoto, JP BR F 1.49x10-1 M/g GB control 78.681 83.18 21.63 62.59 
  2015-039 Rhabdophis tigrinus Kyoto, JP BR F 1.49x10-1 M/g GB toxin 158.363 202.928 65.54 119.58 
21 2015-029 Rhabdophis tigrinus Okayama, JP BR F 1.49x10-1 M/g GB control 41.726 83.722 33.61 251.77 
  2015-029 Rhabdophis tigrinus Okayama, JP BR F 1.49x10-1 M/g GB toxin 86.31 150.087 45.23 255.04 
22 2015-011 Rhabdophis tigrinus Okayama, JP BR F 1.49x10-1 M/g GB control 16.982 56.269 9.89 72.98 
  2015-011 Rhabdophis tigrinus Okayama, JP BR F 1.49x10-1 M/g GB toxin 10.908 23.333 10.15 50.56 
23 989 Thamnophis elegans Cache Co., UT, USA FR F 1.49x10-2 M/g GB control 22.595 60.314 14.23 51.30 
  989 Thamnophis elegans Cache Co., UT, USA FR F 1.49x10-2 M/g GB toxin 38.653 64.63 11.64 28.46 
24 990 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-2 M/g GB control 41.94 63.189 21.56 35.18 
  990 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-2 M/g GB toxin 25.043 37.593 9.43 21.95 
25 995 Thamnophis elegans Cache Co., UT, USA FR F 1.49x10-2 M/g GB control 41.18 103.275 • • 1
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  995 Thamnophis elegans Cache Co., UT, USA FR F 1.49x10-2 M/g GB toxin 36.949 50.629 • • 
26 997 Thamnophis elegans Cache Co., UT, USA FR F 1.49x10-2 M/g GB control 33.893 35.69 • • 
  997 Thamnophis elegans Cache Co., UT, USA FR F 1.49x10-2 M/g GB toxin 62.85 80.428 • • 
27 1003 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-2 M/g GB control 66.422 94.444 100.21 162.11 
  1003 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-2 M/g GB toxin 46.376 64.096 26.24 34.69 
28 1006 Thamnophis sirtalis Cache Co., UT, USA FR M 1.49x10-2 M/g GB control 56.952 74.894 • • 
  1006 Thamnophis sirtalis Cache Co., UT, USA FR M 1.49x10-2 M/g GB toxin 60.367 74.673 • • 
29 1007 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-2 M/g GB control 93.958 94.444 • • 
  1007 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-2 M/g GB toxin 92.215 198.553 • • 
30 SM83 Thamnophis sirtalis Garden Co., NE, USA FR M 1.49x10-2 M/g GB control 56.362 67.079 86.23 57.83 
  SM83 Thamnophis sirtalis Garden Co., NE, USA FR M 1.49x10-2 M/g GB toxin 37.177 96.305 13.43 31.99 
31 SM86 Thamnophis sirtalis Garden Co., NE, USA FR F 1.49x10-2 M/g GB control 103.907 93.958 66.52 46.58 
  SM86 Thamnophis sirtalis Garden Co., NE, USA FR F 1.49x10-2 M/g GB toxin 65.885 113.912 31.41 44.88 
32 SM91 Thamnophis sirtalis Garden Co., NE, USA FR M 1.49x10-2 M/g GB control 74.673 98.351 • • 
  SM91 Thamnophis sirtalis Garden Co., NE, USA FR M 1.49x10-2 M/g GB toxin 99.774 92.603 • • 
33 SM93 Thamnophis radix Garden Co., NE, USA FR M 1.49x10-2 M/g GB control 51.096 124.492 • • 
  SM93 Thamnophis radix Garden Co., NE, USA FR M 1.49x10-2 M/g GB toxin 56.655 114.485 • • 
34 SM97 Thamnophis radix Garden Co., NE, USA FR F 1.49x10-2 M/g GB control 65.885 92.215 15.23 19.85 
  SM97 Thamnophis radix Garden Co., NE, USA FR F 1.49x10-2 M/g GB toxin 93.958 190.042 18.60 23.14 
35 SM99 Thamnophis radix Garden Co., NE, USA FR M 1.49x10-2 M/g GB control 58.458 58.378 30.59 30.35 
  SM99 Thamnophis radix Garden Co., NE, USA FR M 1.49x10-2 M/g GB toxin 27.677 45.399 47.93 176.78 
36 SM100 Thamnophis radix Garden Co., NE, USA FR M 1.49x10-2 M/g GB control 77.307 82.239 • • 
  SM100 Thamnophis radix Garden Co., NE, USA FR M 1.49x10-2 M/g GB toxin 87.737 115.125 • • 
37 SM130 Thamnophis sirtalis Cache Co., UT, USA FR M 1.49x10-2 M/g GB control 43.711 58.449 13.64 13.91 
  SM130 Thamnophis sirtalis Cache Co., UT, USA FR M 1.49x10-2 M/g GB toxin 45.637 100.336 12.30 47.80 
38 SM133 Thamnophis sirtalis Cache Co., UT, USA FR M 1.49x10-2 M/g GB control 85.78 85.235 27.23 93.58 
  SM133 Thamnophis sirtalis Cache Co., UT, USA FR M 1.49x10-2 M/g GB toxin 58.949 84.526 33.00 94.00 
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39 SM101 Thamnophis radix Garden Co., NE, USA FR M 1.49x10-2 M/g OB control 117.847 113.912 • • 
  SM101 Thamnophis radix Garden Co., NE, USA FR M 1.49x10-2 M/g OB toxin 160.789 246.459 • • 
40 SM94 Thamnophis radix Garden Co., NE, USA FR M 1.49x10-2 M/g OB control 51.618 48.202 • • 
  SM94 Thamnophis radix Garden Co., NE, USA FR M 1.49x10-2 M/g OB toxin 51.884 61.315 • • 
41 SM92 Thamnophis radix Garden Co., NE, USA FR F 1.49x10-2 M/g OB control 22.046 22.482 • • 
  SM92 Thamnophis radix Garden Co., NE, USA FR F 1.49x10-2 M/g OB toxin 18.918 24.091 • • 
42 SM84 Thamnophis sirtalis Garden Co., NE, USA FR M 1.49x10-2 M/g OB control 76.971 62.794 46.35 58.72 
  SM84 Thamnophis sirtalis Garden Co., NE, USA FR M 1.49x10-2 M/g OB toxin 51.369 69.772 53.26 85.46 
43 976 Thamnophis sirtalis Cache Co UT, USA FR M 1.49x10-2 M/g OB control 61.691 78.837 • • 
  976 Thamnophis sirtalis Cache Co UT, USA FR M 1.49x10-2 M/g OB toxin 84.808 167.232 • • 
44 SM131 Thamnophis sirtalis Garden Co, NE, USA FR M 1.49x10-2 M/g OB control 122.126 81.984 • • 
  SM131 Thamnophis sirtalis Garden Co, NE, USA FR M 1.49x10-2 M/g OB toxin 67.749 169.53 • • 
45 1004 Thamnophis sirtalis Cache Co., UT, USA FR M 1.49x10-2 M/g OB control 52.062 59.852 • • 
  1004 Thamnophis sirtalis Cache Co., UT, USA FR M 1.49x10-2 M/g OB toxin 51.884 97.823 • • 
46 1005 Thamnophis sirtalis Cache Co., UT, USA FR M 1.49x10-2 M/g OB control 84.808 99.774 • • 
  1005 Thamnophis sirtalis Cache Co., UT, USA FR M 1.49x10-2 M/g OB toxin 90.535 291.681 • • 
47 SM132 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-2 M/g OB control 121.005 153.516 • • 
  SM132 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-2 M/g OB toxin 101.09 164.171 • • 
48 SM134 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-2 M/g OB control 87.667 315.133 • • 
  SM134 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-2 M/g OB toxin 266.318 469.046 • • 
49 SM135 Thamnophis sirtalis Cache Co., UT, USA FR M 1.49x10-2 M/g OB control 48.393 64.977 • • 
  SM135 Thamnophis sirtalis Cache Co., UT, USA FR M 1.49x10-2 M/g OB toxin 46.53 53.439 • • 
50 SM105 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-2 M/g OB control 14.587 15.273 • • 
  SM105 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-2 M/g OB toxin 17.729 73.918 • • 
51 991 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-2 M/g OB control 51.618 35.991 • • 
  991 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-2 M/g OB toxin 81.491 111.371 • • 
52 992 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-2 M/g OB control 68.662 38.055 23.30 26.35 
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  992 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-2 M/g OB toxin 64.939 115.879 20.52 80.83 
53 993 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-2 M/g OB control 44.322 53.947 • • 
  993 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-2 M/g OB toxin 42.159 107.978 • • 
54 998 Thamnophis elegans Cache Co., UT, USA FR F 1.49x10-2 M/g OB control 46.995 97.823 • • 
  998 Thamnophis elegans Cache Co., UT, USA FR F 1.49x10-2 M/g OB toxin 70.322 105.815 • • 
55 KM31 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-1 M/g GB control 41.851 36.229 18.88 17.05 
  KM31 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-1 M/g GB toxin 41.851 90.677 18.49 35.04 
56 KM32 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-1 M/g GB control 26.419 46.686 17.83 21.44 
  KM32 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-1 M/g GB toxin 52.991 106.914 18.13 40.49 
57 KM33 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-1 M/g GB control 54.399 116.47 15.36 73.03 
  KM33 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-1 M/g GB toxin 16.892 114.448 19.55 42.62 
58 KM34 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-1 M/g GB control • • 8.13 20.16 
  KM34 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-1 M/g GB toxin • • 12.68 17.71 
59 KM35 Thamnophis elegans Cache Co., UT, USA FR F 1.49x10-1 M/g GB control 49.498 122.494 15.36 61.04 
  KM35 Thamnophis elegans Cache Co., UT, USA FR F 1.49x10-1 M/g GB toxin 68.276 99.902 16.42 14.68 
60 KM36 Thamnophis elegans Cache Co., UT, USA FR F 1.49x10-1 M/g GB control 43.597 75.708 13.97 41.45 
  KM36 Thamnophis elegans Cache Co., UT, USA FR F 1.49x10-1 M/g GB toxin 81.759 118.901 31.92 48.77 
61 KM37 Thamnophis elegans Cache Co., UT, USA FR F 1.49x10-1 M/g GB control 73.517 106.914 43.83 43.80 
  KM37 Thamnophis elegans Cache Co., UT, USA FR F 1.49x10-1 M/g GB toxin 73.896 141.966 17.68 47.56 
62 KM38 Thamnophis elegans Cache Co., UT, USA FR F 1.49x10-1 M/g GB control 20.028 34.244 17.31 40.44 
  KM38 Thamnophis elegans Cache Co., UT, USA FR F 1.49x10-1 M/g GB toxin 71.575 134.643 34.60 79.15 
63 KM39 Thamnophis elegans Cache Co., UT, USA FR F 1.49x10-1 M/g GB control 55.046 97.363 14.17 17.19 
  KM39 Thamnophis elegans Cache Co., UT, USA FR F 1.49x10-1 M/g GB toxin 15.2 33.915 20.98 65.79 
64 KM40 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-1 M/g GB control • • 10.30 31.18 
  KM40 Thamnophis elegans Cache Co., UT, USA FR M 1.49x10-1 M/g GB toxin • • 10.88 20.42 
65 SM110 Pituophis catenifer Tooele Co., UT, USA NR F 1.49x10-2 M/g GB control 62.183 68.317 • • 
  SM110 Pituophis catenifer Tooele Co., UT, USA NR F 1.49x10-2 M/g GB toxin 38.729 50.416 • • 
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66 SM140 Pituophis catenifer Garden Co., NE, USA NR M 1.49x10-2 M/g GB control 12.94 67.332 15.46 12.59 
  SM140 Pituophis catenifer Garden Co., NE, USA NR M 1.49x10-2 M/g GB toxin 25.116 48.061 9.60 12.27 
67 SM141 Pituophis catenifer Garden Co., NE, USA NR M 1.49x10-2 M/g GB control 12.446 35.338 8.53 17.86 
  SM141 Pituophis catenifer Garden Co., NE, USA NR M 1.49x10-2 M/g GB toxin 38.668 60.681 17.17 19.39 
68 SM143 Pituophis catenifer Garden Co., NE, USA NR M 1.49x10-2 M/g GB control 16.667 43.849 12.86 20.96 
  SM143 Pituophis catenifer Garden Co., NE, USA NR M 1.49x10-2 M/g GB toxin 38.403 22.105 16.01 52.40 
69 SM144 Pituophis catenifer Garden Co., NE, USA NR F 1.49x10-2 M/g GB control 9.475 22.703 • • 
  SM144 Pituophis catenifer Garden Co., NE, USA NR F 1.49x10-2 M/g GB toxin 15.387 68.283 • • 
70 SM145 Pituophis catenifer Garden Co., NE, USA NR M 1.49x10-2 M/g GB control 17.628 59.267 13.22 19.18 
  SM145 Pituophis catenifer Garden Co., NE, USA NR M 1.49x10-2 M/g GB toxin 41.784 62.744 18.10 21.72 
71 SM67 Pituophis catenifer Garden Co., NE, USA NR M 1.49x10-2 M/g GB control 37.261 51.356 • • 
  SM67 Pituophis catenifer Garden Co., NE, USA NR M 1.49x10-2 M/g GB toxin 16.261 20.168 • • 
72 2015-055 Elaphe quadrivirgata Kyoto, JP NR F 1.49x10-2 M/g GB control 8.921 45.181 10.42 29.74 
  2015-055 Elaphe quadrivirgata Kyoto, JP NR F 1.49x10-2 M/g GB toxin 40.945 133.79 22.07 35.34 
73 2015-058 Elaphe quadrivirgata Wakayama, JP NR M 1.49x10-2 M/g GB control 10.498 57.894 • • 
  2015-058 Elaphe quadrivirgata Wakayama, JP NR M 1.49x10-2 M/g GB toxin 5.549 123.798 • • 
74 2015-062 Elaphe quadrivirgata Wakayama, JP NR F 1.49x10-2 M/g GB control 65.974 78.155 57.23 147.36 
  2015-062 Elaphe quadrivirgata Wakayama, JP NR F 1.49x10-2 M/g GB toxin 57.653 62.331 60.44 88.80 
75 2015-063 Elaphe quadrivirgata Wakayama, JP NR M 1.49x10-2 M/g GB control 42.496 66.742 • • 
  2015-063 Elaphe quadrivirgata Wakayama, JP NR M 1.49x10-2 M/g GB toxin 17.407 99.945 • • 
76 2015-071 Elaphe quadrivirgata Shimane, JP NR M 1.49x10-2 M/g GB control 25.993 102.706 12.31 91.58 
  2015-071 Elaphe quadrivirgata Shimane, JP NR M 1.49x10-2 M/g GB toxin 37.781 81.365 24.65 39.39 
77 2015-081 Elaphe quadrivirgata Kyoto, JP NR M 1.49x10-2 M/g GB control 22.548 36.375 7.97 30.49 
  2015-081 Elaphe quadrivirgata Kyoto, JP NR M 1.49x10-2 M/g GB toxin 16.791 49.175 18.00 53.07 
78 2015-082 Elaphe quadrivirgata Kyoto, JP NR F 1.49x10-2 M/g GB control 10.366 62.999 7.40 23.07 
  2015-082 Elaphe quadrivirgata Kyoto, JP NR F 1.49x10-2 M/g GB toxin 5.433 125.432 13.99 145.41 
79 2015-083 Elaphe quadrivirgata Kyoto, JP NR F 1.49x10-2 M/g GB control 44 72.585 30.73 34.95 
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  2015-083 Elaphe quadrivirgata Kyoto, JP NR F 1.49x10-2 M/g GB toxin 0.531 129.484 20.48 131.69 
80 SM142 Pituophis catenifer Garden Co., NE, USA NR F 1.49x10-2 M/g OB control • • 24.37 14.92 
  SM142 Pituophis catenifer Garden Co., NE, USA NR F 1.49x10-2 M/g OB toxin • • 14.60 9.79 
81 SM108 Pituophis catenifer Tooele Co., UT, USA NR F 1.49x10-2 M/g OB control 14.74 9.585 • • 
  SM108 Pituophis catenifer Tooele Co., UT, USA NR F 1.49x10-2 M/g OB toxin 9.73 15.425 • • 
82 SM146 Pituophis catenifer Garden Co., NE, USA NR M 1.49x10-2 M/g OB control 21.547 34.298 15.67 18.70 
  SM146 Pituophis catenifer Garden Co., NE, USA NR M 1.49x10-2 M/g OB toxin 34.879 19.201 11.44 17.70 
83 SM147 Pituophis catenifer Garden Co., NE, USA NR M 1.49x10-2 M/g OB control 36.522 29.777 • • 
  SM147 Pituophis catenifer Garden Co., NE, USA NR M 1.49x10-2 M/g OB toxin 21.429 56.867 • • 
84 SM148 Pituophis catenifer Garden Co., NE, USA NR F 1.49x10-2 M/g OB control 19.951 20.745 • • 
  SM148 Pituophis catenifer Garden Co., NE, USA NR F 1.49x10-2 M/g OB toxin 19.918 31.222 • • 
85 SM62 Pituophis catenifer Garden Co., NE, USA NR M 1.49x10-2 M/g OB control 8.877 26.364 • • 
  SM62 Pituophis catenifer Garden Co., NE, USA NR M 1.49x10-2 M/g OB toxin 15.976 21.552 • • 
86 SM65 Pituophis catenifer Garden Co., NE, USA NR M 1.49x10-2 M/g OB control 36.949 35.69 • • 
  SM65 Pituophis catenifer Garden Co., NE, USA NR M 1.49x10-2 M/g OB toxin 22.482 31.893 • • 
87 SM66 Pituophis catenifer Garden Co., NE, USA NR F 1.49x10-2 M/g OB control 14.9775 24.219 • • 
  SM66 Pituophis catenifer Garden Co., NE, USA NR F 1.49x10-2 M/g OB toxin 13.621 35.997 • • 
88 2015-087 Elaphe quadrivirgata Shiga, JP NR M 1.49x10-2 M/g OB control 37.361 71.876 10.09 46.53 
  2015-087 Elaphe quadrivirgata Shiga, JP NR M 1.49x10-2 M/g OB toxin 27.998 91.129 19.40 123.38 
89 2015-088 Elaphe quadrivirgata Shiga, JP NR M 1.49x10-2 M/g OB control 5.701 16.708 7.27 20.63 
  2015-088 Elaphe quadrivirgata Shiga, JP NR M 1.49x10-2 M/g OB toxin 1.147 59.877 7.63 125.48 
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Table 5-8. Number of individuals used in experiment and statistical analyses. Individuals are divided by species group (BR, GR, 
NN), then species (Rhabdophis tigrinus, Thamnophis sirtalis, T. elegans, T. radix, Elaphe quadrivirgata, Pituophis catenifer),    
and finally treatment (LOW BD, LOW CD, HIGH BD) for (A) corticosterone measurements and (B) aldosterone measurements. 
 
 
A         BR (n = 22) 
 
B GR (n = 39) B NN (n = 24) 
Rhabdophis tigrinus Thamnophis sirtalis Thamnophis elegans Thamnophis radix Elaphe quadrivirgata Pituophis catenifer 
LOW 
BD 
LOW 
CD 
HIGH 
BD 
LOW 
BD 
LOW 
CD 
HIGH 
BD 
LOW 
BD 
LOW 
CD 
HIGH 
BD 
LOW 
BD 
LOW 
CD 
HIGH 
BD 
LOW 
BD 
LOW 
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5. Discussion 
Previous studies of the evolution of cardiotonic steroid resistance in vertebrates 
have focused largely on the comparative target-site sensitivity of Na
+
/K
+
-ATPase 
(Mohammadi et al., 2016a; Ujvari et al., 2015; Ujvari et al., 2013; Moore et al., 2009), 
and there have been few investigations of potential differences at the organismal scale. 
The results of this study demonstrate for the first time the effects of exposure to 
cardiotonic steroids on select endocrine responses of snakes. Our results also provide 
evidence for the presence of physiological adaptations beyond target-site insensitivity in 
Rhabdophis tigrinus, which has evolved dietary specialization involving consumption of 
toxic prey. Although the availability of experimental subjects limited us to a single toad-
eating specialist and required us to pool species in the GR and NN groups, we 
nonetheless observed variations in corticosteroid responses among the functionally 
different species groups. Future studies would benefit from testing these responses in 
additional toad-specialized species to determine whether our observations on R. tigrinus 
are associated with a dietary specialization on toads or other interspecific variation. 
An increase in corticosterone in response to a chemical stressor is not unusual and 
has been documented in a variety of species in response to various chemicals (Neuman-
Lee et al., 2016b; Adams et al., 2009; Franceschini et al., 2008; Hopkins et al., 1997). 
Differences in these responses may reflect species-specific physiological adaptations 
(Hopkins et al., 2016; Neuman-Lee et al., 2016a). We have shown that exposure to low 
concentrations of gamabufotalin elicits an increase in corticosterone in all three species 
groups. Although the treatment responses did not increase significantly compared to the 
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control responses (i.e., to 5% DMSO alone) within each group, the responses differed 
significantly between species groups (Fig. 5-2; Table 5-1).  
Contrary to our predictions, the stress responses to gamabufotalin and ouabain 
were not highest in NN snakes, which did not survive either treatment, but rather in GR 
snakes. Given the ubiquity of Na
+
/K
+
-ATPase among tissues, the effect on NN snakes 
may have been so rapid and profound that slower corticosterone responses were pre-
empted. The HPA axis is regulated by a potent negative feedback loop, and in some cases 
of disruption of physiological homeostasis the HPA axis can be suppressed (Dhabhar, 
2009; Miller et al., 2007; Rich and Romero, 2005). Such suppression of the HPA axis 
may have resulted from these acute stressors (Narayan and Hero, 2014). The ouabain 
response in the NN snakes was much lower than the gamabufotalin response (Fig. 5-2). 
This discrepancy might be explained by the fact that ouabain exposure took twice as long 
as gamabufotalin to elicit fatality in these snakes. It is thus possible that the low ouabain 
response of NN snakes reflected an inappropriately short post-injection effect window 
(i.e., 30 minutes post-injection) for this treatment in this species group. It is also possible 
that the stress response reached its maximum attainable level at these treatment 
concentrations (Hews and Baniki, 2013; Robert et al., 2009), masking any differences 
between the effects of BDs and CDs. Increasing the gamabufotalin dose 10-fold did not 
elicit a statistically significant response in GR and BR snakes. However, this treatment 
did cause an increased corticosterone response in the BR snakes that was not discernable 
at the lower dose (Fig. 5-2). 
Perhaps the most unexpected finding of this study was the strong behavioral 
response and elevated corticosterone level of GR snakes exposed to ouabain. Despite 
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high baseline corticosterone levels, which are normally associated with lowered 
corticosterone responses (Rich and Romero, 2005; Moore and Jessop, 2003), GR snakes 
exhibited a very high stress response to ouabain (Fig. 5-2). CDs differ from BDs by the 
possession of five, rather than six, carbons on the C17 lactone ring and often by the 
presence of a sugar moiety at C3 (Fig. 5-1). The sugar moiety significantly increases the 
polarity of the molecule, which can affect uptake and transport of the compound through 
the body (King and Mainwaring, 1974). CDs with different polarities have been shown to 
elicit significantly different cardiovascular effects in mammals (reviewed in Erdmann et 
al., 2013). Generally, non-polar CDs are absorbed more quickly by cells (Rasmann and 
Agrawal, 2011; Cavet et al., 1996), which suggests that BDs should be taken up more 
readily than CDs. However, the polarity of the steroids also affects their interactions with 
circulating binding globulins (Antolovic et al., 1998). It is conceivable that the 
composition and concentration of binding globulins in snakes that are specialized to prey 
on toads differ from those in snakes that simply exhibit target-site insensitivity but do not 
feed frequently on toads. Although there has been significant progress in our 
understanding of the physiological consequences of mammalian endogenous cardiotonic 
steroids, no comparable work has been conducted in reptiles. Future studies of that kind 
would greatly advance our understanding of the evolution of BD resistance in snakes. 
The results of the aldosterone assays revealed consistently higher responses in BR 
snakes than in either of the other species groups, regardless of treatment and challenge 
level (Fig. 5-4). BR snakes also had a higher aldosterone response compared to their 
corticosterone response, whereas the other two species groups had higher corticosterone 
responses than aldosterone. Furthermore, the 5% DMSO control dose seems to have had 
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a large effect on the aldosterone response of BR snakes (Figures 5-4 and 5-5), but that 
response was not observed in the other species groups. DMSO can cause vasodilation and 
decreased blood pressure (Jacob and Herschler, 1986) and can also affect renal function 
in mammals (Santos et al., 2003). The association between DMSO and osmoregulation 
suggests it may affect aldosterone, which plays a significant role in maintaining ion 
balance and blood pressure (Norris, 2006; Weber, 2001; Tuck et al., 1981; Laragh, 1973). 
However, it remains puzzling that these effects were absent in GR and NN snakes. The 
high aldosterone response of BR snakes could reflect the presence of more numerous 
aldosterone-producing interrenal cells in the adrenal glands. Importantly, aldosterone is 
strongly associated with regulation of Na
+
/K
+
-ATPase (Salyer et al., 2013; Ikeda et al., 
1991; Verrey et al., 1987). Ikeda et al. (1991) conducted a series of in vitro experiments 
in which they added aldosterone to cardiac cells. Those cells experienced a three-fold 
increase in Na
+
/K
+
-ATPase mRNA within six hours and reached a plateau in 12 hours, 
suggesting that aldosterone causes an increase in Na
+
/K
+
-ATPase content in cell 
membranes. It is conceivable that aldosterone plays a role in suppressing the toxic effects 
of dietary BDs in BR snakes by signaling the expression of the mutated Na
+
/K
+
-ATPase 
isoform (ATP1a3) in certain tissues, notably the heart and kidneys. The role of the latter 
in osmoregulation makes kidneys a likely target of increased aldosterone production. To 
confirm this relationship, the effects of aldosterone injections on expression levels of 
ATP1a3 should be tested in various tissues. 
Another interesting result of this study was the difference in corticosterone 
responses of male versus female BR snakes (Figs. 5-3). Although we were not able to test 
these differences statistically for the aldosterone responses, Figure 5-5 suggests that the 
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same pattern might hold true for this hormone. Sex differences in corticosterone levels in 
response to stress are known for other species of snakes (Neuman-Lee et al., 2016b; 
Sykes and Klukowski, 2009; Moore and Jessop, 2003). Comparisons of adrenal mass in 
bufophagous and non-bufophagous snakes not only revealed significant enlargement in 
most bufophagous species, including R. tigrinus, but also demonstrated sexual 
dimorphism in size, with males of those species having significantly larger adrenal glands 
than females (Mohammadi et al., 2013). The observed responses of both corticosterone 
and aldosterone to gamabufotalin in BR snakes are consistent with such sexual 
dimorphism, with hormonal responses of males being higher than those of females. Male 
responses to ouabain were also high, but female responses to both ouabain and to the 
DMSO control were equally high (whereas males did not exhibit high levels in response 
to DMSO). However, we note that the sample size for that group was small (n = 2), and 
the high response was driven by a single individual (2015-065; Table 5-7). Thus, the 
observed response may not represent an accurate measurement of that group’s response 
to the DMSO control. Although we do not yet know which adrenal tissues are enlarged in 
bufophagous snakes, the results of this study suggest that corticosteroid-producing 
interrenal tissues may be hypertrophied in both sexes and further enlarged in males.  
To date, there is no explanation for the sexual dimorphism in adrenal gland mass 
in BR snakes, nor for the sexual differences in hormonal responses that we observed. It is 
possible that, in addition to sequestering BDs from toads in their nuchal glands, males 
may be storing exogenous BDs in their adrenal glands, whereas females may transfer 
much of those BDs to their ova. In R. tigrinus, the BR species of this study, females can 
provision their offspring with exogenous BDs by transfer to the yolk and through direct 
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transfer to developing embryos in utero (Hutchinson et al., 2008). The adrenal glands are 
known to secrete and to store endogenous cardiotonic steroids in mammals (Manunta et 
al., 2009; Schoner, 2002; Kitano et al., 1998; Laredo et al., 1995; Laredo et al., 1994; 
Boulanger et al., 1993), so the tissue may have a particular affinity for these compounds. 
Indeed, Kitano et al. (1998) showed that exogenous ouabain, obtained from diet, 
accumulates in the adrenal glands of rats, and a similar mechanism might occur in BR 
snakes. Further work on the physiology of adrenal glands in snakes is needed to clarify 
these issues. Furthermore, given the ability of exogenous BDs from the female’s diet to 
accumulate in the nuchal glands of embryonic R. tigrinus, the effect of such compounds 
on the developing adrenals should also be investigated. 
In summary, this study reveals strong differences in corticosteroid hormone 
responses to cardiotonic steroids between a snake that exhibits dietary specialization on 
toads, snakes that possess genetic resistance to toad toxins but do not specialize on toads, 
and snakes that are not resistant to toad toxins. Whether these differences reflect dietary 
specialization alone or are also influenced by other interspecific differences remains to be 
determined. Furthermore, high aldosterone responses in the toad-specialized species 
suggest the occurrence of complex physiological adaptations beyond Na
+
/K
+
-ATPase 
target-site insensitivity, which has been the primary focus of previous studies on 
bufadienolide resistance in snakes. Although more comprehensive sampling of species is 
necessary to determine the extent of these patterns, this study provides an important basis 
for more expansive work. Furthermore, we have demonstrated increased adrenal hormone 
activity in response to acute cardiotonic steroid exposure in snakes. Chronic stress can 
have depressive effects on the HPA axis (Dhabhar, 2009; Rich and Romero, 2005), and 
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expanding this study to examine the effects of chronic BD exposure in snakes may 
provide results that are more ecologically relevant to the responses of toad-eating species 
to cardiotonic steroids. 
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CHAPTER 6 
THE EFFECTS OF CARDIOTONIC STEROID EXPOSURE ON CARDIAC 
CONTRACTILITY OF SNAKES THAT POSSESS RESISTANCE-CONFERRING 
MUTATIONS TO NA
+
/K
+
-ATPASE 
 
 
 
 Resistance to toad toxins (bufadienolides) in snakes is conferred by mutations of 
Na
+
/K
+
-ATPase, which lower the target enzyme’s affinity to the toxins. Previous studies 
have shown that, despite such genetic resistance, ingestion or exposure to bufadienolides 
can have negative physiological consequences in certain snakes. Bufadienolides are one 
of two classes of cardiotonic steroids, which have been used extensively throughout 
history, including in modern medicine, for their cardioactive properties. A recent upsurge 
of studies investigating the evolutionary origins of cardiotonic steroid resistance in a wide 
range of organisms has focused on the molecular mechanisms of this adaptation. Few 
studies have investigated the physiological responses to consumption of dietary 
cardiotonic steroids in vertebrates. A recent study revealed that the cardiac tissue of a 
genetically resistant species of snake expresses significantly higher levels of resistant 
Na
+
/K
+
-ATPase mRNA than other tissues, indicating the importance of the heart in 
resistance physiology. Here we tested the cardiac response of two species of genetically 
resistant natricine snakes (Thamnophis sirtalis and Rhabdophis tigrinus) to two classes of 
cardiotonic steroids (gamabufotalin, a bufadienolide, and ouabain, a cardenolide). We 
found that the two species responded differently to the two compounds. The 
bufadienolide had an overall depressive effect on the heart rate of T. sirtalis, whereas the 
cardenolide caused irregular heart rates. Neither compound had a strong effect on the 
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heart rate of R. tigrinus. This result is not surprising, inasmuch as R. tigrinus sequesters 
bufadienolide toxins in high concentrations in its defensive nuchal glands. 
 
INTRODUCTION 
Cardiotonic steroids include a wide variety of animal- and plant-derived toxins 
that affect cardiac contractility by binding to the α-subunit of the Na+/K+-ATPase of cell 
membranes and disabling the enzyme (Krenn and Kopp, 1998; Barrueto et al., 2006; 
Dvela et al., 2007). The deactivation of membrane Na
+
/K
+
-ATPases causes a cascade of 
intracellular ion imbalances, which result in strengthened and more frequent cardiac 
contractions, often with lethal consequences (Barry and Bridge, 1993; Rose and Valdes, 
Jr., 1994). Humans have exploited this mechanism for over 3,000 years, using these 
compounds to treat ailments of the heart (Krenn and Kopp, 1998; Schoner, 2002; 
Mijatovic et al., 2007). All cardiotonic steroids share the common structure of a steroidal 
skeleton with a lactone ring on C17 (Dvela et al., 2007). Primarily plant-derived 
cardiotonic steroids such as digitalis and ouabain, which contain a five-carbon lactone 
ring, are known as cardenolides (CDs) and have been widely used in contemporary 
Western pharmaceuticals (Schoner and Scheiner-Bobis, 2007; Prassas and Diamandis, 
2008). Primarily animal-derived cardiotonic steroids, which contain a six-carbon lactone 
ring, are known as bufadienolides (BDs; Krenn and Kopp, 1998). BDs are best known 
from toads (Bufonidae), but they also occur in fireflies (Lampyridae; Eisner, et al. 1978; 
Krenn and Kopp, 1998; Dvela et al., 2007), and a few plants (Krenn and Kopp, 1998). 
BDs are used in traditional Chinese medicine for purposes similar to the Western use of 
CDs (Gowda et al., 2003; Ma et al., 2012). Furthermore, both BDs and CDs are produced 
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by the adrenal cortex in mammals (Shaikh et al., 1991; Dmitrieva et al., 2000). Although 
previously regarded solely as defensive compounds, the ubiquity of cardiotonic steroids 
in organisms has shifted attention to their role as cardiovascular hormones (Dvela et al., 
2007). 
 Cardiotonic steroids affect Na
+
/K
+
-ATPases of all cells, but the effects on the 
heart have been traditionally deemed important because that is where the main 
therapeutic and lethal effects are known to occur (Barry and Bridges, 1993; Rose and 
Valdes 1994). In the heart, Na
+
/K
+
-ATPases act as indirect regulators of contractions by 
maintaining intracellular (Na⁺ ) levels. In a properly functioning cell, intracellular Ca²⁺  
ions are taken up by the sarcoplasmic reticulum, then released in controlled levels to 
sarcoplasm, where they bind to the protein complex troponin, causing a conformational 
change in actin and myosin filaments, which produces a contraction (Barry and Bridge, 
1993). When Na
+
/K
+
-ATPases are disabled, the membrane stops transporting Na⁺  out of 
the cell. The resulting elevated intracellular Na⁺  level deactivates the Ca²⁺ /Na⁺  
exchanger, which compensates for high Na⁺  levels by terminating its import into the 
cell. However, by doing so, the Ca²⁺ /Na⁺  exchanger also terminates the export of Ca²⁺  
out of the cell, causing an increase in intracellular Ca²⁺ . To rectify this further shift away 
from homeostasis, the cell moves the excess Ca²⁺  to the sarcoplasmic reticulum where, 
to regain equilibrium, it is then released to sarcoplasm in higher concentrations and at 
faster rates (Barry and Bridge, 1993). In myocardial cells, this shift can enhance 
contractile strength and heart rate. Thus, in low doses cardiotonic steroids can have 
beneficial effects on the heart. However, when Na
+
/K
+
-ATPases are disabled for a 
prolonged period, these symptoms can lead to arrhythmia and eventual cardiac failure 
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(Rose and Valdes, 1994). Many plants and animals produce or sequester lethal 
concentrations of these compounds as a means of chemical defense (Krenn and Kopp, 
1998; Hutchinson et al., 2007). 
 Although the quantities of BDs produced for chemical defense by toads are lethal 
to most organisms, certain species of snakes have evolved target-site insensitivity through 
mutations of Na
+
/K
+
-ATPase (Ujvari et al., 2015, Mohammadi et al., 2016a) and can 
tolerate the normally lethal effects of BDs (Mohammadi et al., 2016b). Target-site 
insensitivity has been identified in one of three isoforms of the Na
+
/K
+
-ATPase in snakes 
(Ujvari et al., 2015; Mohammadi et al., 2016a), and in at least one resistant species of 
snake the gene that encodes that isoform (ATP1a3) is expressed at significantly higher 
levels in the heart than in any other tissue (Mohammadi et al., 2017a). Physiological 
investigations of the trade-offs of exposure to cardiotonic steroids revealed significantly 
higher endocrine hormonal responses to cardiotonic steroids in resistant species of snakes 
compared to nonresistant species (Mohammadi et al., 2017b). These hormonal responses 
differed according to the snake’s potential level of toxin exposure in the wild and whether 
the snake was exposed to a BD or a CD. Snakes of the genus Thamnophis had a strong 
stress response to the CD, ouabain, whereas the BD-sequestering species Rhabdophis 
tigrinus did not, and neither had a strong stress response to the BD, gamabufotalin 
(Mohammadi et al., 2017b). On the other hand, R. tigrinus had a very strong aldosterone 
response to both the CD and BD, whereas the Thamnophis spp. did not (Mohammadi et 
al., 2017b). Furthermore, enlargement of the adrenal glands has been associated with 
snakes whose diets consist heavily (>80%) of toads (Mohammadi et al., 2013). Although 
these studies have indicated the presence of physiological consequences of cardiotonic 
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steroid exposure in resistant species, the exact physiological pathways involved in 
dealing with the toxins, beyond target-site insensitivity, remain to be elucidated. 
 To understand the physiology and trade-offs associated with evolved resistance to 
cardiotonic steroids in snakes, it is important to test the cardiac effects of the toxins in 
resistant species. One previous study investigated this question by measuring the effects 
of BDs on cardiac contractility of a resistant snake, Thamnophis sirtalis (Licht and Low, 
1968). The study revealed that at very high BD concentrations, T. sirtalis responded with 
cardiac arrhythmia, ventricular fibrillation, and tachycardia, which resulted in cardiac 
arrest 16 hours after exposure (Licht and Low, 1968). Although T. sirtalis is resistant and 
will feed on toads occasionally or heavily depending on the population, location, and 
season, they have a highly variable diet and do not specialize on toads (Gregory and 
Stewart, 1975; Gregory, 1978; Kephart and Arnold, 1982). Furthermore, Licht and Low 
(1968) tested exposure to crude toad BD extract from the cane toad, Rhinella marina, a 
genus of toad that the T. sirtalis does not normally encounter, and the highest 
concentration administered to the snakes exceeded the amount that could be collected 
from a single toad. We expanded upon that study by testing the cardiac response to both a 
BD and a CD in two species of resistant snakes. T. sirtalis is considered resistant but not 
chronically exposed to BDs under natural conditions, due to its highly variable diet. In 
contrast, the Japanese tiger keelback, R. tigrinus, is considered both resistant and 
chronically exposed to BDs. Although both species are usually occasional predators of 
toads (Gregory and Stewart, 1975; Arnold, 1978; Tanaka and Ota, 2002; Hirai, 2004), R. 
tigrinus stores dietary bufadienolides acquired from toads in its tissues (Hutchinson et al., 
2007), and we thus considered that species to be chronically exposed to the toxins under 
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natural conditions. We expected that T. sirtalis would respond to the toxins with a 
significant increase in heart rate, whereas R. tigrinus would not respond as strongly. 
 
MATERIALS AND METHODS 
Experimental animals 
 Snakes were collected from the field in Utah (Cache County; permit no. 
1COLL9134), Nebraska (Garden County; permit no. 477), and Japan (Kyoto, Okayama, 
Shimane, and Wakayama Prefectures; no permit required). A total of 27 snakes from two 
species (Thamnophis sirtalis and Rhabdophis tigrinus) were used in this experiment 
(Table 1).  
 All snakes were housed and cared for and handled in accordance with Utah State 
University Institutional Animal Care and Use Committee (IACUC) regulations (protocol 
#2078) and with Kyoto University Graduate School of Science (protocol #H2605). 
Snakes from Utah and Nebraska were brought to Utah State University (Logan, Utah, 
USA), housed individually in 37.8 L glass terraria with newspaper substrate, and 
provided with a hide shelter and water ad libitum. Snakes from Japan were brought to 
Kyoto University (Kyoto, Kyoto Prefecture, Japan) and housed separately in plastic 
terraria (18.9 L) with newspaper substrate, water ad libitum, and a hide shelter. R. 
tigrinus were fed frogs (Pelophylax nigromaculatus) collected from the field, twice per 
week, due to their unusually rapid rate of starvation (unpublished). T. sirtalis were fed 
commercially purchased thawed mice (RodentPro.com, LLC) once per week. 
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Heart rate monitoring  
 Snakes were removed from their terraria and palpated to determine the location of 
their heart. For each snake, small incisions of the skin were made on either side of the 
heart and either side of the trunk near the cloaca. Flat-tipped copper alligator clips were 
used as electrodes and were applied subcutaneously at each incision site, and the snake 
was then lightly taped to the bottom of a plastic container (54.5 cm l x 36.5 cm w x 14.5 
cm h) to restrain movement, which can cause fluctuations in heart rate and dislodge the 
electrodes. When the snake was secured, the leads from a heart monitor (CardiMax FX-
2111) were attached to the copper alligator clips, and the monitor was turned on to 
measure heart rate. The containers were covered with a thin cloth to provide shelter, and 
the snakes were left undisturbed to acclimate for one hour. Following acclimation, heart 
rate was recorded manually from the digital readout every minute for 20 minutes to 
collect an average baseline beats per minute (bpm) for each individual. At 21 minutes, 
each snake was given a randomly assigned, mass adjusted dose of either a control fluid 
(5% dimethyl sulfoxide (DMSO; Fisher Scientific, Inc.), 0.149 M/g of the BD 
gamabufotalin (GB; PiChemicals ®, Lot # PI201406082068 and # PI1201206031583), or 
0.149 M/g of the CD ouabain (OB; Acrōs Organics, Lot # A0343825) by intraperitoneal 
injection in the posterior trunk region (Mohammadi et al., 2016b). DMSO served as the 
solvent for the BD and CD solutions. The BD dose was selected based on previously 
published experiments and represents 100 times the intravenous LD50 of mice and 
approximately 10 times the intraperitoneal lethal dose for a non-resistant snake (Yoshida 
et al., 1976; Mohammadi et al., 2016b). Following injection, each snake was left to 
recover from the handling/injection stress for five minutes, and then the post-injection 
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heart rate was recorded every minute for 80 minutes. All experiments were performed at 
24-25°C. 
Statistical analysis 
 Data were analyzed for the effects of fixed and random factors on heart rate using 
a mixed-model repeated-measures ANOVA (treatment: control versus BD versus OB; 
species: R. tigrinus versus T. sirtalis; injection time: pre-injection baseline versus post-
injection response) x 101 (minutes: 1-101). Heart rate data were log-transformed to better 
meet the assumptions of homogeneity of variance and linearity. Individuals were 
considered a random factor nested within species. Pre-planned contrasts with Holm-
Bonferroni corrections were used to compare differences between factor levels. The 
statistical analysis was performed using JMP 12.2.0 (SAS Institute Inc., 2015). To 
account for missing data in some time series we also used a random coefficient model 
(Bliese and Ployhart, 2002) in R (R Core Team 2015) using the mixed model package 
nlme (Pinheiro and Bates, 2000). Our models analyzed the change in heart rate over 
time, with fixed effects for treatment and body mass and random effects for each 
individual snake nested within species. The significance level was set at α < 0.05 for all 
statistical comparisons.  
 
RESULTS 
 The mean baseline heart rates of T. sirtalis were 41 bpm prior to the control 
injection (5% DMSO), 46 (± 3.24 S.E.) bpm prior to OB, and 46 (± 2.09 S.E.) bpm prior 
to GB. Mean baseline heart rates of R. tigrinus were 55 (± 1.73 S.E.) bpm prior to the 
control injection (5% DMSO), 47 (± 1.83 S.E.) bpm prior to OB, and 44 (± 2.83) bpm 
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prior to GB. Mean post-injection heart rates of T. sirtalis were 37 (± 1.44 S.E.) bpm for 
control (5% DMSO), 47 (± 3.26 S.E.) bpm for OB, and 40 (± 1.04 S.E.) bpm for GB. 
Mean post-injection heart rates of R. tigrinus were 57 (± 2.32 S.E.) bpm for control (5% 
DMSO), 49 (± 1.77 S.E.) bpm for OB, and 47 (± 2.55 S.E.) bpm for GB. There was no 
indication of prolonged post-injection changes in heart rate in response to the control (5% 
DMSO) in either species (figs. 6-1A and 6-2A). OB exposure caused strong fluctuations 
in heart rate in T. sirtalis but not in R. tigrinus (fig. 6-1B and 6-2B). Furthermore, OB 
caused strong body movement responses in T. sirtalis that interfered with heart rate 
measurements, thereby significantly reducing the amount of data we were able to collect 
at each time point for that treatment. There was an overall depression of heart rate in GB-
treated T. sirtalis (fig. 6-1C). R. tigrinus exhibited prolonged variations in heart rate 
following injection of GB and decreased heart rate following injection of OB (fig. 6-2B 
and 6-2C).  
 The mixed-model repeated-measures ANOVA revealed significant effects of 
species, injection time, and time on heart rate. Significant two-way interactions of species 
x treatment, species x injection time, and treatment x injection time, and significant three-
way interactions of treatment x injection time x time on heart rate were also detected. See 
Table 6-2 for a summary of test results. Contrast analyses revealed significant differences 
between control and post-injection OB responses of T. sirtalis, and between control–OB 
and control–GB responses of R. tigrinus. Contrast analyses also revealed significant 
differences between pre-injection and post-injection heart rates of T. sirtalis exposed to 
OB and R. tigrinus exposed to OB. See Table 6-2 for a summary of contrast results. 
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Results from random coefficient models were in agreement with the above results. 
Our model showed that heart rate decreased over time in T. sirtalis given GB, with a 
significant three-way interaction among treatment, species, and time (Table 6-3; t = 
3.59(2440), p = 0.0003) 
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TABLES AND FIGURES 
 
 
Table 6-1. List of snakes used for this experiment, including locality, sex, morphometrics, treatment, mass of toxin administered,     
and volume of final solution. 
ID Species Locality Sex 
Mass  
(g) 
SVL 
(cm) 
TL 
(cm) 
Toxin administered 
 Mass toxin 
administered 
(mg) 
Volume  
injected 
(mL) 
2015-019 Rhabdophis tigrinus Tsuyama, Okayama F 70 652 829 0.149 M/g GB 7 1.167 
2015-045 Rhabdophis tigrinus Shizuhala, Kyoto F 118 771 951 0.149 M/g GB 11.8 1.967 
2015-005 Rhabdophis tigrinus Oheyama, Kyoto F 132 805 1017 0.149 M/g GB 13.2 2.2 
2015-047 Rhabdophis tigrinus Nachikatsuura, Wakayama F 48 566 701 0.149 M/g OB 4.8 0.8 
2015-068 Rhabdophis tigrinus Hikawa, Shimane F 100 774 974 0.149 M/g OB 10 1.667 
2015-046 Rhabdophis tigrinus Nachikatsuura, Wakayama F 122 794 1031 0.149 M/g OB 12.2 2.033 
2015-052 Rhabdophis tigrinus Nachikatsuura, Wakayama F 140 798 1038 0.149 M/g OB 14 2.333 
2015-053 Rhabdophis tigrinus Nachikatsuura, Wakayama M 118 655 902 0.149 M/g OB 11.8 1.967 
2015-051 Rhabdophis tigrinus Nachikatsuura, Wakayama M 45 528 732 0.149 M/g OB 4.5 0.75 
2015-084 Rhabdophis tigrinus Tauta, Kyoto F 130 72.3 90.2 5% DMSO Control - 0.433 
2015-011 Rhabdophis tigrinus Tsuyama, Okayama F 120 55.7 67.7 5% DMSO Control - 0.4 
2015-029 Rhabdophis tigrinus Tsuyama, Okayama F 75 71.1 89.9 5% DMSO Control - 0.25 
2015-015 Rhabdophis tigrinus Tsuyama, Okayama F 41 22.2 41 5% DMSO Control - 0.137 
2015-003 Rhabdophis tigrinus Sakyo Kyoto F 180 89.4 110.1 5% DMSO Control - 0.6 
2015-085 Rhabdophis tigrinus Tauta, Kyoto M 90 77.8 92.8 5% DMSO Control - 0.3 
BR6 Thamnophis sirtalis Cache Co., Utah M 32 47 64 0.149 M/g GB 3.195 1.065 
BR12 Thamnophis sirtalis Cache Co., Utah M 18 40 56 0.149 M/g GB 1.79 0.298 
BR16 Thamnophis sirtalis Cache Co., Utah M 19 42 58 0.149 M/g GB 1.85 0.308 
1192 Thamnophis sirtalis Cache Co., Utah M 52 520 750 0.149 M/g GB 5.237 0.873 
1188 Thamnophis sirtalis Cache Co., Utah M 39 470 610 0.149 M/g GB 3.85 0.642 
1181 Thamnophis sirtalis Cache Co., Utah F 146 680 810 0.149 M/g OB 14.58 2.43 
BR3 Thamnophis sirtalis Cache Co., Utah M 48 51 69 0.149 M/g OB 4.82 0.803 
1
2
3
 
1
4
9
 
1
2
3
 
1
2
3
 
1
2
3
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(Table 6-1 continued.) 
 
1189 Thamnophis sirtalis Cache Co., Utah M 35 440 600 0.149 M/g OB 3.47 0.578 
BR1 Thamnophis sirtalis Cache Co., Utah M 30 47 63 5% DMSO Control - 0.1 
BR9 Thamnophis sirtalis Cache Co., Utah M 23 43 60 5% DMSO Control - 0.077 
BR14 Thamnophis sirtalis Cache Co., Utah M 22 41 55 5% DMSO Control - 0.075 
BR20 Thamnophis sirtalis Cache Co., Utah M 20 41 55 5% DMSO Control - 0.068 
1
5
0
 
1
2
3
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Table 6-2. Summary of repeated measures ANOVA results and contrast comparisons 
for the analysis of OB and GB effects on heart rate. Factors and interactions of factors 
that had significant effects on heart rate are bolded. Contrast comparisons that were 
significantly different are also bolded. P-values for contrast comparisons were adjusted 
using Holm-Bonferroni corrections. 
 
Effect Tests df F ratio p-value 
mass 1, 20 2.4403 0.1341 
species 
treatment 
1, 26 
2, 30 
20.9044 
0.3765 
0.0001 
0.6894 
injection time 2, 2508 4.6285 0.0315 
time 1, 2507 37.1572 <0.0001 
species*treatment 2, 30 8.1965 0.0015 
species*injection time 1, 2508 7.5822 0.0059 
treatment*injection time 2, 2508 4.5922 0.0102 
species*time 1, 2507 0.0057 0.9400 
treatment*time 2, 2507 2.3707 0.0936 
injection time*time 1, 2507 0.5514 0.4578 
species*treatment*injection time 2, 2508 2.8205 0.0598 
species*treatment*time 2, 2507 0.6430 0.5258 
species*injection time*time 1, 2507 3.4647 0.0628 
treatment*injection time*time 2, 2507 7.3820 0.0006 
species*treatment*injection time*time 2, 2507 2.4033 0.0906 
 
      
Contrasts adjusted p-value     
T. sirtalis – control vs. OB 0.1181     
T. sirtalis – control vs. GB 0.1002     
R. tigrinus – control vs. OB 0.0056     
R. tigrinus – control vs. GB 0.0186     
T. sirtalis control – pre vs. post-injection 1.0000     
T. sirtalis OB – pre vs. post-injection 0.1980     
T. sirtalis GB – pre vs. post-injection 0.0160     
R. tigrinus control – pre vs. post-injection 1.0000     
R. tigrinus OB – pre vs. post-injection 0.0012     
R. tigrinus GB – pre vs. post-injection 0.1688     
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Table 6-3. Summary of best-fitting (ΔAIC = 1902) random coefficient model. 
Regression coefficient for intercept represents the average heart rate (bpm) of a 
Rhabdophis tigrinus of average mass in the control treatment at time 0. The model 
includes random effects for time (SD = 2.52), nested within snake ID (SD = 4.39), nested 
within species (SD = 4.39; residual variance = 1.68). Factors and interactions of factors 
that had significant effects on heart rate are bolded. 
 
 
 
Term 
Regression 
coefficient S.E. df t-value p-value 
intercept 64.89 0.84 2440 77.17 <0.0001 
time -0.06 0.01 99 -4.80 <0.0001 
GB -9.23 0.91 2440 -10.13 <0.0001 
OB -7.58 0.75 2440 -10.17 <0.0001 
T. sirtalis -23.01 0.89 2440 -25.77 <0.0001 
mass (g) -0.05 0.00 2440 -12.40 <0.0001 
time*GB -0.02 0.02 2440 -1.14 0.25 
time*OB -0.02 0.01 2440 -1.78 0.08 
time*T. sirtalis 0.01 0.01 2440 0.39 0.69 
GB*T. sirtalis 18.38 1.26 2440 14.59 <0.0001 
OB*T. sirtalis 15.52 1.37 2440 11.34 <0.0001 
time*GB*T. sirtalis -0.10 0.02 2440 -4.53 <0.0001 
time*OB*T. sirtalis 0.10 0.03 2440 3.59 0.0003 
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Figure 6-1. Mean post-injection heart rates over time of Thamnophis sirtalis in response 
to (A) control (5% DSMO; n = 4), (B) ouabain (n = 3), and (C) gamabufotalin (n = 6) 
injections. Mean baseline heart rate for each treatment (A-C) is represented by a red, 
dotted line. Minutes 21-28 represent the time immediately after snakes received treatment 
injections and are typically followed by an increase in heart rate as a response to the 
physical handling involved with the injection. Error bars represent standard error (± 1). 
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Figure 6-2. Mean post-injection heart rates over time of Rhabdophis tigrinus in response 
to (A) control (5% DSMO; n = 6), (B) ouabain (n = 6), and (C) gamabufotalin (n = 3) 
injections. Mean baseline heart rate for each treatment (A-C) is represented by a red, 
dotted line. Minutes 21-28 represent the time immediately after snakes received treatment 
injection and are typically followed by an increase in heart rate as a response to the 
physical handling involved with the injection. Error bars represent standard error (± 1). 
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DISCUSSION 
 The molecular mechanisms and evolutionary origins of cardiotonic steroid 
resistance among organisms have been, and continue to be, widely investigated (Dobler 
et al., 2012; Zhen et al., 2012; Ujvari et al., 2013; Dalla et al., 2013; Ujvari et al., 2015; 
Aardema and Andolfatto, 2016; Pierce et al., 2016; Mohammadi et al., 2016). Although 
physiological investigations of insects have revealed resistance-complementing functions, 
such as detoxification and compartmentalization of ingested toxins (Scudder and 
Meredith, 1982; Despres et al., 2007; Petschenka et al., 2013a; Petschenka et al., 2013b; 
Bramer et al., 2016), such studies are lacking in vertebrate systems. This study provides 
important insight into the physiology of cardiotonic steroid-resistant vertebrates. We have 
found that exposure to GB does not significantly affect the heart rate of R. tigrinus but 
causes a significant depression in heart rate of T. sirtalis. Exposure to OB caused 
significant changes in heart rate in both species (Figs. 6-1B and 6-2B). However, 
behavioral responses, including frequent body movements, prevented us from obtaining 
consistent post-injection heart rate measurements in OB-exposed T. sirtalis. We therefore 
acknowledge that our conclusions regarding OB-exposed T. sirtalis are based upon 
limited data. Additional study using wireless ECG system would be informative. 
Although the experimental constraints precluded a robust statistical comparison, we 
nevertheless observed a pattern of strong variation in heart rate and behavioral distress. 
This finding aligns with those of Mohammadi et al. (2017b), who showed that snakes of 
the genus Thamnophis had a significantly higher stress response (as measured by 
corticosterone) to OB exposure than to GB exposure. Mohammadi et al. (2017b) further 
showed that high stress response did not occur in R. tigrinus exposed to either of the two 
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toxins. Although we observed a statistically significant overall decrease in heart rate 
of R. tigrinus exposed to OB, there was no significant change in heart rate when exposed 
to GB (Fig. 6-2B and 6-2C). Conversely, T. sirtalis experienced a significant decrease in 
heart rate when exposed to GB (Fig. 6-1C). 
Licht and Low (1968) conducted a similar experiment with T. sirtalis, using orally 
administered crude parotoid gland secretion from cane toads (Rhinella marina). Their 
results showed that at low doses (3 mg/g body mass and 10 mg/g body mass), the heart 
rate of T. sirtalis generally increased. At the highest dose (20 mg/g body mass) the heart 
rate increased, and then the snake died. Key differences in experimental procedures make 
comparison of our results with those of Licht and Low (1968) difficult. First, the exact 
composition of BDs and other compounds in the crude parotoid secretions was unknown. 
Furthermore, the highest dose administered far exceeded the amount that could be 
collected from a single toad and therefore represented a much higher dose than any snake 
would normally ingest at one time. Finally, we do not yet know how uptake of 
cardiotonic steroids differs between oral and intraperitoneal administration. The toxicity 
of a compound can vary between these two delivery routes, depending on the compound. 
Some are more toxic when ingested, whereas others are more toxic when administered by 
intraperitoneal injection (Stump et al., 1999; Abdel-Barry and Hakiem, 2000; Aune et al., 
2002). 
 R. tigrinus sequesters dietary BDs in specialized defensive glands (Hutchinson et 
al., 2007; Mori et al., 2012). These snakes possess enlarged adrenal glands and produce 
high levels of aldosterone, a hormone secreted by the adrenal glands that signals the 
expression of Na
+
/K
+
-ATPases (Ikeda et al., 1991; Mohammadi et al., 2013; Mohammadi 
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et al., 2017a). It is therefore conceivable that R. tigrinus possesses physiological 
mechanisms that help it better deal with chronic exposure to the toxins. Although adrenal 
enlargement and increased adrenal hormone production suggest the possible existence of 
such mechanisms, further research is needed to elucidate what those mechanisms may be. 
 Both CDs and BDs have similar modes of action, although BDs are often 
considered more toxic. In a review of human case reports, Barrueto et al. (2006) found 
that out of 924 individuals reported to have ingested cardiotonic steroids, the mortality 
rate for CD ingestion was 6%, whereas that for BD ingestion was 29.6%. However, these 
data were compiled from individual case reports that did not address such variables as 
dose or body absorbance rates. Furthermore, BDs are most commonly ingested by 
humans in the form of Chan Su, a traditional Chinese medicinal tea stone whose BD 
concentration is not readily controlled (Chan et al., 1995; Ma et al., 2012; Barrueto et al., 
2006). Differences in the form in which BDs and CDs are administered in traditional 
medicine may therefore influence their perceived toxicities.  
 Studies on the physiological effects of specific cardiotonic steroids in mammals 
have revealed that CDs generally cause depression of heart rate, whereas BDs cause an 
increase (reviewed in Dvela et al., 2007). However, these effects are more compound-
specific than they are class-specific. For example, the CD ouabain and the BD bufalin 
both shorten the duration of the action potential of a cardiac contraction, whereas the CD 
digoxin does not have this effect (Kieval et al., 1988; Ruch et al., 2003; Dvela et al., 
2007). The only established cellular receptor for cardiotonic steroids is the α-subunit of 
the Na
+
/K
+
-ATPase (Krenn and Kopp, 1998; Barrueto et al., 2006; Dvela et al., 2007). 
Differences in the physiological effects of various cardiotonic steroids are therefore most 
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likely explained by the way differing molecular structures affect the toxins’ binding 
characteristics. Furthermore, the structure and distribution of various α-isoforms will also 
influence the physiological response. Therefore, a multitude of pathways can influence 
the biological responses of various cardiotonic steroids. We do not yet know the relative 
distribution of α-isoforms in snakes, with the exception of α-3, which contains resistance-
conferring mutations in some species and is expressed at significantly higher levels in the 
heart than any other tissue (Mohammadi et al., 2017b). However, α-1 and α-2 remain to 
be investigated in snakes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 159 
References 
Aardema ML, Andolfatto P. 2016. Phylogenetic incongruence and the evolutionary 
origins of cardenolide‐resistant forms of Na+, K+‐ATPase in Danaus butterflies. 
Evolution. 70:1913–1921 
 
Abdel-Barry JA, Al-Hakiem MH. 2000. Acute intraperitoneal and oral toxicity of the leaf 
glycosidic extract of Trigonella foenum-graecum in mice. J Ethnopharm 70:65–68. 
Arnold SJ. 1978. Some effects of early experience on feeding responses in the common 
garter snake, Thamnophis sirtalis. Anim Behav 26:455–462. 
Aune T, Sørby R, Yasumoto T, Ramstad H, Landsverk T. 2002. Comparison of oral and 
intraperitoneal toxicity of yessotoxin towards mice. Toxicon 40:77–82. 
Barrueto F, Kirrane BM, Cotter BW, Hoffman RS, Nelson LS. 2006. Cardioactive steroid 
poisoning: a comparison of plant-and animal-derived compounds. J Med Toxicol 
2:152–155. 
Barry WH, Bridge JH. 1993. Intracellular calcium homeostasis in cardiac myocytes. 
Circulation 87:1806–1815. 
Bliese PD, Ployhart RE. 2002. Growth modeling using random coefficient models: 
Model building, testing, and illustrations. Organiz Res Meth 5:362–387. 
Bramer C, Friedrich F, Dobler S. 2016. Defense by plant toxins in milkweed bugs 
(Heteroptera: Lygaeinae) through the evolution of a sophisticated storage 
compartment. System Entomol 42:15–30. 
Chan WY, Ng TB, Yeung HW. 1995. Examination for toxicity of a Chinese drug, the 
toad glandular secretory product chan su, in pregnant mice and embryos. 
Neonatology 67:376–380. 
Dalla S, Swarts HG, Koenderink JB, Dobler S. 2013. Amino acid substitutions of Na, K-
ATPase conferring decreased sensitivity to cardenolides in insects compared to 
mammals. Ins Biochem Mol Biol 43:1109–1115. 
Despres L, David J-P, Gallet C. 2007. The evolutionary ecology of insect resistance to 
plant chemicals. Trends Ecol Evol 22:298–307. 
Dmitrieva RI, Bagrov AY, Lalli E, Sassone-Corsi P, Stocco DM, Doris PA. 2000. 
Mammalian bufadienolide is synthesized from cholesterol in the adrenal cortex by a 
pathway that is independent of cholesterol side-chain cleavage. Hypertension 
36:442–448. 
 160 
Dobler S, Dalla S, Wagschal V, Agrawal AA. 2012. Community-wide convergent 
evolution in insect adaptation to toxic cardenolides by substitutions in the Na, K-
ATPase. Proc Natl Acad Sci USA 109:13040–13045. 
Dvela M, Rosen H, Feldmann T, Nesher M, Lichtstein D. 2007. Diverse biological 
responses to different cardiotonic steroids. Pathophysiology 14:159–166. 
Eisner T, Wiemer DF, Haynes LW, Meinwald J. 1978. Lucibufagins: defensive steroids 
from the fireflies Photinus ignitus and P. marginellus (Coleoptera: Lampyridae). 
Proc Natl Acad Sci USA 75:905–908. 
Gowda RM, Cohen RA, Khan IA. 2003. Toad venom poisoning: resemblance to digoxin 
toxicity and therapeutic implications. Heart 89:e14–e14. 
Gregory PT, Stewart KW. 1975. Long-distance dispersal and feeding strategy of the red-
sided garter snake (Thamnophis sirtalis parietalis) in the Interlake of Manitoba. Can 
J Zool 53:238–245. 
Gregory PT. 1978. Feeding habits and diet overlap of three species of garter snakes 
(Thamnophis) on Vancouver Island. Can J Zool 56:1967–1974. 
Hirai T. 2004. Dietary shifts of frog eating snakes in response to seasonal changes in prey 
availability. J Herpetol 38:455–460. 
Hutchinson DA, Mori A, Savitzky AH, Burghardt GM, Wu X, Meinwald J, Schroeder 
FC. 2007. Dietary sequestration of defensive steroids in nuchal glands of the Asian 
snake Rhabdophis tigrinus. Proc Natl Acad Sci USA 104:2265–2270. 
Ikeda U, Hyman R, Smith TW, Medford RM. 1991. Aldosterone-mediated regulation of 
Na+, K (+)-ATPase gene expression in adult and neonatal rat cardiocytes. J Biol 
Chem 266:12058–12066. 
Kephart DG, Arnold SJ. 1982. Garter snake diets in a fluctuating environment: a seven-
year study. Ecology:1232–1236. 
Kieval RS, Butler VP, Derguini F, Bruening RC, Rosen MR. 1988. Cellular 
electrophysiologic effects of vertebrate digitalis-like substances. J Amer Coll Cardiol 
11:637–643. 
Krenn L, Kopp B. 1998. Bufadienolides from animal and plant sources. Phytochemistry 
48:1–29. 
Licht LE, Low B. 1968. Cardiac response of snakes after ingestion of toad parotoid 
venom. Copeia 31:547–551 
 161 
Ma H, Zhou J, Jiang J, Duan J, Xu H, Tang Y, Lv G, Zhang J, Zhan Z, Ding A. 2012. 
The novel antidote Bezoar Bovis prevents the cardiotoxicity of Toad (Bufo bufo 
gargarizans Canto) Venom in mice. Exp Toxicol Pathol 64:417–423. 
Mijatovic T, Van Quaquebeke E, Delest B, Debeir O, Darro F, Kiss R. 2007. Cardiotonic 
steroids on the road to anti-cancer therapy. Bioch Biophys Acta (BBA)-Rev Cancer 
1776:32–57. 
Mohammadi S, Savitzky AH, Lohr J, Dobler S. 2017a. Mutations to the cardiotonic 
steroid binding site of Na+/K+-ATPase are associated with high level of resistance to 
gamabufotalin in a natricine snake. Gene 614:21–25. 
Mohammadi S, French SS, Neuman-Lee LA, Durham SL, Kojima Y, Mori A, Brodie ED 
Jr., Savitzky AH. 2017b. Corticosteroid responses of snakes to toxins from toads 
(bufadienolides) and plants (cardenolides) reflect differences in dietary 
specializations. Gen. Comp. Endocrin. In Press. 
Mohammadi S, Brodie ED Jr., Neuman-Lee LA, Savitzky AH. 2016a. Mutations to the 
cardiotonic steroid binding site of Na+/K+-ATPase are associated with high level of 
resistance to gamabufotalin in a natricine snake. Toxicon 114:13–15. 
Mohammadi S, Brodie ED Jr., Neuman-Lee LA, Savitzky AH. 2016b. Mutations to the 
cardiotonic steroid binding site of Na+/K+-ATPase are associated with high level of 
resistance to gamabufotalin in a natricine snake. Toxicon 114:13–5. 
Mohammadi S, McCoy KA, Hutchinson DA, Gauthier DT, Savitzky AH. 2013. 
Independently evolved toad-eating snakes exhibit sexually dimorphic enlargement of 
adrenal glands. J Zool 290:237–245. 
Mori A, Burghardt GM, Savitzky AH, Roberts KA, Hutchinson DA, Goris RC. 2012. 
Nuchal glands: a novel defensive system in snakes. Chemoecology 22:187–198. 
Petschenka G, Fandrich S, Sander N, Wagschal V, Boppré M, Dobler S. 2013a. Stepwise 
evolution of resistance to toxic cardenolides via genetic substitutions in the Na+/K+-
ATPase of milkweed butterflies (Lepidoptera: Danaini). Evolution 67:2753–2761. 
Petschenka G, Pick C, Wagschal V, Dobler S. 2013b. Functional evidence for 
physiological mechanisms to circumvent neurotoxicity of cardenolides in an adapted 
and a non-adapted hawk-moth species. Proc Biol Sci 280:20123089. 
Pierce AA, Roode JC, Tao L. 2016. Comparative genetics of Na+/K+‐ATPase in 
monarch butterfly populations with varying host plant toxicity. Biol J Linn Soc. 
119:194–200. 
Pinheiro JC, Bates DM. Theory and computational methods for linear mixed-effects 
models. Mixed-Effects Models in S and S-PLUS. 2000:57–96. 
 162 
Prassas I, Diamandis EP. 2008. Novel therapeutic applications of cardiac glycosides. 
Nat Rev Drug Disc 7:926–935. 
Rose AM, Valdes R. 1994. Understanding the sodium pump and its relevance to disease. 
Clin Chem 40:1674–1685. 
Ruch SR, Nishio M, Wasserstrom JA. 2003. Effect of cardiac glycosides on action 
potential characteristics and contractility in cat ventricular myocytes: role of calcium 
overload. J Pharmacol Exp Therap 307:419–428. 
Schoner W, Scheiner-Bobis G. 2007. Endogenous and exogenous cardiac glycosides and 
their mechanisms of action. Am J Cardiovasc Drugs 7:173–189. 
Schoner W. 2002. Endogenous cardiac glycosides, a new class of steroid hormones. Eur J 
Biochem 269:2440–2448. 
Scudder GGE, Meredith J. 1982. The permeability of the midgut of three insects to 
cardiac glycosides. J Ins Physiol 28:689–694. 
Shaikh IM, Lau BW, Siegfried BA, Valdes R. 1991. Isolation of digoxin-like 
immunoreactive factors from mammalian adrenal cortex. J Biol Chem 266:13672–
13678. 
Stump DG, Holson JF, Fleeman TL, Nemec MD, Farr CH. 1999. Comparative effects of 
single intraperitoneal or oral doses of sodium arsenate or arsenic trioxide during in 
utero development. Teratology 60:283–291. 
Tanaka K, Ota H. 2002. Natural history of two colubrid snakes, Elaphe quadrivirgata 
and Rhabdophis tigrinus, on Yakushima Island, southwestern Japan. Amphibia-
Reptilia 23:323–331. 
Team RC. 2013. R: A language and environment for statistical computing. 
Ujvari B, Casewell NR, Sunagar K, Arbuckle K, Wüster W, Lo N, O’Meally D, 
Beckmann C, King GF, Deplazes E. 2015. Widespread convergence in toxin 
resistance by predictable molecular evolution. Proc Natl Acad Sci USA 112:11911–
11916. 
Ujvari B, Mun H-C, Conigrave AD, Bray A, Osterkamp J, Halling P, Madsen T. 2013. 
Isolation breeds naivety: Island living robs Australian varanid lizards of toad-toxin 
immunity via four-base-pair mutation. Evolution 67:289–294. 
Yoshida S, Kamano Y, Sakai T. 1976. Studies on the surface anesthetic activity of 
bufadienolides isolated from Ch'an Su. Chem Pharma Bull 24:1714-1717. 
 
Zhen Y, Aardema ML, Medina EM, Schumer M, Andolfatto P. 2012. Parallel molecular 
evolution in an herbivore community. Science 337:1634–1637. 
 163 
 CHAPTER 7 
CONCLUSION kk 
 
 
 The preceding five chapters provide evidence that target-site insensitivity of the 
Na+/K+-ATPase (NKA) is necessary to survive acute toxicity of bufadienolides but it is 
not sufficient to explain all physiological mechanisms involved in tolerance of the toxins 
on a chronic basis. A broad survey of NKA genes in diverse lineages of snakes revealed 
that genetic resistance to bufadienolides is widespread among snakes, especially in the 
natricine and dipsadine lineages, which are almost entirely composed of resistant taxa. 
However, many species that exhibit molecular resistance are not, in fact, predators of 
toads, revealing that bufophagy and resistance to bufadienolides are not tightly coupled, 
contrary to the conclusions of previous studies. 
 A closer look at the tissue-specific distribution of sensitivity to the toxins in 
resistant species revealed that there is variation in different organs. Whereas the heart and 
kidneys are highly resistant, the brain, liver, and gut are sensitive. Organ-specific 
variation in bufadienolide sensitivity of resistant snakes suggests that there may be 
physiological mechanisms that offset the need for resistance in the sensitive organs. 
Indeed, the blood-brain barrier of snakes prevents ingested toxins from reaching the 
brain, which may explains the lack of resistance in that tissue. However, the mechanisms 
responsible for reduced resistance in the gut and liver remain to be elucidated. 
 Measurements of gene expression levels of ATP1a3 mRNA, the NKA α-subunit 
paralog with resistance-conferring mutations, have revealed that the heart expresses 
significantly higher levels than any other tissue. Conversely, gut and kidney expressed 
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relatively low levels of ATP1a3 mRNA, and the liver expressed almost undetectable 
levels. Furthermore, heart was the only tissue that significantly upregulated expression of 
ATP1a3 in response to a snake’s exposure to a bufadienolide. These results mirror those 
of the tissue-sensitivity assay, except in the case of kidney, which showed high resistance 
in the sensitivity assay, but low ATP1a3 mRNA expression. It is possible that the kidneys 
express an alternate paralog of the NKA, one that might also carry resistance-conferring 
mutations. Although snakes possess three paralogs of the NKA α-subunit, including 
ATP1a1, ATP1a2, and ATP1a3, only one (ATP1a3) has been investigated. Future 
research should investigate the sequences of ATP1a1 and ATP1a2 and determine their 
tissue-specific expression levels. 
 Investigations of select physiological responses to cardiotonic steroid exposure 
have revealed evidence that bufophagy is accompanied with negative physiological 
consequences and that toad-specialized resistant species respond differently from 
nontoad-specialized but resistant species. The presence of physiological consequences of 
bufophagy could explain why it was secondarily lost in many lineages of snakes that 
retained resistance-conferring mutations. Testing the effects of cardiotonic steroids on 
heart rates in Rhabdophis tigrinus and Thamnophis sirtalis revealed strong fluctuations of 
heart rate in the former and significant depression of heart rate in the latter. These species 
differ in the amount of bufadienolides they encounter in their natural diets. Whereas R. 
tigrinus feeds regularly on toads and sequesters bufadienolides in its specialized nuchal 
glands, T. sirtalis does not often feed on toads. It is possible that a high degree of dietary 
specialization on toads is associated with differing physiological mechanisms for dealing 
with chronic exposure to the toxins, which might explain the difference in heart rate 
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responses observed between the two species. However, in order to confirm these 
associations, further replication through testing of additional, phylogenetically 
independent species is required. 
 Testing the effects of cardiotonic steroid exposure on the adrenal hormone 
responses of select snakes revealed that R. tigrinus possesses a strong aldosterone 
response. Because aldosterone acts in part as a signal for the expression of NKA, it is 
possible that these snakes produce high levels of the hormone to counteract the negative 
effects of chronic bufadienolide exposure. By increasing the number of resistant NKAs in 
certain tissues that receive high exposure to ingested bufadienolides, a snake may 
increase protection of that tissue. Future research should test the effects of aldosterone 
exposure on snakes’ NKA (ATP1a3) gene expression to confirm this hypothesis. Testing 
the effects of cardiotonic steroids on the hormonal response of snakes also revealed that 
snakes of the genus Thamnophis have a significantly elevated stress response to a 
cardenolide, whereas they did not have that response when exposed to a bufadienolide. 
This suggests that the two classes of cardiotonic steroids have differing effects on the 
physiologies of these snakes, and it is interesting that we do not see the same pattern of 
responses in R. tigrinus, which did not exhibit a significant stress response to either toxin. 
Overall, the hormonal responses further indicate that the physiological mechanisms 
involved in dealing with the toxins differs between snakes that are adapted to feed 
regularly on toads and those that are resistant to, but do not feed regularly on, such toxic 
prey. 
 The studies comprising this dissertation provide an initial view of a complex 
adaptation. Although they advance our understanding of the mechanisms underlying 
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some of snakes’ physiological capacity to consume toads, expansion of these studies, 
compare a greater diversity of species, will be necessary to explain many of the newly 
discovered patterns.  
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        States, Canada, and Northern Mexico Volume 2: Crotalus. Copeia. 2013:177-182. 
 
Manuscripts in preparation 
 
Mohammadi, S., G. Petschenka, A. Mori, Susannah S. French, and A.H. Savitzky. In prep. 
Tissue-specific variation in cardiotonic steroid sensitivity of Na+/K+-ATPase. Target journal: 
Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology. 
 
Mohammadi, S., T. Eggertsen*, N. Aardema*, Y. Kojima, A. Mori, D.A. Hutchinson, and A.H. 
Savitzky. In prep. Exposure to cardiac glycosides decreases cardiac contractility in snakes that 
possess resistance-conferring mutations of Na+/K+-ATPase. Target journal: Journal of 
Experimental Zoology. 
 
Hill, J.G, S. Mohammadi, B.M. Kluever, T. Tamashiro*, D. Bagsby*, Y. Amano*, D.R. Karns, 
K.Thirakupt. and H.K. Voris. In prep. Natural history of the big eyed pit viper (Cryptelytrops 
macrops): a tropical, arboreal pitviper, in northeast Thailand. Target journal: Copeia. 
 
Fellowships, Grants, and Awards       Total = $66,538 
 
2016        Utah State University, Department of Biology Doctoral Researcher of the Year 
2016        ASIH Clark Hubbs Travel Award ($600) 
2016        USU RGS Dissertation Enhancement Grant ($9,448) 
2015        USU College of Science ZoBell Scholarship for academic achievement ($1,000) 
2015        Joseph E. Greaves Scholarship in Biology ($15,000) 
2015        USU Ecology Center Graduate Research Award ($3,800) 
2015        NSF East Asia and Pacific Summer Institute Fellowship ($10,000) 
2014        USU Ecology Center Travel Award ($500) 
2014        USU Center for Women and Gender Travel Award ($500) 
2014        ASIH Clark Hubbs Travel Award ($300) 
2014        International Society of Chemical Ecology Student Presentation Award ($300) 
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2014        USU Ecology Center Graduate Research Award ($2,000) 
2013        Hansen Life Science Retreat Outstanding Poster Presentation Award ($50) 
2013        USU Graduate Enhancement Award ($4,000) 
2012        USU Research and Projects Grant ($1,000) 
2012        USU Center for Women and Gender Research Grant ($500) 
2012        SICB Grants-in-aid of Research ($1,000) 
2011        Smithsonian Encyclopedia of Life Rubenstein Fellowship ($8,000)  
2011        Virginia S. Bagley Scholarship ($8,500) 
  
Teaching Experience                 
 
Courses taught as Instructor 
Non-majors General Biology Lecture – Utah State University         Spring 2017 
Herpetology Lab – Utah State University                2014-2015 
Human Physiology Lab – Utah State University                              2015 
 
Guest lectures 
Human Physiology (cardiovascular physiology) – Utah State University          2014-2016 
Comparative Animal Physiology Lab (snake physiology) – Utah State University      2015 
Herpetology (snake evolution and radiation) – Utah State University        2015 
Biology (evolution of dinosaurs) – Venture Academy (high school)       2014 
Evolution (snake evolution and phylogenetics) – Old Dominion University       2010 
Ecology (frog diversity in Costa Rica) – Northern VA Community College      2006 
 
Courses taught as Graduate Teaching Assistant 
Human Physiology Lab – Utah State University              2013-2016 
Evolutionary Biology (science writing) – Utah State University           2012-2016 
Human Anatomy Lab – Utah State University                          2012-2013 
General Biology Lab - Utah State University                      2011 
 
 
Mentoring Experience 
 
Mentored 11 undergraduates and 1 high school student 
 Includes 7 women and 4 under-represented minority students  
  
Old Dominion University: Sarah Barns☥, Lucille Brunner, Donna Bucci, Amanda Bieber, 
Mandy Pearson, Marjorie Tabango, Michael Graham 
 
Utah State University: Jonathan Gonzalez*✦☥, Dylan Bills*, Taylor Eggerston*, Niklas 
Ardema*, Savannah Knight (high school student) 
 
*student presented or published their work  ✦student acquired funding of their own  ☥student 
went on to (or plans to go on to) graduate school 
 
Professional Societies, Workshops, and Training 
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Societies (within last 5 years): International Society of Chemical Ecology, American Society 
of Ichthyologists and Herpetologists, Society of Integrative and Comparative Biology, Society for 
the Study of Evolution. 
Workshops: “How Can I Improve My Teaching Technique” (2016), USU Radiation Safety 
Training (2013-2015), Agilent Technologies HPLC Master Class (2014), Getting Started as a 
Successful Proposal Writer and Academician (2014), Quartzy Lab Management System (2014), 
Social Media and Academia Applications (2014), College Teaching Seminar (2011). 
 
Notable Field Work 
 
Kyoto Prefecture, Japan                    June-Aug 2015 
 Project: Physiological mechanisms of toad toxin resistance in Rhabdophis tigrinus. 
 Principal Investigators: Alan H. Savitkzy, Akira Mori 
Sakaerat Biosphere Reserve, Nakon Ratchasima, Thailand                May-Aug 2007
 Project: Ecology and thermal biology of the big-eyed pit viper (Trimeresurus macrops) 
 Principal Investigators: Harold K. Voris, Jacques G. Hill 
Braulio Carrillo National Park, Costa Rica         Dec-Jan 2005
 Project: Survey frog populations and collect specimens for the US National Museum 
 amphibian and reptile collection. 
 Principal Investigator: myself 
Braulio Carrillo National Park, Costa Rica            Dec-Jan 2003
 Project: Insect diversity study for the Smithsonian Arthropods of La Selva (ALAS)  
 project.  
             Principal Investigators: David G. Furth 
 
Professional Presentations and Seminars                                            * poster  ** invited talk 
 
2016** Mohammadi, S. Molecular and physiological mechanisms of toxin  
         resistance in snakes. Department of Biology, Whitman College, Walla Walla, WA.  
         [Departmental seminar] 
 
2016** Mohammadi, S. Molecular mechanisms and physiological consequences of toxin  
         resistance in snakes. Department of Zoology, Universitàt Hamburg. Hamburg, Germany.  
        [Departmental seminar] 
 
2016** Mohammadi, S. Molecular mechanisms and physiological consequences of toxin  
          resistance in snakes. Department of Biology, Georgia Southwestern State University,  
         Americus, GA. [Departmental seminar] 
 
2015*  Gonzalez, J., S. Mohammadi, and A.H. Savitzky. The molecular basis for bufadienolide  
        resistance in toad-eating snakes. Society for Advancing Chicanos/Hispanics and Native  
        Americans in Science National Conference. Washington, DC. [National STEM promotion- 
        focused scientific meeting] 
 
2015*  Mohammadi, S., A.H. Savitzky ,G. Petschenka, and J. Gonzalez. Tissue-specific     
         sensitivity to cardiotonic steroids in resistant and non-resistant snakes. Hansen Life   
          Science Retreat. Logan, UT. [Local biochemical scientific meeting] 
 
2015** Mohammadi, S. The evolution of bufadienolide resistance in snakes. Department of  
           Zoology, Kyoto University. Sakyo, Kyoto, Japan. [Departmental seminar] 
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2014*   Mohammadi, S., A.H. Savitzky ,G. Petschenka, and J. Gonzalez. Tissue-specific     
         sensitivity to cardiotonic steroids in resistant and non-resistant snakes. Hansen Life   
          Science Retreat. Logan, UT. [Local biochemical scientific meeting] 
 
2014    Mohammadi, S., A.H. Savitzky, L. Neuman-Lee, and G. Petschenka. Molecular and  
          physiological mechanisms of bufadienolide-resistance in Toad-Eating Snakes. JMIH.  
             Chattanooga, TN. [National scientific meeting] 
 
2014** Mohammadi, S., A.H. Savitzky, and G. Petschenka. Molecular and Physiological  
         Mechanisms of Bufadienolide-resistance in toad-eating snakes. International Society of 
         Chemical Ecology Annual Meeting. Champaign-Urbana, IL. [International scientific  
         meeting] 
 
2013*  Mohammadi, S., D. Springthorpe, D. Bills, and A.H. Savitzky. A miniature transmitter  
         for recording cardiac function in reptiles. Hansen Life Science Retreat. Logan, UT. [Local  
        biochemical scientific meeting] 
 
2012*   Mohammadi, S., A. Mori, D.A. Hutchinson, and A.H. Savitzky. The evolution of toxin  
             resistance in toad-eating snakes. World Congress of Herpetology. Vancouver, Canada.  
         [International scientific meeting] 
 
2010     Mohammadi, S., A.H. Savitzky, and K.A. McCoy. A comparison of adrenal glands in  
             toad eating and non-toad eating snakes. JMIH. Providence, RI. [National scientific  
             meeting] 
 
2010     Hill, J.G., D.S. McLeod, K.M. Hesed, S. Mohammadi, T. Artchawakom. Herpetofaunal  
             diversity at Sakaerat Environmental Research Station, northeast Thailand: revisiting a  
             historically important site. JMIH. Providence, RI. [National scientific meeting] 
 
2009*   Mohammadi, S., K.A. McCoy, A.H. Savitzky. A comparison of adrenal glands in toad  
             eating and non-toad eating snakes. JMIH. Portland, OR. [National scientific meeting] 
 
Professional Services 
 
2015-present Science Advisory Board, Bioinformatics LLC member 
2014-present ASIH Web Content Committee member 
2014-present ASIH Long Range Planning Committee member 
2016  USU Department of Biology and Ecology Center Candidate Search Committee 
2014-2015 USU Biology Graduate Student Silent Auction organizer 
2014-2015 USU Biology Graduate Student Plant Sale organizer 
2014-2016  ASIH Centennial Planning Committee member 
2014-2015 USU Graduate Student Fundraising Committee chair 
2014  ASIH Graduate Student Committee chair 
2013  ASIH Graduate Student Committee chair-elect 
2012  USU Biology Graduate Student Association president 
2011  USU Biology Graduate Student Association vice president 
2011  ASIH Graduate Student Workshop  Committee co-organizer 
2010  Encyclopedia of Life online snakes and lizards curator 
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2009  ASIH Graduate Student Workshop organizer 
Reviewer for: Asian Herpetological Research 
 
 
Press 
 
2016   NSF - https://nsf.gov/news/news_summ.jsp?cntn_id=190535&org=NSF&from=news   
2016   AAAS Eureka Alert! - https://www.eurekalert.org/pub_releases/2016-11/usu-
fwf112216.php   
2016   ScienceDaily.com - https://www.sciencedaily.com/releases/2016/11/161122193506.htm    
2016   Phys.org - http://phys.org/news/2016-11-feast-scientist-snake-species-resist.html  
2016   Utah State Today - http://www.usu.edu/today/index.cfm?id=56330&nl=500  
2016   Utah Public Radio - http://upr.org/post/snakes-resist-toad-toxin  
 
Outreach and Volunteer Work 
 
My public outreach efforts involve exhibiting live animals and demonstrating research materials 
to the general public with the aim of increasing science de-mystification and bridging the gap 
between scientists and the public. 
2016     USU “Science Unwrapped” public outreach, Logan UT (400+ visitors) 
2015     USU “Science Unwrapped” public outreach, Logan UT (300+ visitors) 
2014     USU “Science Unwrapped” public outreach, Logan UT (350+ visitors) 
2014     Venture Academy student outreach presentation, Ogden UT (20+ students) 
2014     Thomas Edison Charter School science fair judge, Logan UT (50+ entries) 
2013     Bear River M. Bird Refuge “Sense of Wonder Day”, Brigham City, UT (300+ visitors) 
2013     Edith Bowen School Science Night public outreach, Logan UT (200+ visitors) 
2011     USU “Science Unwrapped” public outreach, Logan UT (400+ visitors) 
2011     Smithsonian NMNH “The Scientist Is In” public outreach, Washington DC (350 visitors) 
2007     Public school outreach tour about local herpetofauna, Thailand (500+ students) 
2006     Clearing and staining specimen demonstration, Smithsonian NMNH (20 summer 
interns) 
 
Languages 
 
English (fluent) 
Farsi (fluent) 
French (fluent)  
